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The World Health Organization (WHO) reports that 2.1 billion people worldwide lack 
access to safely-managed water sources.  Sand filtration at point-of-use is widely used but does 
not meet WHO performance targets to reduce virus and bacteria levels in drinking water.  This 
research evaluated chitosan, an organic coagulant-flocculant, to improve microbial and turbidity 
reductions by sand filtration.  Bench-scale 3.9-cm diameter intermittently-operated slow sand 
column filters with 16-cm sand layers of two different grain sizes were dosed daily over 57-days 
with microbially-spiked surface water volumes corresponding to daily household use.  E. coli 
bacteria and MS2 coliphage virus reductions were quantified biweekly using culture methods.  
Bacteria and virus reductions were significantly improved at optimal chitosan doses of 10 and 30 
mg/L (Wilcoxon Rank-Sum, p < 0.05), and achieved log10 reductions meeting 2-star WHO 
performance levels.  Microbial and turbidity reductions generally improved over filter operating 
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CHAPTER 1: INTRODUCTION 
 
1.1 Background and Significance 
 
1.1.1 Safe Drinking Water 
 
Clean and safe water is vital to lead a healthy, productive life; however, an estimated 2.1 
billion people worldwide are at risk of harmful waterborne diseases due to fecal contamination of 
drinking water sources and supplies (WHO & UNICEF, 2017). Diarrheal diseases associated 
with water, sanitation and hygiene (WaSH) conditions are responsible for over 840,000 deaths in 
low and middle income countries (LMICs) each year, of which approximately 360,000 deaths 
are children under the age of five (WHO, 2014).  Waterborne diseases linked to fecal 
contamination include diarrhea, cholera, dysentery, typhoid, poliomyelitis and other enteroviral 
diseases, infectious hepatitis due to hepatitis A and E viruses, and respiratory illnesses.  The four 
pathogens attributable to the majority of cases of diarrheal illness in children are rotavirus, 
Cryptosporidium, enterotoxigenic Escherichia coli, and Shigella (Kotloff et al., 2013).  Possible 
sources of drinking water contamination include improper human excreta and sewage 
management, ineffective sewage treatment, agricultural waste runoff, inadequate water treatment 
systems, deteriorating water distribution and storage systems and poor hygiene practices in water 
management.  
In 2002, the 2015 Millennium Development Goal Target 7c was established and marked 
the first global effort to expand access to WaSH services, specifically aiming to halve the 
number of people without access to basic services by 2015, including improved drinking water.  
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This initial target served as the predecessor for the newly established and better 
articulated 2030 Sustainable Development Goal 6, which broadly aims to “ensure availability 
and sustainable management of water and sanitation for all.” These international agendas serve 
to stimulate action and momentum for progress in WaSH coverage and raise the political stakes 
for the international community to address these persistent and difficult problems.  Targets 6.1 
and 6.2 of SDG 6 focus on expanding access to safe water services.  Water services are 
characterized by safety, access and availability and fall into five general categories of access and 
coverage: safely managed, basic, limited, unimproved and surface water.  Safely managed 
services must be improved water sources, contamination-free, accessible on premises and at all 
times.  Improved water sources are piped supplies to homes or public standpipes or non-piped 
supplies, including protected wells and springs, boreholes, packaged water or rainwater 
collection systems.  Basic services are considered improved sources accessible within a 30-
minute round trip.  Limited services are improved sources that take greater than 30 minutes to 
collect water and return home.  Unimproved services do not meet any of the aforementioned 
criteria and include unprotected wells and springs.  Finally, the surface water service level is 
defined as the use of any open body of water as a primary water source.  Though 89% of the 
global population has access to at least basic drinking water services, 844 million people still 
depend on limited or unimproved drinking water sources for their daily water needs.  Within this 
vulnerable group, over 150 million people rely on untreated surface water sources (WHO & 
UNICEF, 2017).  
Residents in rural areas and in LMICs are particularly susceptible to contracting 
waterborne diseases due to the lack of improved water services, functional and effective water 
treatment systems, and inadequate waste collection and management practices.  As of 2015, the 
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global proportion of urban residents with access to safely managed water services exceeded 85%, 
compared to 55% for rural residents.  In the least developed countries, only 53% of the urban 
population and 25% of the rural population use safely managed services, or 33% of the total 
population.  This is far lower than the estimated 94% of the total population using safely 
managed drinking water services in North America and Europe.  The 2.1 billion people that lack 
access to safely managed services, including the 1.3 billion people using basic services, are at 
risk of harmful waterborne diseases due to substantial fecal contamination of both improved and 
unimproved water sources (WHO & UNICEF, 2017).  Furthermore, the proportion of the global 
population living in urban areas is expected to grow from 55% as of 2018 to 68% in 2050 
(DESA & UN, 2018).  This shift in population dynamics may put increased strain on outdated 
and deteriorating water distribution systems in urban areas. 
Although access to improved water sources is expanding globally, access alone does not 
mean the absence of a health risk.  Fecal contamination of improved sources or the containers in 
which the water from these sources is stored is widespread and highly variable between source 
and location.  Therefore, access to improved sources cannot be used as a proxy for access to safe 
water (Bain et al., 2014; Shaheed, Orgill, Montgomery, Jeuland, & Brown, 2014; Yang et al., 
2013).  Heitzinger et al. (2015) found that 90% of households studied in rural Peru had access to 
improved water sources, yet E. coli contamination was present in 47% of source water samples 
and 43% of stored water samples.  Onda et al. (2012) reported that in 2010, approximately 1 
billion of the 5.8 billion people with access to improved water sources were likely using 
contaminated water sources.  
According to a study by Macy and Quick (2002), approximately 30% of the global 
diarrheal disease burden may be attributable to drinking contaminated water sources.  Recurring 
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diarrheal disease from drinking contaminated water reduces productivity time for individuals and 
results in community-wide significant negative economic impacts.  It is estimated that 1.5 billion 
working days would be gained globally with universal basic access to water supply and 
sanitation with point of use (POU) water treatment (Hutton, Haller, & Bartram, 2007).  
Recurring WaSH-related illnesses negatively impacts growth and development of children.  
Globally, children miss over 440 million school days as a result of illness from WaSH related 
diseases (Moszynski, 2006).  Children under 5 would gain 6.8 billion healthy days due to averted 
cases of diarrhea with improved access to basic water supply and sanitation services coupled 
with POU treatment (Hutton et al., 2007).  In order to promote social and economic 
development, improvements to WaSH infrastructure, including the provision of high-quality 
drinking water, are needed.  
Concerns over microbially contaminated improved and unimproved water sources 
illustrate a need for further water treatment to ensure water safety.  While large-scale and well-
managed treatment systems are a preferred approach to provide access to sources of safe water, 
these systems require technical expertise and costly resources to build and maintain, therefore 
they are often inaccessible to rural and disadvantaged populations.  International funding is 
limited so implementation organizations are keen to invest in technologies and systems that are 
low-cost but highly effective and sustainable at reducing diarrheal disease burdens in these 
LMIC.  The quality of drinking water in the home, formerly not recognized as an important 
health factor compared to other WaSH interventions, is now considered an important factor when 
assessing diarrheal disease risk (Clasen, Roberts, Rabie, Schmidt, & Cairncross, 2006; Clasen, 
Schmidt, Rabie, Roberts, & Cairncross, 2007; Fewtrell et al., 2005).  Accessible, affordable, 
practical and sustainable water treatment options are needed for these vulnerable populations. 
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1.1.2 Household Water Treatment and Safe Storage  
 
One critical intervention that improves water safety of both improved and unimproved 
water sources for at-risk populations is household water treatment and safe storage (HWTS).  
HWTS water treatment technologies are also referred to as point of use (POU) water treatment 
technologies (Nath, Bloomfield, & Jones, 2006). The WHO Guidelines for Drinking-Water 
Quality (GDWQ) consider HWTS a priority intervention measure, or recommended interim 
measure, for those with no or basic access to drinking water services or those with access to 
unsafe drinking water services in water safety planning (WSP).  WSPs are comprehensive risk 
assessment, monitoring and management approaches that aim to ensure the provision of safe 
drinking water (WHO, 2017). Various physical, chemical and biological household treatment 
options are widely implemented, including chlorination, solar disinfection, 
flocculant/disinfectant powder, slow sand filtration and ceramic filtration (Sobsey, 2002; Sobsey, 
Stauber, Casanova, Brown, & Elliott, 2008).  Yet even with the extensive availability of these 
POU treatment technology options, millions continue to suffer from preventable waterborne 
illnesses due to the inability of these technologies to meet highly protective performance criteria 
supported by the World Health Organization.  These criteria were determined by evaluating the 
tolerable burden of disease, or acceptable risk, associated with exposure to background 
pathogens in untreated water.  The health-based targets are presented in terms of the theoretical 
maximum number of disability-adjusted life years (DALYs) attributable to waterborne disease 
per person when using the technology (WHO, 2011).  In 2016, the WHO published initial results 
of performance evaluations based on 1- , 2- and 3-star protective reduction requirements for 
water treatment technologies.  The performance targets are presented in Table 1.  3-star or 
highly protective technologies must achieve log10 reductions for bacteria, viruses and protozoan 
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cysts greater than 4, 5, and 4, respectively.  This would confer a substantial health benefit to 
users, limiting DALYs attributable to drinking-water diseases to 10-6 per person.  For 2-star or 
protective status, the HWT technology much achieve >2, >3 and >2 log10 reductions for bacteria, 
viruses and protozoan cysts, respectively.  DALYs would be limited to 10-4 per person using a 2-
star POU water treatment technology.  In order to be considered a 1-star, interim (minimally 
protective) technology, protective performance requirements for two of the three pathogens must 
be met, along with epidemiological evidence of diarrheal disease reduction in credible field 
studies (WHO, 2016; WHO, 2011).  The WHO GDWQ have also established a target level for 
turbidity in drinking water of < 1 NTU (WHO, 2017). 






























Meets at least Tier 2 criteria for two classes of pathogens Targeted 
protection 
- Fails to meet WHO performance criteria 
Little or no 
protection 
Adapted from (WHO, 2016) 
POU technologies have generally failed to achieve target reductions in field settings, 
often achieving only half of the reported maximum log10 reduction performance observed in 
laboratory studies (Sobsey et al., 2008).  The WHO now reports baseline and maximum log10 
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reduction values (LRVs) for all POU technologies to illustrate the differences between 
reductions achieved in field use and those achieved in a controlled laboratory setting. Biosand 
filtration, for example, can achieve a maximum LRV of 3 for viruses; however, in practice only 
up to a 0.5 log10 reduction is typically observed (WHO, 2011).  Despite these shortcomings, 
epidemiological studies suggest that the reduction in diarrheal disease attributable to POU 
technologies is between 30-40%, suggesting that these technologies still provide substantial 
value to users (Clasen et al., 2007; Fewtrell et al., 2005). 
Many POU treatment options employing a single treatment barrier do not effectively 
target all three classes of microbes and therefore do not meet 2-star or 3-star reduction targets 
specified by the WHO.  For example, most household water filtration options, such as biosand 
and ceramic filters, are inadequate for virus removal and household water chlorination is 
ineffective in reducing the infectivity of Cryptosporidium oocysts. Improvements to the available 
household water treatment options, especially those that are a single treatment barrier, are needed 
to further improve drinking water quality and to ultimately save lives.  Combining technologies 
or adding additional steps to treatment processes may substantially improve existing HWT 
technologies, as long as cost, ease of use and accessibility constraints are managed.   
1.1.3 Sand Filtration Technologies 
 
Sand filtration technologies, notably rapid sand filters (RSF), slow sand filters (SSF) and 
biosand filters (BSF), are commonly used water treatment technologies due to their low 
manufacturing cost and simple design.  Filtration is effective as a drinking water treatment 
process because as water passes through the small pores in the filter, microbes and particulate 
organic matter are physically removed.  RSFs and SSFs remove contaminants via physical, 
biological and chemical processes, although RSFs rely primarily on chemical and physical 
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removal mechanisms.  Both types of processes can be used at industrial or community scales as 
well as at the household level.  BSFs are an adaptation of SSFs.  Typically used at the 
household/POU level, BSFs are smaller sand filters that flow intermittently and use a biological 
layer called the schmutzdecke at the top of the sand column to aid in contaminant removal, 
analogous to that of a conventional slow sand filter.  
Specific pathogen reductions vary depending on the design, materials and operating 
conditions of the filter device and other performance-related factors.  Baseline LRVs for RSFs 
and SSFs as a standalone treatment mechanism are around 1 to 2-log10, far from the highly 
protective WHO targets for bacteria, viruses and protozoa of 4, 5, 4, respectively (WHO, 2011).  
Various studies have shown that SSFs and BSFs are able to extensively remove protozoa from 
water (Hijnen, Schijven, Bonné, Visser, & Medema, 2004; Palmateer et al., 1999).  The 
maximum LRV achieved by BSFs for both bacterial and viral indicators in lab performance 
evaluation studies is 3, suggesting significant limitations in the microbial efficacy of this 
technology to treat water at the household level under typical use conditions (Sobsey et al., 
2008).  
While some sand filters may achieve the protective requirements specified by the WHO 
for bacteria and protozoan cysts, most do not and, therefore, only offer users limited protection.  
Furthermore, virus reductions are often quite low using granular microporous filtration 
technologies due to their small size relative to the size of the media pores; hence, these filtration 
methods offer little protection from harmful enteric viruses.   In order to meet WHO’s 3-star, 
highly protective requirements, a supplemental treatment should be considered to improve these 
existing filtration treatment processes.   
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1.1.4 Chitosan, a Natural Coagulant  
 
Coagulation with chitosan may be an effective addition to existing filtration treatment 
technologies.  Chitosan, a derivative of chitin, is a biodegradable polysaccharide and a byproduct 
of the crustacean fishing industry.  When chitosan is added to water, suspended material 
including viruses, bacteria and spores are coagulated, the particles then flocculate together during 
slow mixing and eventually they can be settled out of the water columns.  Inorganic coagulants, 
including ferric sulfate and aluminum sulfate, are commonly used in large water treatment 
facilities; however, they are highly pH and dose dependent for optimizing performance, which 
limits their use at the household level (Crittenden, Trussell, Hand, Howe, & Tchobanoglous, 
2012).  Previous studies have found that pH and dose levels do not significantly affect the 
efficacy of chitosan as a coagulant (Christensen, Håkonsen, Robertson, & Myrmel, 2016; Fabris, 
Chow, & Drikas, 2010; Soros, 2015; Soros, Amburgey, Stauber, Sobsey, & Casanova, 2019).  
Furthermore, chitosan is inexpensive, non-toxic, easy-to-use, naturally occurring and readily 
available in most places around the world.  The accessibility, affordability, and coagulation 
efficacy of chitosan make it a promising supplemental treatment step to existing water filtration 
treatment technologies.  
The use of chitosan as a coagulant in conjunction with sand filtration technologies could 
potentially reach the aforementioned 3-star microbe reductions as defined in the international 
scheme to evaluate POU water treatment technologies (WHO, 2016).  It also has the potential to 
improve and extend the lifespan of currently used SSFs and BSFs.  Chitosan may extend the use 
of sand filters by removing excess organic material and microbes prior to filtration, which would 
otherwise accumulate in the pores of the filter, lower the flow rate and potentially impact the 
effectiveness of the filter.  
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Previous literature that assessed chitosan as a coagulant found that it effectively reduced 
bacteria and virus concentrations and turbidity in model and natural waters treated by chitosan 
coagulation followed by microporous ceramic filtration, with no appreciable change in pH 
(Christensen et al., 2016; Fabris et al., 2010; Soros, 2015; Soros et al., 2019); however, no 
research is currently available regarding how chitosan coagulation-flocculation may improve 
microbial and turbidity reductions achieved via intermittently-operated slow sand filtration.  
Furthermore, the use of chitosan as a supplemental water pre-treatment step for existing 
intermittently-operated slow sand filtration technologies has also not been assessed with natural 
waters.   
The purpose of this study was to assess the efficacy of chitosan as a coagulant in natural 
waters, followed by treatment with intermittently-operated slow sand filters.  Variables such as 
optimal dosage of chitosan, sand grain size, and flow rate were evaluated for their potential 
effect on turbidity and microbe reduction.  The reductions of turbidity and the indicator microbes 




1. To enhance the performance of intermittently-operated slow sand filtration using 
coagulation-flocculation sedimentation by chitosan  
a. Improving removal of bacteria and viruses  
b. Improving removal of turbidity 
c. Meeting WHO performance targets  
2. To optimize a chitosan dose that achieves maximum reduction values using the proposed 
dual-treatment barrier to:  
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a. Maximize removal of bacteria and viruses   
b. Maximize removal of turbidity  
c. Assess feasibility in household settings  
3. To examine the impact of intermittently-operated slow sand filter design parameters on 
bacteria, viruses and turbidity removal by varying:  
a. Sand grain sizes in filter columns 
b. Filter operating time
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CHAPTER 2: REVIEW OF THE LITERATURE 
 
2.1 Point of Use (POU) Water Treatment 
 
In high income countries (HICs), centralized drinking water treatment and source water 
protection policies are commonplace; however, in LMIC regions this is typically not the case.  
As of 2015, 69% of the global population has access to piped water systems.  In 2017 the 
WHO/UNICEF Joint Monitoring Program (JMP) report concluded over 800 million people do 
not even have access to basic drinking water services, of which about 160 million drink untreated 
surface water (WHO & UNICEF, 2017).  Providing centralized, piped water systems to these 
disadvantaged communities may take decades due to high capital investments, operation and 
maintenance (O&M) costs and a lack of fee or billing structures in smaller communities.  
Additionally, in many LMIC countries municipal water supplies still require treatment before 
consumption and residual chlorine levels may not be sufficient in the distribution systems to 
maintain high quality drinking water (Reller, Mong, Hoekstra, & Quick, 2001; Weber et al., 
1994).  In the interim, smaller-scale solutions to clean water access must be developed and 
implemented that are low-cost and readily understood and adapted by communities.   
WaSH control measures, specifically POU treatment technologies, are considered an 
effective means to provide improved access to clean drinking water and ultimately prevent 
waterborne diseases (Clasen et al., 2007; Fewtrell et al., 2005; M. Sobsey, 2002; WHO, 2017).  
POU technologies installed and used in the household and that incorporate safe water storage 
practices are also commonly referred to as household water treatment and safe storage (HWTS) 
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technologies.  In 2003, when the Third World Water forum in Kyoto recognized the International 
Network to Promote Household Water Treatment and Safe Storage (INPHWTSS), POU 
treatment technologies became a much-discussed subject and promising avenue for the 
international community to address water access needs.  In the years since, hundreds of studies 
have been published evaluating different household-scale water treatment technologies and their 
health impact in communities, both microbially and economically (Clasen & Cairncross, 2004).  
Household-scale water treatment can be effective at reducing diarrheal diseases with correct and 
sustained use, and household water quality is now recognized as a key variable when 
determining risk of diarrheal disease (Clasen & Cairncross, 2004; Clasen et al., 2006; Fewtrell et 
al., 2005; Sobsey, Handzel, & Venczel, 2003).  A systematic review and meta-analysis of various 
POU treatment mechanisms by Clasen et al. (2007) reported that POU interventions reduce the 
prevalence of diarrheal disease in people of all ages.  Additionally, interventions to improve 
water quality in the home were more effective at reducing diarrheal disease than interventions 
targeting water sources (Clasen et al., 2006).  The results from these studies demonstrate a clear 
benefit to using POU technologies to prevent illness, promote healthy development and increase 
lifetime productivity.   
2.1.1 Role of POU Systems 
 
POU water treatment technologies are commonly used in both HIC and LMIC to treat 
improved and unimproved water sources.  In HIC, POU devices are often used as a second 
treatment technology to improve aesthetics and taste (Lykins Jr, Goodrich, Clark, & Harrison, 
1994).  In LMICs, POU treatment is used either as an additional treatment step for contaminated 
improved water sources or as a standalone treatment method for various water sources.  POU 
water treatment employs many different technologies and methods to improve water quality, 
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including physical removal via sedimentation and filtration, chemical, UV and solar disinfection 
and coagulation/flocculation processes.  Most available technologies target microbial quality but 
some POU devices also remove chemical contaminants.  As of 2007, 19 million people used 
POU devices to treat their water worldwide, and an additional 350 million boiled their water as a 
form of POU treatment (Clasen, 2009). 
POU technologies are considered a practical and low-cost means of increasing clean 
water access, especially to those households at higher risk of consuming contaminated water due 
to water collection and storage options and practices (Sobsey, 2006).  Although not considered 
an improved means of providing clean water as defined in SDG 6, POU technologies make water 
safe to drink at the point of consumption and therefore should be considered a valuable tool to 
reduce diarrheal disease burden (Sobsey, 2002, 2006).  POU technologies also offer additional 
protection for vulnerable populations, including those with HIV/AIDs, children under 5, and the 
elderly (Gadewar & Fasano, 2005; LULE et al., 2005).   POU systems are also valuable in crisis 
situations where water provision and treatment infrastructure are inadequate, unreliable, 
nonfunctional or nonexistent, as in refugee camps and in the aftermath of destructive natural and 
anthropogenic disasters (Kayaga & Reed, 2011).     
2.1.2 POU Technologies 
 
POU technologies employ physical and chemical processes to treat water.  Physical 
treatment mechanisms include boiling, heating via fuel or solar energy, ultraviolet (UV) 
radiation, filtration and sedimentation.  Chemical treatment mechanisms include coagulation-
flocculation, precipitation, chemical disinfection, adsorption and ion exchange.  These methods 
can be used as standalone treatment systems or used in combination or in series to improve 
treatment capacity.  No single POU system is best suited for all situations because some 
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treatment technologies are not effective against all pathogens and chemical contaminants.  
Capital and O&M costs, ease-of-use, durability, volume of water treated, time required to treat 
water, treatment efficiency over a range of water qualities and aesthetics are all factors that 
impact the performance and sustainability of a POU system.  Cultural acceptability, resource 
availability and supply chain reliability are important community-based and enabling factors that 
influence POU device uptake and sustained and effective use (Sobsey et al., 2008).  
2.1.3 POU Systems: Treatment Efficiency and Health Impacts 
 
Sobsey et al. (2008) and WHO (2011) reviewed the most commonly used and well-
documented POU technologies and reported baseline and maximum LRVs for bacteria, viruses 
and protozoa as well as diarrheal disease reductions achieved by these systems in controlled 
studies.  These LRVs are documented in Table 2.  Maximum LRVs are the highest achievable 
LRV for these systems when tests are performed in a laboratory setting.  The baseline LRVs 
represent a more realistic value obtained from the field by a non-professional user.  The baseline 
LRVs are typically less than half the projected maximum LRV for the specific treatment process 
and pathogen group.  Studied and characterized factors for why these treatment processes 

































Pore size/structure, tortuosity, flow 
rate, filter medium composition, 
augmentation with silver or other 
chemical agents (Sobsey, 2002; 
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Turbidity and chlorine demand; 
concentration x contact time 
(Crittenden et al., 2005; Sobsey, 












Physical removal of chlorine-
resistant pathogens by coagulation-
flocculation; turbidity; challenge 
viral agent (Souter et al., 2003; 
Sobsey, 2002) 
(a) LRV: Log10 reduction value: Log10(pretreatment conc.) – Log10(post-treatment conc.) 
(b) Baseline LRV: LRV typically expected in actual field practice when done by relatively 
unskilled persons who apply the treatment to waters of varying quality and where there are 
minimum facilities or supporting instruments to optimize treatment conditions and practices  
(c) Maximum LRV: LRV possible when treatment is optimized by skilled operators who are 
supported with instrumentation and other tools to maintain the highest level of performance in 
waters of predictable and unchanging quality  
(d) Minimally effective in reducing concentration of infectious Cryptosporidium parvum oocysts  
Adapted from (Sobsey et al., 2008; WHO, 2011) 
Despite the pathogen reduction variation achieved by these POU treatment processes, 
epidemiological studies have documented considerable diarrheal disease reductions associated 
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with the use of these POU systems.  All five POU processes documented above achieve between 
a 30-40% reduction in diarrheal disease  (Clasen et al., 2007; Fewtrell et al., 2005).  Bias may 
have influenced greater than 50% of reported reductions in these studies, therefore further 
rigorously designed and conducted epidemiological-microbiological studies are required to fully 
assess the health impacts associated with POU treatment processes (Hunter, 2009).  
In the Sobsey et al. review (2008), a scoring system was applied to the LRVs, reductions 
in diarrheal disease incidence, and the aforementioned sustainability factors of ease-of-use, cost 
and supply chain logistics, in order to quantify the sustainability of these technologies.  Filtration 
technologies, specifically ceramic and BSFs, achieved the highest overall scores using the 
sustainability criteria, largely due to high reports of daily and long-term use; however, high 
breakage rates were reported for ceramic pot and candle filters.  BSFs excelled compared to 
other POU processes when evaluating use over time, with reported compliance rates exceeding 
85% 8 years post-implementation (Sobsey et al., 2008).  A more recent study in the Dominican 
Republic reported compliance rates of 90% after 1 year of implementation (Aiken, Stauber, 
Ortiz, & Sobsey, 2011).  A meta-analysis of BSF use and adoption documented an average 83% 
compliance rate, ranging from 10-100%, across 25 studies (Nakamoto, Graham, & Gimbel, 
2014).  Other advantages of using BSFs include absence of recurring costs, limited and simple 
maintenance procedures and effective performance at a wide range of influent turbidity levels 
(M. W. Jenkins, Tiwari, & Darby, 2011).  
Considering the high sustainability rating for the BSF, focusing on the optimization of 
intermittently-operated slow sand filter POU technologies and the implementation of these 
systems may have the greatest sustained health and economic impact; however, reported LRVs 
for BSFs do not meet the WHO 2- or 3-star performance targets for reductions of bacteria, 
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viruses and protozoan parasites, suggesting the design and operation of these filters require 
improvements to achieve greater microbial reductions (Sobsey et al., 2008; WHO, 2011). 
2.1.4 Granular Media Filtration  
 
Filtration involves the physical removal of suspended particles in a solution as the 
solution passes through a porous media.  The use of granular medium filtration to treat water 
dates back to around 2000 BC, when medical records mentioned that filtration through sand 
clarifies water.  As of the 1750s, filtration technologies were commercialized and patented and in 
the early 1800s countries such as England and Scotland began using centralized water systems 
employing sand filtration technologies to treat and distribute their water.  The Chelsea Water 
Works Company in London used the first slow sand filter (SSF) in 1829 and by the mid 1800s, 
sand filtration became popular as correlations between reductions in waterborne disease and the 
use of sand filtration technologies were recognized.  In the 1880s, the United States developed 
and installed the first rapid sand filter (RSF) system and RSFs are now used in 99% of all 
centralized water treatment systems (Crittenden et al., 2012). 
Granular medium filtration uses a granular material such as sand as the porous medium.  
Granular media filtration removes sediment, algae, clay, microorganisms and other organic and 
inorganic particles from water.  Granular media filtration is employed at centralized water 
treatment facilities, community-scale water treatment facilities and even at the household level.  
Most municipal water treatment and distribution systems use RSF technologies, which typically 
require a coagulation pretreatment, a uniform porous media size, and a backwashing process.  
RSF is dependent on depth-filtration to remove particles from water.  These particles become 
trapped throughout the media bed when they collide and adhere to the sand media as they pass 
through the filter.  Even particles much smaller than the pore size in a RSF can be captured via 
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the mechanisms known to influence removal, including sedimentation, adsorption and 
interception (pore size exclusion and mechanical straining).  At the municipal level, RSFs are 
continuously operated at a flow rate between 5-15m/h (Crittenden et al., 2012).  
Unlike RSFs, SSFs do not require the porous media to be of uniform size, do not always 
use backwashing as a cleaning mechanism, typically do not require a coagulation pretreatment 
step and are run at a filtration rate 50 to 100 times slower than RSF systems.  Facilitated by non-
uniformity of pore sizes and a reduced filtration rate, SSFs trap particulate matter in water in the 
first few centimeters of the sand bed.  A schmutzdecke also develops on the surface of SSF 
media as the filter matures.  The schmutzdecke is a biological filtration layer that assists in both 
the physical removal and predation/biodegradation of the trapped organic matter.  SSF systems 
are cleaned or regenerated by scraping off the top layer of the media bed.  At the municipal level, 
SSFs operated at a filtration rate of approximately 0.08-0.25 m/h and are operated continuously 
(Crittenden et al., 2012). 
 Biosand filters (BSF), developed in the 1980s by Dr. David Manz at the University of 
Calgary, are essentially a household-scale adaptation of SSFs.  BSFs may also be described as 
intermittently operated household-scale slow sand filters (ISSFs).  After laboratory and field 
evaluation and design modifications in the early 1990s, the first BSF was patented and installed 
in households in Nicaragua (CAWST, 2012).  Concrete and plastic variations of the BSF design 
are still being developed and modified today.  BSFs rely heavily on the physical accumulation 
and biological degradation processes of organic particulate contaminants, including microbes, 
occurring on and in the sand bed to clarify water; however, physical and chemical treatment 
processes also contribute to their performance.  The sand serves as a microbially active 
environment where pathogens are retained and subjected to predation by other microorganisms 
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living in the filter, are physically removed via mechanical trapping by biofilms produced by 
those microorganisms, adsorb onto the porous media surface or die off during the residence time 
in the filter (Elliott, DiGiano, & Sobsey, 2011).  Unlike RSFs and SSFs, BSFs are intermittently 
operated.  When a batch of water is added to the filter, water that was in contact with the 
microbial community on and within the filter sand media flows out.  Recommended BSF 
operation involves dosing the BSF once per day to promote the growth of the microbial 
community within the filter.  BSFs can be operated as many as 4 times per day, but an idle time 
of at least several hours between doses is recommended so a sufficient residence time within the 
filter can promote microbial attenuation (CAWST, 2012).  
2.1.5 Microbial Reductions and Health Impacts Achieved by POU Sand Filtration 
 
 Both field and laboratory evaluations of BSF performance report wide ranges of 
reductions achieved for both bacteria and virus indicators as well as for turbidity.  Table 3 
summarizes the effectiveness of BSFs at removing target organisms and turbidity as published in 
the Center for Affordable Water and Sanitation Technology (CAWST) biosand construction 
page (2012).  
Table 3. Biosand Filter Effectiveness at Removing Target Organisms 
Parameter Effectiveness Laboratory Results 
Bacteria Effective (>90%)  98.7%1, 2 
Viruses Somewhat effective (>80%)  85.9%3 
Cryptosporidium  Very effective (>99%) 99.88%4 
Giardia Very effective (>99%)  >99.99%4 
Turbidity  87%3 
Adapted from CAWST 2012. 1. Elliot et al. 2008 2. Young-Rojanschi et al. 2014a 3. Young-
Rojanschi et al. 2014b 4. Palmateer et al. 1999 
 
 Though BSFs are effective at removing protozoan parasites, they do not meet the 3-star 
performance targets for HWT technologies as specified by the WHO for bacteria, >4-log10, and 
viruses, >5-log10 (WHO, 2016).  Laboratory study designs evaluating these filters have varied 
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widely from bench-scale to full-size experiments and subsequent reported reductions are also 
variable in results.  Full-scale evaluations of the 60L BSFs produced by Davnor Water 
Treatment Technologies Ltd. reported average E. coli reductions of 94-99% (Stauber et al., 
2006).  Optimized designs of BSFs achieved reductions between 1.3-1.5-log10 for fecal coliforms 
and 0.8-log10 for MS2 coliphage in laboratory settings (M. Jenkins et al., 2009).  Full-scale 
evaluations of the Version 10 BSF reported MS2 coliphage reductions exceeding 4-log10 after 
the first 43 days of filter operation and between 4 to 7-log10 reductions through 294 days of use 
(Wang et al., 2014).    
Studies in field settings typically report lower reduction rates.  Fecal indicator bacteria 
reductions were found to be 84-88% in studies evaluating continued use and health impact of 
BSFs in the Dominican Republic (Aiken et al., 2011).  Plastic BSFs used in Ghana reportedly 
achieved average E. coli reductions of 97% (Stauber, Kominek, Liang, Osman, & Sobsey, 2012).  
Reduction rates of 83% for E. coli were reported in a study evaluating concrete BSFs in the 
Dominican Republic (Stauber, Ortiz, Loomis, & Sobsey, 2009).  Average reductions of 93% for 
E. coli were reported in another BSF evaluation in the Dominican Republic (Stauber et al., 
2006).  Studies evaluating optimized BSFs filters in Kenya achieved reductions of 1.3-log10 for 
fecal coliforms (M. Jenkins et al., 2009).  Only 80% E. coli removal was observed with BSFs 
used in Nicaragua (Fiore, Minnings, & Fiore, 2010). 
Several design and operation characteristics may impact achieved LRVs.  Filter ripening 
time, daily volume charged, idle time between charges, cleaning procedures, sand media 
composition, filtration rate and deep-bed media aging are all parameters that may affect filtration 
efficiency (Elliott, Stauber, DiGiano, de Aceituno, & Sobsey, 2015; Elliott, Stauber, Koksal, 
DiGiano, & Sobsey, 2008; M. Jenkins et al., 2009).  Some of these parameters have been 
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evaluated in bench- and full-scale laboratory studies.  Results from several studies have 
demonstrated that enhanced microbial reductions are a product of improved microbial 
attenuation when idle time within the filter is optimized.  This is achieved by increasing the pore 
to daily charge volume ratio, reducing daily charge volume, and reducing the operating head 
(Elliott et al., 2008; M. W. Jenkins et al., 2011; Stauber et al., 2006).  Sand grain size has been 
identified as a critical parameter, with smaller grain sizes improving fecal coliform reductions by 
0.4-log10 and MS2 reductions by 0.5-log10 (M. W. Jenkins et al., 2011).  Filter sand surface 
maintenance by scouring can negatively impact reductions of thermotolerant coliforms by 
upwards of 1-log10, but allowing filters an idle period of 18-24 hours after maintenance 
overcomes this negative impact (Singer, Skinner, & Cantwell, 2017).  While intermittent dosing 
is a realistic use parameter in household settings, prior research has demonstrated reduced 
effectiveness of slow sand filtration when operated intermittently (R., Joshi, Dhage, & Tajne, 
1980).  Recent studies found continuous operation of BSFs achieve significantly higher LRVs 
compared to intermittently operated BSFs.  Microbial reductions are improved by greater than 2-
log10 for E. coli and 1.5-log10 for viruses (Young-Rojanschi & Madramootoo, 2014).  Lower 
filtration rates have been correlated with improved filter performance for bacteria removal 
(Napotnik & Jellison, 2014; Singer et al., 2017). 
As previously mentioned, positive health impacts have been associated with using BSFs 
in field settings.  The odds of reporting diarrheal disease in households using BSFs in the 
Dominican Republic was 0.39 times lower than for households not using BSFs (Aiken et al., 
2011).  In Ghana, the prevalence ratio for diarrhea comparing households that did and did not 
receive a BSF was 0.40 (Stauber, Kominek, et al., 2012).  Consistent use of BSFs was found to 
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reduce diarrheal disease by greater than 50% in Cambodia (Stauber, Printy, McCarty, Liang, & 
Sobsey, 2012). 
Recent research has explored ways to improve BSF performance.  Modifications to 
existing operation recommendations and alternative sand media have made marginal 
improvements (M. Jenkins et al., 2009; M. W. Jenkins et al., 2011).  Including additional 
treatment steps within the BSF design to make it a dual barrier water treatment technology have 
also been investigated.  When biosand filtration is followed by UV disinfection as a dual-
treatment system, effluent water had E. coli concentrations less than 1 CFU/100 mL.  This 
observation was true for both BSFs of small grain size (d = 0.70 mm) and large grain size (dmax = 
2.0 mm) (Frank, Scheie, Cachro, & Muñoz, 2014).  BSFs modified with a layer of zero valent 
iron as an additional disinfection layer have produced marginal improvements in bacteria and 
turbidity reductions (Yildiz, 2016).  BSFs with a 10-cm thick layer of iron oxide-coated sand 
media were found to have greater removal performance by at least 1-log10 for fecal coliform and 
E. coli bacteria compared to conventional BSFs (Ahammed & Davra, 2011).  Iron oxide-
amended bench-scale column BSFs removed 5-log10 MS2 coliphage and greater than 4-log10 
rotavirus.  Full-scale iron-amended BSFs removed over 4-log10 MS2 coliphage in the first 5 
months of use (Bradley, Straub, Maraccini, Markazi, & Nguyen, 2011).    
2.1.6 Viral Reduction Limitations of Sand Filtration 
 
Viruses, which are important etiologic agents of diarrhea, infectious hepatitis and other 
diseases, are particularly difficult to treat with granular media filtration devices due to their small 
size.  Viral pathogens, including adenoviruses, astroviruses, caliciviruses, enteroviruses, 
Hepatitis A & E, rotaviruses and orthoreoviruses, can be transmitted from person to person 
through contaminated drinking water (WHO, 2017).  Viruses contribute to diarrheal disease 
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burdens in LMIC. A systematic analysis of 195 countries found that rotavirus was the leading 
cause of diarrhea in children of all ages (Troeger et al., 2018).  
Studies evaluating virus removal with SSFs and BSFs have reported reductions of less 
than 0.5-log10 to greater than 5-log10 for indicator organisms and enteric viruses (Elliott et al., 
2015; Wang et al., 2014).   High variability in reported virus reductions is likely attributable to 
differences in filter design and operation, source water characteristics and indicator organisms.  
MS2 coliphage is the most common virus indicator organism used in filter evaluations for virus 
removal.  Most studies report reductions between 0.2-1.5-log10 for MS2 coliphage with BSFs 
(Elliott et al., 2008; M. W. Jenkins et al., 2011; Young-Rojanschi & Madramootoo, 2014).  
Recent studies of long-term BSF operation have reported LRVs ranging from 3-5 for MS2; 
however, this level of removal was not achieved until after 3 months of filter operation (Wang et 
al., 2014).  
Higher performance in virus removal has been correlated with lower filtration rates, 
extended filter operation time, increased sand bed depth, higher temperatures, and longer idle 
periods between batch doses (DeLoyde, 2007; Elliott et al., 2011).  Mechanisms by which 
viruses are removed in biosand filtration include adsorption to granular media, attachment to 
biofilms, biological activity, predation, and physical straining.  Although the schmutzdecke is 
important for bacteria removal, studies have not observed an impact on virus removal capacity 
when the schmutzdecke is disturbed or removed (DeLoyde, 2007; Hijnen et al., 2004).  This 
evidence, combined with observed improvements in virus reductions over filter operation time, 
suggest that media aging in the filters is responsible for enhanced virus removal (Elliott et al., 
2011, 2015).  Recent studies have demonstrated positive correlations with virus attenuation and 
media aging, suggesting that activity of the microbial community is likely the primary 
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mechanism of virus removal in BSFs (Elliott et al., 2011; Wang et al., 2014).  Virus attenuation 
may be the result of both predation and virus inactivation by proteolytic enzymes (Elliott et al., 
2011).    
 Increasing idle times and decreasing water charge-to-pore volume ratios may improve 
virus reduction performance for BSFs, but this significantly limits the amount of water a 
household can treat per day if they only have one POU treatment device.  Additionally, it is not 
reasonable to tell users that water treated with a BSF is not safe to use until appropriate media 
aging has occurred.  Though BSFs are somewhat effective at removing bacteria and turbidity 
from water, clear limitations still exist with regards to their virus removal capacity.  
Conventional water treatment systems utilize coagulation-flocculation-sedimentation to capture 
viruses into larger particles prior to filtration.  Only one study has evaluated using coagulation 
with filtration as a dual treatment barrier in household settings.  This group found improved 
microbial and turbidity reductions after slow sand filtration using a natural coagulant extracted 
from Opuntia cochenillifera; however, they did not evaluate virus removal in the study (Freitas 
& Sabogal-Paz, 2019).  Further coagulant options should be considered and evaluated with 
ISSFs to improve the removal capacity of this sustainable and accessible technology.  
2.2 Coagulation-Flocculation 
 
 Conventional water treatment facilities remove inorganic, organic, and colloidal particles 
as well as dissolved organic matter from water using coagulation and flocculation processes 
followed by sedimentation and filtration.  Chemical coagulants are added to water in order to 
destabilize the suspended and dissolved particles so they aggregate during flocculation.  The 
formed flocculent particles are removed from water by settling out of solution (gravity 
sedimentation) or by filtration.  Inorganic coagulants, including alum, ferric sulfate and ferric 
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chloride, hydrolyze when added to water and adsorb to particles.  They form lengthy polymeric 
hydroxy molecules that have positive charges along the chain due to their iron or aluminum 
moieties.  These positive charges make it possible to attract and adsorb to negatively charged 
particles in water, including viruses and other microbes of health concern.  The surface charge or 
electrical potential of viruses depends on the pH and the dissolved solids types and 
concentrations in the water. It is also important to note that viruses differ in their surface charge 
properties, such as their isoelectric point, the pH at which they have zero surface charge and this 
may influence their adsorption to surfaces and their ability to be coagulated.  The extent to the 
isoelectric point of viruses influences the extent of virus interactions with abiotic surfaces 
remains uncertain (Dika, Duval, Francius, Perrin, & Gantzer, 2015). 
However, it is known that particles such as microbes are destabilized as the coagulants 
form bridges between particles or neutralize their charge.  Particle destabilization can also occur 
when charged polymers, or organic polyelectrolytes, are added to water.  Inorganic coagulants 
are typically used at municipal water treatment facilities. Flocculation serves to aggregate the 
destabilized particles into larger particles for removal (Crittenden et al., 2012).  The coagulation-
flocculation process is considered the most important treatment step to physically remove 
contaminants (Bellamy, Cleasby, Logsdon, & Allen, 1993; Cleasby, Dharmarajah, Sindt, & 
Baumann, 1989).   
2.2.1 Coagulation Mechanisms 
 
 In water treatment practices, coagulants destabilize particles and enhance removal by 
three primary mechanisms: adsorption and charge neutralization, adsorption and interparticle 
bridging, and precipitation and enmeshment.  Compressing the ionic double layer surface of 
particulates by increasing ionic strength is also considered a coagulation mechanism; however, 
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this is not a practical mechanism for drinking water treatment (Crittenden et al., 2012).  In the 
neutral pH range, most colloids and other suspended particles in water have a negative charge.  
Charge neutralization involves the destabilization of particulates in water when oppositely 
charged ions or polymers adsorb onto the surface of those particles and neutralize the negative 
charge.  When particles have a neutral charge, they flocculate.  This process is dose dependent.  
If too much ion or polymer is added, the particles may become stable again via charge reversal 
(Black, Birkner, & Morgan, 1966).  Interparticle bridging involves the adsorption of a single 
polymer chain on multiple particles which creates a bridge between those particles.  The optimal 
dose to maximize interparticle bridging is proportional to the concentration of particles in the 
water to be treated.  These two destabilization mechanisms are the main mechanisms for polymer 
coagulation.  Precipitation and enmeshment and charge neutralization are the primary 
mechanisms of destabilization and removal when hydrolyzed or pre-hydrolyzed metal salts are 
added to water.  At low doses, when the salts hydrolyze in water they adsorb to the surface of 
particles and neutralize their charge.  At high doses, particulate matter in water is trapped in 
insoluble precipitates that form as the metal salts bind to the surface of the particles.  
Precipitation and enmeshment is the predominant mechanism used in water treatment facilities 
(Crittenden et al., 2012).   
2.2.2 Salts and Polymers 
 
 Optimized coagulation-flocculation processes are dependent on many factors including 
the coagulant, the influent water quality and composition of suspended particulates, temperature, 
pH and dose.  Aluminum and ferric ion salts, the most common inorganic coagulants used for 
water treatment, are pH-dependent and require high doses to be effective; however, they are 
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equally effective at the same dose for any particulate type.  They are less effective at colder 
temperatures and require rapid, instantaneous mixing times (Crittenden et al., 2012).    
 The optimization of polymers for coagulation in different settings is complex.  Optimal 
doses, mixing conditions and pH depends on the polymer and the polymer-solution interactions.  
Nonionic polymers are widely considered useful filter aids and anionic polymers are considered 
useful flocculant aids, both of which improve the strength of the formed floc.  Cationic polymers 
can be used as primary coagulants but typically only if followed by direct filtration.  Synthetic 
organic polymers are more commonly used in water treatment than natural organic polymers; 
however, both are typically not used as the primary coagulant for water treatment facilities.  
Organic polymers are effective at lower doses than inorganic coagulants, and using both together 
can reduce the amount of inorganic coagulant required by as much as 40-80% (Crittenden et al., 
2012). 
 Health and environmental impacts associated with the chemicals used in water treatment 
processes is of growing concern.  Traditional inorganic coagulants produce toxic residual sludges 
that may have substantial and persistent adverse environmental effects if not properly disposed 
(Matilainen, Vepsäläinen, & Sillanpää, 2010).  High residuals of the inorganic salts have 
negative neurological impacts and are considered a risk factor for Alzheimer’s (Rondeau, 
Commenges, Jacqmin-Gadda, & Dartigues, 2000).  The use of these coagulants requires 
additional chemical treatment to limit corrosion in distribution systems (Matilainen et al., 2010).  
Furthermore, pH and dose control constraints as well as the burden of high solids residuals make 
inorganic coagulants difficult to optimize for POU treatment.  These drawbacks indicate a need 
for environmentally friendly, readily available, safe and sustainable alternatives to inorganic salts 
for water treatment by chemical coagulation (Niquette, Monette, Azzouz, & Hausler, 2004). 
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Natural food- and plant-based polymers that are non-toxic and biodegradable may be 
promising coagulant alternatives.  Extracts from maize, red bean, Moringa oleifera and 
Strychnos potatorum, acorns and chestnuts have been evaluated as potential coagulants both for 
municipal and POU treatment (Babu & Chaudhuri, 2005; Ghebremichael, 2004; Gunaratna, 
Garcia, Andersson, & Dalhammar, 2007; Šćiban, Klašnja, Antov, & Škrbić, 2009).  A Polymer 
extract from the cactus Opuntia spp. achieved average turbidity reductions of 98% (Miller, 
Fugate, Craver, Smith, & Zimmerman, 2008).  Polymers extracted from acorns and nuts reached 
70-80% turbidity removal (Šćiban et al., 2009).  S. potatorum and M. oleifera, evaluated as 
potential coagulants coupled with RSF for household use, significantly reduced turbidity, 
bacteria and viruses in water. Approximately 2-log10 reduction for bacteria and over 3-log10 
reduction for viruses were reported with S. potatorum and M. oleifera, respectively, followed by 
direct filtration (Babu & Chaudhuri, 2005).  Although some of these plant-based organic 
coagulants were found to be effective, their access may be limited to the geographic settings in 
which they grow and are not widely produced and distributed in quantity via commercial 
suppliers.  High operational costs at water treatment facilities may limit natural coagulants from 
use as the primary coagulant; however, natural coagulants may be more practical in low-resource 
settings as well as for POU treatment (Niquette et al., 2004).   
2.3 Chitosan, A Natural Polymer Coagulant 
 
Coagulation with chitosan, a natural biodegradable polymer, may be an effective addition 
to existing POU treatment technologies.  It is a derivative of chitin, the second most abundant 
polysaccharide globally (Rinaudo, 2006).  Crustacean shells considered waste by the seafood 
industry are converted to chitin via decalcification and deproteination (Cheung, Ng, Wong, & 
Chan, 2015).  Deacetylation of chitin produces chitosan.  Chitosan is a cationic polymer that is 
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water insoluble but dissolves in most acids.  The chitosan polymer chain consists of randomly 
distributed β-(1-4)-linked ᴅ-glucosamine and N-acetyl-ᴅ-glucosamine moieties (Cheung et al., 
2015).  Commercially available chitosan products range in molecular weight and degree of 
deacetylation, which influence their physical-chemical characteristics.  High molecular weight, 
which also influences the length of the polymer chain, is associated with high viscosity.  High 
degree of deacetylation, which ranges between 40% and 98%, is associated with increased 
solubility (Mourya & Inamdar, 2008).  High degree of deacetylation is also associated with 
greater numbers of positive charges along the polymer chain.  Positive charges accrue as amine 
groups protonate when chitosan dissolves in water (Kumar, Muzzarelli, Muzzarelli, Sashiwa, & 
Domb, 2004).  Chitosan salts, a product of treating chitosan with acids to modify functional 
groups on the polymer via cross-linking and grafting, are more soluble in water and are useful in 
a variety of applications (Cheung et al., 2015).   
Chitosan is non-toxic, readily available worldwide, and the US Food and Drug 
Administration granted it Generally Recognized as Safe (GRAS) status (Kean & Thanou, 2010).  
Characteristics of chitosan include biocompatibility, low allergenicity, biodegradability and 
antimicrobial activity  (Kumar et al., 2004; Martins et al., 2014).  Chitosan has been studied for 
potential applications in the biomedical, pharmaceutical and dietary supplement, and water and 
water and wastewater treatment industries (Cheung et al., 2015; Elieh-Ali-Komi & Hamblin, 
2016).  This research focuses on the use of chitosan as a coagulant for POU drinking water 
treatment.   
2.3.1 Chitosan and Coagulation-Flocculation 
 
When chitosan is added to water, the positive charges along the polymer chain facilitate 
adsorption interactions with negatively charged suspended particles, metals and dyes (Boamah et 
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al., 2015; Tran et al., 2015; Vakili et al., 2014).  Many modified chitosans are considered 
effective chelating agents that bind and subsequently remove metals (Boamah et al., 2015).  
Organic pollutants of health concern, including pesticides, herbicides and polycyclic aromatic 
hydrocarbons, are readily adsorbed and removed with chitosan (Tran et al., 2015).  In addition to 
its bactericide potential under specific conditions, chitosan also effectively adsorbs to particles in 
water and enhances turbidity and microbial removal by filtration processes (Abebe, Chen, & 
Sobsey, 2016; Soros, 2015; Soros et al., 2019).   
Interparticle bridging and charge neutralization are the primary coagulation mechanisms 
associated with chitosan.  The long polymeric structure and distributed positive charges allow 
chitosan to attach and bridge with numerous negatively charged colloidal particles, resulting in 
coagulation and sedimentation of flocs of destabilized particles (Abebe et al., 2016). As with any 
other polymer coagulant, factors including dose, pH, mixing conditions and influent water 
quality impact the particle removal capacity of chitosan.   
2.3.2 Chitosan for Colloid Removal  
 
The extent of turbidity removal documented in the literature varies depending on particle 
and chitosan type.  Greater kaolin and bentonite removal is achieved with higher molecular 
weight chitosans (Chen, Chen, & Wu, 2003; Domard, Rinaudo, & Terrassin, 1989).  Greater 
bentonite removal is also achieved with higher DD of chitosan (Chen et al., 2003).  Jar tests 
using chitosan with model waters exhibited similar trends and found that higher chitosan doses 
were not associated with increased turbidity removal.  Other identified factors that influence 
turbidity removal with chitosan include clay type and functional groups (Soros et al., 2019).  
Turbidity reduction by chitosan coagulation and ceramic filtration in natural waters consistently 
met US EPA standards and WHO performance targets of < 1 NTU (Abebe et al., 2016).  
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Coagulation-flocculation with alum in conjunction with chitosan resulted in turbidity removals 
between 74.3 to 98.2% (Bina, Mehdinejad, Nikaeen, & Attar, 2009).  
Information regarding the ability of chitosan to remove microorganisms from water via 
coagulation-flocculation is limited.  Strand et al. (2001) documented an inverse relationship with 
DD and flocculation efficiency: higher DD (99%) required 10 times less chitosan hydrochloride 
for bacterial flocculation than lower DD (38%).  Bina et al. (2009) observed LRVs between 2-4 
for E. coli when water was treated with alum in conjunction with chitosan.  Jar tests using 
chitosan alone with model waters exhibited log10 reductions of 3-5 for E. coli and MS2 at various 
chitosan dosages (Soros, 2015).  Recent evidence published by Abebe et al. (2016) suggests that 
microbial log10 reductions by chitosan coagulation followed by ceramic filtration range between 
4.7 and 7.5 for E. coli and between 2.8 and 4.5 for MS2 coliphage using model waters.  
Few studies have assessed the use of chitosan coagulation with RSFs and none are 
currently available that explore chitosan with SSFs and BSFs.  C. parvum oocyst removal 
reached 4.2-log10 for water treated with 3 mg/L chitosan followed by rapid sand filtration 
(Brown & Emelko, 2009).  Christensen et al. (2017) assessed coagulation by chitosan combined 
with RSF, filtration rate = 5.9 m/h, and reported 4.5-5-log10 for E. coli, ~2.5-log10 for MS2 and S. 
Typhimurium 28B, and ~3-log10 for C. parvum.  The same experimental setup resulted in 61% 
turbidity removal at low doses of 2-6 mg/L chitosan (Christensen et al., 2016).   
2.3.3 Chitosan with POU Filtration 
 
Inorganic coagulants, including ferric sulfate and aluminum sulfate, are commonly used 
in conventional water treatment facilities; however, they are pH and dose dependent for optimum 
coagulation-flocculation performance, which limits their use at the household level.  They are 
also toxic at high doses, especially aluminum salts, therefore it is unadvised to ask minimally-
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trained individuals to oversee dosing and treatment with these coagulants.  Furthermore, alum 
quality varies significantly from source to source and adding excess alum to drinking water 
makes it salty and unpalatable (Preston, Lantagne, Kotlarz, & Jellison, 2010).  Coagulation-
flocculation at the POU has not been adopted in part due to the limitations of inorganic 
coagulants.  Few coagulation products are specifically optimized for household use.  PUR, which 
was developed and marketed by Proctor and Gamble, is the most well-known and commercially 
available POU flocculant-disinfectant product. PUR utilizes iron sulfate as the primary coagulant 
and calcium hypochlorite as the disinfectant.  No natural polymeric coagulants are currently 
optimized for use in household settings.  A coagulant-flocculant system using a natural coagulant 
that is easily paired with existing filtration technologies is needed to enhance microbial removal 
performance for POU treatment.   
Chitosan is inexpensive, non-toxic, easy-to-use, naturally occurring and readily available 
in most places around the world.  The accessibility, affordability, and efficacy of chitosan make 
it an ideal supplemental treatment step to existing water treatment technologies.  Previous studies 
have found that pH and dose adjustments do not significantly impact the efficacy of chitosan as a 
coagulant in water, especially in turbidity removal (Christensen et al., 2016; Fabris et al., 2010; 
Soros, 2015; Soros et al., 2019).  Chitosan has never been evaluated as a credible water treatment 
product to remove microbes and turbidity in conjunction with intermittently-operated slow sand 
filtration technologies.  Previous studies have determined that modified chitosans effectively 
remove bacteria and viruses from water both in jar tests, with RSF and with ceramic filtration 
(Abebe et al., 2016; Christensen et al., 2017; Soros, 2015); however, the performance of chitosan 
and intermittently-operated slow sand filtration as a dual treatment barrier has not been 
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evaluated.  If high microbial removal over long-term use is achieved and maintained, chitosan 
may be a simple, affordable and effective means to improve household water filtration devices.  
2.4 Summary 
 
There is not an effective granular media filtration system for POU household treatment 
that removes viruses with sufficient efficacy to meet WHO performance targets for high (3-log10) 
and very high (5-log10) LRVs.  Addressing this problem with traditional inorganic coagulants is 
not feasible due to the difficulties of precisely controlling coagulant dose and key water quality 
parameters, such as pH, to optimize performance; however, chitosan may be an attractive 
alternative because of its aforementioned desirable properties of effective performance at a range 
of different doses in waters of different quality.  Previous studies using chitosan coagulation 
pretreatment have shown that viruses are more efficiently removed with other filtration 
technologies such as microporous ceramic filters and RSFs (Abebe et al., 2016; Christensen et 
al., 2017).  Because substantially greater virus reductions are observed when water is pretreated 
with chitosan before filtration, evaluating chitosan pre-treatment with intermittently-operated 
slow sand filters or similar simple filters is a logical next step to investigate chitosan 
coagulation-flocculation for applicability in POU water treatment. This study explores that 




CHAPTER 3: METHODS 
 
The bench-scale dual barrier treatment of chitosan coagulation pre-treatment and 
filtration using small-scale sand filter columns of 16 cm sand depth was evaluated over a period 
of 57 days. The experiments compared microbial and turbidity reductions of chitosan coagulated 
water in sand columns filled with two different sands, commercial Accusand and well-
characterized rapid silica sand media used by the Orange Water and Sewer Authority in 
Carrboro, NC.  OWASA is a public, non-profit municipal utility servicing southern Orange 
County, NC.  The modified sand filter columns were not specifically designed and operated 
based on any sand filter preparation and operation guidance.  The BSF guidance served as a 
general reference for how to properly build and charge the filters; however, sand filter depth, 
water flow rate, maximum head, idle periods between daily charges with microbe-laden test 
water and amount of water held in the media between daily water charges was not controlled in 
the design and operation of this bench experiment.  The bench experiment served as proof-of-
concept to evaluate how chitosan pretreated water impacts the microbial and turbidity reductions 
achieved by ISSFs.  Biological activity was not considered a primary variable of interest in these 
studies so design and dosing of the sand column filters was not optimized for growth and 
maintenance of a schmutzdecke and the filters were not operated to simulate a full-scale BSF.  
The sand columns used in this study were ISSFs with falling head and manual dosing, subjected 
to weekly cleaning of the top 3 cm of the sand layer to maintain reasonable water flow.  
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3.1 Overview of Protocol 
 
16 bench-scale, 3.9 cm diameter column sand filters of 16 cm sand depth were designed 
and constructed.  They were intermittently-operated via a single 500 mL daily charge over a 57-
day evaluation period.  Non-pathogenic bacteria and virus surrogates were used to evaluate the 
removal of bacteria and viruses from water via chitosan coagulation-flocculation followed by 
intermittently-operated slow sand filtration.  Reductions in turbidity were based on decline in 
turbidity levels of the natural surface water samples.  Natural surface waters were spiked with 
surrogate microbe stock suspensions on each testing day at target levels that allow for the 
measurement of greater than 6-log10 removal.  Samples of untreated water were taken for initial 
microbial evaluation, then waters were dosed with target volumes of a 2 g/L stock liquid chitosan 
solution to achieve designated chitosan concentrations.  A 30-minute mixing and settling 
procedure was commenced to facilitate coagulation-flocculation-sedimentation.  Post-chitosan 
coagulation-flocculation samples were taken prior to dispensing the chitosan-treated water into 
the bench-scale sand filters.  Effluent water samples were taken from the filtrate of each filter.  
Culture-based assays were used to quantify microbial concentrations in waters for all samples. 
Log10 reductions were calculated between the influent and effluent samples.   
3.2 Column Design, Preparation and Operation 
 
The design of the sand filter columns used in the bench-scale experiment are shown in 
Figure 1.  A total of 16 columns were operated in parallel for the experiment, of which 8 were 
loaded with silica sand media used in OWASA’s rapid sand filters and 8 others were loaded with 
standard Accusand silica (Unimin Corp., Le Sueur, MN, USA).  These sand conditions are 
referred to as Accusand and silica sand in the remainder of the report.  The sand filter columns 
were not designed and operated for a specific flow rate.  Instead the sand columns outlet tubes 
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were adjusted in height to decrease/increase the flow rate in an attempt to maintain flow rates 
among sand conditions within a somewhat uniform range of values.  The target filtration rate for 
the Accusand-filled columns was 0.4-0.6 m/h and the target filtration rate for the silica sand-
filled columns was 1.0-1.4 m/h. The target filtration rate for the Accusand columns was 
determined based on the suggested filtration rate for BSFs, 0.4 m/h (CAWST, 2012).  The silica 
sand filtration rate was a compromise due to limitations in the filter design.  Had the effluent 
tube been moved any higher on the sand column, the falling head would have reached the 
effluent tube and the flow would cease without filtering over 50 mL of water.  This would result 
in incorrect filtration rate measurements because refilling would bring the filters back to 
maximum head during measurements and flow would fluctuate.   
 Accusand was used due to its low organic matter content, chemical purity, and low 
uniformity coefficient (Schroth, Ahearn, Selker, & Istok, 1996).  The Accusand media in the 
columns was a blend of three sieve fraction sizes (U.S. Standard Mesh 30/40, 40/60, and 50/70).  
The combination of these sieve fractions provided a smaller average grain size (d10 = 0.24 mm; 
d60/d10 = 1.40) compared to the silica sand (d10 = 0.50 mm; d60/d10 = 1.40).  The 
recommended range of d10 values, or the effective size range, for BSFs is between 0.15 mm and 
0.20 mm in order to achieve a filtration rate of 0.4 m/hr (CAWST, 2012).  The Accusand 
combination used in this experiment had a slightly higher effective size than is recommended, 
while the silica sand media is greater than double what is recommended for BSFs and ISSFs.  
Accusand sieve analysis results are presented in Appendix 1.  A full characterization of the silica 
sand media, conducted by Pennoni Associates Inc., is presented in Appendix 2.  A particle size 
analysis conducted by Trimat Materials Testing, Inc. is presented in Appendix 3.  Both the silica 
sand and Accusand media were pre-washed via 24-hour exposure to 10% concentrated HCl, and 
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subsequently rinsed until the effluent water reached a pH of 5 (Litton & Olson, 1993).  The 
underdrain of each column was 1-3 cm layer of Poly-fil polyester fiber fill.   
The daily charge volume of water for the sand column filters, 500mL per filter per day, 
was determined by comparing the surface area ratio of a full-scale BSF treating 20 L/day to the 
corresponding dimensions of the sand column filters.  A volume of 20 L/day is considered the 
minimum amount of water required per person per day for basic drinking, hygiene and food 
preparation needs (Howard & Bartram, 2003).  For the bench-scale study, 10L of water was used 
per day for all 16 filters.  The total daily charge volume for each dose (2.5L) was distributed to 
four 500 mL graduated cylinders so that the challenge organism concentrations were identical for 
each chitosan dose condition.  The additional 0.5 L was included to account for aliquots of sand 
filter column influent and post-chitosan coagulated-flocculated and settled water that were taken 
before dosing such treated water into the filters, as well as limit the amount of settled floc in the 
water added to the sand filters.  Four different chitosan doses were evaluated and the daily 
charge volume of water for each chitosan dose was prepared in separate containers that also 
received approximately the same concentration of microorganisms.  The daily charge volume to 
the columns was introduced in 50 mL aliquots. Each filter had a standard maximum head volume 
of 7 cm in order to maintain similar daily filtration rates across all filters.  An external reservoir 
was not used to introduce the total daily charge water volume at one time, so no consistent 
pattern of decline in head was observed or controlled for in the experiment.  Additionally, the 
filters were not operated like typical BSFs.  Weekly scouring of the top 3 cm layer of each sand 
column may have effectively disrupted any growth of a schmutzdecke.  Despite weekly scouring, 
the flow rate declined in the filter columns over each week of operation and generally over the 
57-day dosing period of the experiment.  The location of the outlet tube for sand filter column 
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effluent water was lowered in an attempt to adjust for this flow rate decline in order to maintain 
similar flow rates over the duration of the study period.  The weekly scouring procedure 
involved: (1)  disrupting the top 3 cm of sand in each filter column with a sterile 5-mL pipette for 
30 seconds, (2) then adding 50 mL of DI water to the top of the columns in order to suspend the 
material released from this scoured top layer of the sand bed and (3) then aspirating this resulting 
mixture from the top of the sand filter column into the pipette and discharging it to waste.  This 
cleaning procedure was repeated twice in succession for each sand column filter, and then the 
filters were returned back to daily use.  
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Figure 1. Cross-section of bench-scale columns used in 57-day evaluation 
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3.3 Challenge Water for Microbial Evaluation  
 
A diagram of the experimental design is presented in Figure 2.  The challenge water for 
chitosan coagulation-flocculation-sedimentation and then sand filter column dosing was obtained 
by periodic surface grab sampling from University Lake in Carrboro, NC.  University Lake is 
one of the protected reservoirs OWASA uses to supply drinking water to the residents of Chapel 
Hill and Carrboro, NC.  University Lake does not receive any identifiable wastewater discharges.  
The average water quality parameters of University Lake over the study period, October 22nd – 
December 22nd, 2018, are provided in Table 4.  Based on longitudinal water quality data 
provided by OWASA, the fall turnover event for University Lake occurred around the end of 
November to early December 2018.  Water was collected every 1.5 weeks and stored at 4°C for 
daily use.  The day before dosing, the stored water was left out overnight to reach room 
temperature (about 20°C).  Such water storage conditions were intended to achieve a low and 
relatively consistent water storage temperature over the course of the 57-day experiment and 











Table 4. Average water quality parameters for University Lake over the 57-day study period 
(October 24th – December 21st, 2018) 
Parameter Units Average Values (+/- SDa) 
pH  6.87 (+/- 0.228) 
Temperature  °C 9.90 (+/- 3.40) 
Specific Conductance mS/cm 0.088 (+/- 0.011) 
Conductivity uS/cm 62.70 (+/- 10.25) 
Dissolved Oxygen %  % 98.06 (+/- 14.79) 
Dissolved Oxygen Concentration mg/L  11.12 (+/- 1.75) 
Chlorophyll  ug/L  10.80 (+/- 8.27)  
BGA Phycocyanin Cells/mL 3385.80 (+/- 1298.36) 
Fluoride mg/L  <0.10 
Total Coliform  MPN/100 mL 1762.5 (+/- 2363.7)  
E. coli MPN/100 mL 112.15 (+/- 155.78) 
TOC mg/L 7.11 (+/- 1.615)  
UV254 cm-1 0.225 (+/- 0.048) 
DOC mg/L 6.04 (+/- 1.43)  
Alkalinity mg/L CaCO3 23.10 (+/- 4.56)  
aSD = standard deviation 
The non-pathogenic test microbes used as bacterial and viral surrogates in this 
experiment were E. coli KO11 (ATCC# 55124) and Male-specific (F+) coliphage 
(bacteriophage) MS2 (ATCC# 15597-B1), respectively.  E. coli KO11 was chosen because of its 
resistance to the antibiotic chloramphenicol, which was added to agar media to select for the 
bacterium of interest while excluding other interfering or background microorganisms.  E. coli 
KO11 is also relatively easy to culture in the laboratory and is a similar size and morphology to 
common waterborne pathogens such as Shigella spp., Campylobacter spp., Salmonella spp., and 
Vibrio spp.  These characteristics make it a representative model organism for the evaluation of 
bacterial pathogen reductions achieved by chitosan coagulation-flocculation-sedimentation and 
physical removal by sand column filters.   
Bacteriophage MS2 was a suitable virus indicator organism because it shares many 
common characteristics with noroviruses, enteroviruses and hepatitis A and E viruses with based 
on shape, size, nucleic acid and outer protein capsid.  MS2 is also simple to propagate and store 
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in the laboratory, not pathogenic, and can be enumerated easily for its infectivity using 
standardized culture-based assays.  Previous research has also determined that MS2 is a 
conservative estimator of viral reductions achieved via filtration mechanisms as well as 
coagulation, flocculation, and sedimentation treatments (Kinoshita, Bales, Maguire, & Gerba, 
1993; Powelson, Simpson, & Gerba, 1990; Schijven, De Bruin, Hassanizadeh, & De Roda 
Husman, 2003; Schijven, Hassanizadeh, & De Bruin, 2002). 
 All microbe stock suspensions were prepared to ensure at least a 6 log10 per 100 mL 
spiking concentrations in test water so that reductions of 99.9999% or 6 log10 could be measured.  
A 1 mL volume of frozen suspension of overnight log10 phase growth culture of E. coli KO11 
was added to 200 mL tryptic soy broth (TSB) with 1% V/V chloramphenicol stock solution 
(100x stock concentration, 3.4 g/L chloramphenicol dissolved in ethanol, filtered through 0.22-
µm-pore-size membrane filter) in a shaker flask.  The culture was incubated at 37°C on a shaker 
table set to 100 rpm for 18-24 hours.  The resulting culture was distributed into four 50 mL 
falcon tubes and centrifuged at 3000 rpm for 15 minutes at 4°C in a Sorvall refrigerated 
centrifuge with H6000a swing bucket rotor.  Approximately 45 mL of the supernatant was 
decanted and disposed, then the equivalent volume of phosphate buffer (PB) was added 
(Standard Methods buffer, with 5 mL/L 0.4 M MgCl2 concentrated stock solution) and vortexed.  
The suspension was centrifuged and washed three times with this buffer composition.  The final 
suspension of E. coli was vortexed in PB (Standard Methods buffer, with 5 mL/L 0.4 M MgCl2 
concentrated stock solution) until the pellet was completely dispersed in solution.  The resulting 
E. coli concentration of this suspension was approximately 106 CFU/mL.  Each 2.5-liter batch of 
test water received 15 mL of this concentrated E. coli KO11 suspension per day.  Washed E. coli 
KO11 cells were prepared each sample day, and leftover washed cells were used on non-
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sampling days.  A 1 mL volume of propagated and chloroform extracted MS2 bacteriophage 
stock at a titer of 1x1011 PFU/mL, stored in -80°C, was added to each 2.5 L batch of challenge 
water daily.  
 
Figure 2. Diagram of experimental design for batch water preparation and dosing into filters 
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3.4 Chitosan Dosing and Mixing 
 
Chitosan acetate (CH3COO−) was selected as the coagulant based on previous work that 
identified it in a systematic screening as one of the most effective chitosan coagulant types for 
bacteria and virus reduction (Soros, 2015; Soros et al., 2019)  Food grade chitosan was 
purchased from Sarchem Laboratories, Inc in powder form.  According to their certificate of 
analysis, the degree of deacetylation and pH of the food grade chitosan acetate are 90.3% and 
4.2, respectively.  The full certificate of analysis can be found in Appendix 4. 
A 2 g/L solution of liquid chitosan was prepared using 2 g chitosan acetate and 1 liter of 
autoclaved lab grade deionized water.  Each batch of test water received an appropriate volume 
of liquid chitosan solution to achieve the target dose.  Three doses of chitosan were tested in the 
57-day bench-scale study along with a control condition with no chitosan treatment: 0 mg/L, 3 
mg/L, 10 mg/L and 30 mg/L.  Duplicate sand column filters were run for each dose for each sand 
type.  Doses were calculated using the dilution equation below: 
Concentration (Stock) x Volume (Stock) = Concentration (Sample) x Volume (Sample) 
After adding liquid chitosan to the test water, the solutions were rapidly mixed at 
approximately 100 rpm for 1 minute, then the water was left to settle for 5 minutes.  The water 
was then slowly mixed for 1 minute at approximately 25-30 rpm, left to settle for 5 minutes, and 
then slow mixed for a final minute before settling for a final 17 minutes.  Total coagulation-
flocculation-settling time for all test waters was 30 minutes.  At 30 minutes, post-chitosan 
samples were taken for analysis and 500 mL of the challenge water was dosed to each filter.   
3.5 Measurement of Flow in Sand Filter Columns 
 
Flow rates for all sand filters were measured twice per week, on sampling days, over the 
course of the evaluation period.  The measure of flow through the filters followed a standard 
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procedure: the timer was started when the challenge water was dosed into the upper receptacle 
with a maximum head of 7cm.  The time it took for 50 mL of water to flow through the sand 
filter was recorded.  All outlet tubes were adjusted in location to achieve an approximately 
similar flow rate and flow rate measurement served to ensure these flow rates were comparable 
for each filter sand column type.  Flow rates were not kept consistent between sand types.   
3.6 Sampling of Sand Filter Columns 
 
Samples from chitosan coagulation and sand columns filtration were processed twice per 
week over the 57-day study period, resulting in 17 total challenge experiments.  Samples were 
taken from the pretreated and prefiltered spiked water (influent), the post coagulation treated 
unfiltered water (post-chitosan), and the post-treated and post sand column filtered water 
(effluent).  These samples were taken for both the test (chitosan treated) and control filters.  
Dosing occurred in the morning, and on test days, sample processing and assays were performed 
on the same day.  For effluent filtered samples, only 50 mL were taken for analysis.  The 50 mL 
samples were retrieved after at least 250 mL of the daily charge volume had already passed 
through the filter.  This ensured that the water sampled corresponded to the day it was dosed, not 
any idle water remaining in the filter from the previous day.  After all samples were collected 
and assays were completed, samples were stored in labeled sterile containers at 4°C.  Serial 10-
fold dilutions for each sample were made with PB (Standard Method buffers, with 5 mL/L 0.4 M 
MgCl2 concentrated stock solution).   
3.7 Turbidity and pH  
 
A Hach turbidimeter was used to measure the turbidity of influent, post-chitosan 
coagulated and sand filter effluent waters.  A Denver Instrument, model 215, pH meter was used 
to measure the pH of influent, post-chitosan coagulated and sand filter effluent waters.  All 
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samples were thoroughly vortexed before measurements were taken, and turbidity values were 
recorded for all samples after 1 and 2 minutes in the turbidimeter.  Turbidity values for post-
chitosan coagulated samples were taken again after a 3-hour settling period.  If samples were not 
processed within 48 hours of the experiment, they were frozen at -20°C to prevent any regrowth 
in the samples.  
3.8 Microbial Methods 
 
Culture based methods were used to quantify microbial concentrations for the influent, 
post-chitosan coagulated and sand filter effluent samples.  The spread plate method was used to 
quantify E. coli KO11 concentrations as colony forming units (CFU) per mL (Eaton, Clesceri, 
Greenberg, & Franson, 1998).  Awesome agar, consisting of 40 g/L tryptic soy agar plus 30 
mg/L neutral red and 10 g/L lactose, amended with 1% (V/V) chloramphenicol stock (100x stock 
concentration, 3.4 g/L chloramphenicol dissolved in ethanol, filtered through 0.22-µm-pore-size 
membrane filter), was used to limit background organism interference.  The double agar layer 
(DAL) plaque assay method (EPA 1601) on TSA plates with 1% (V/V) streptomycin/ampicillin 
stock (100x stock concentration, 1.5 g/L ampicillin sodium salt and 1.5 g/L streptomycin sulfate 
dissolved in deionized water, filtered through 0.22-µm-pore-size membrane filter) and E. coli 
Famp bacteria host was used to quantify MS2 as plaque forming units (PFU)/mL (Environmental 
Protection Agency, 2001).  
3.9 Data Management and Statistical Analysis 
 
 All data were recorded and maintained spreadsheets in excel and then further analyzed by 
statistical methods in RStudio.  E. coli K011 and MS2 concentrations were calculated using two 
replicates per sample dilution.  Influent to effluent log10 reduction values (LRVs) were calculated 
using the following equation:  
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Log reduction = log10(Influent water concentration) - log10(effluent water concentration) 
Two separate statistical analyses were performed: a cumulative analysis of all data ignoring time 
(day of experiment) as a variable, and a binned analysis to assess how filter performance 
changed with time over the 57-day experiment period.  The 17 total experiments over the 57-day 
study period were grouped into four time bins, as shown in Table 5.  
Table 5. Time bin assignments for experiments 
Bin Experiment Numbers in Bins (Intervals) for n = 17 Total Experiment Days 
1 1-5 (n = 5) 
2 6-9 (n = 4) 
3 10-13 (n = 4) 
4 14-17 (n = 4) 
 
The data for both analyses did not conform to a Gaussian distribution according to the 
Kolmogorov-Smirnov test.  Non-parametric statistics were used to compare median log10 
reductions achieved across chitosan doses and the two sand types.  The Kruskal-Wallis test was 
used to compare log10 reductions achieved by all chitosan doses for the same sand type and to 
compare all intervals across all doses and stratified by dose.  The Wilcoxon rank-sum test was 
used to compare reductions of bacteria and viruses between chitosan doses for the same sand 
type, between sand types with the same chitosan dose and between intervals across doses and 
stratified by dose.  The unpaired p-values reported were adjusted for multiple comparisons using 
the Bonferroni correction.  The Spearman Rank Correlation was used to evaluate correlations 
between microbial log10 reductions, turbidity reductions and sand column effluent filtration rates.  
This correlation method is well suited for nonparametric data because, rather than measuring a 
linear association between variables, it measures the monotonic relationship between the 
variables.  An alpha level of 0.05 (p < 0.05) was used as the significance level for all statistical 
tests.  
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Although the data did not conform to a Gaussian distribution, bar and line graphs were 
created to visualize differences between filters in terms of average LRVs and changes in LRVs 
over time.  Bar graphs of average LRVs with standard deviation error bars were created in Excel.  
Line graphs of the LRVs achieved for each filter over time were created in Excel.  Box plots of 
the calculated log10 reductions for both the cumulative and binned analyses were computed in 
RStudio.   The ends of the box represent the 25th and 75th percentiles and the whiskers represent 
the 5th and 95th percentiles of the data distribution.  The horizontal line in the box represents the 




CHAPTER 4: RESULTS 
 
4.1 Results and Descriptive Statistics for Microbial and Turbidity Reductions from Water 
by Chitosan Coagulation and Sand Column Filtration 
 
The average E. coli KO11 LRVs for each column over the 57-day duration of operation 
are summarized in Figure 3 for columns of both sand types.  The average MS2 coliphage LRVs 
are summarized in Figure 4.  The average turbidity LRVs for each column are summarized in 
Figure 5.  The error bars represent the standard deviation of the average values.  The raw LRV 
data for all filters on each sampling day is presented in Appendix 4 (E. coli KO11), Appendix 5 
(MS2 coliphage) and Appendix 6 (turbidity).  The average LRVs by combined chitosan 
coagulation and sand filtration ranged from less than 0.5-log10 to greater than 4.5-log10 for E. coli 
KO11 in Accusand columns and from 0.5-log10 to nearly 4-log10 for silica columns (Figure 3).  
The average LRVs reported for Accusand columns were higher than those reported for silica 
sand columns for all chitosan doses except 3 mg/L, which were both around 1 LRV.  Control 
filters not dosed with chitosan (dose = 0 mg/L) did not exceed a 0.5-log10 E. coli KO11 LRV for 
both sand types.  Filters dosed with water coagulated with 10 mg/L chitosan achieved average 
LRVs of about 4.5-log10 and nearly 4-log10 for Accusand and silica sand columns, respectively.  
Although greater variability is observed between duplicate filters of each sand type, those dosed 
with water coagulated with 30 mg/L chitosan reached average LRVs exceeding 3.5-log10 for 
Accusand-filled columns and greater than 1.5-log10 for silica sand-filled columns.  
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Figure 3. Average Log10 Reduction Values with standard deviation error bars for E. coli KO11in 
water treated by chitosan coagulation and Accusand and silica sand column filtration, based on 
17 successive samples collected throughout the 57-day experiment period. 
The average LRVs by combined chitosan coagulation and sand filtration ranged from less 
than 0.5-log10 to nearly 4.5-log10 for MS2 coliphage in the Accusand-filled columns and ranged 
from less than 0.5-log10 to nearly 4-log10 for the silica sand-filled columns (Figure 4).  As was 
observed with E. coli KO11 LRVs, the MS2 coliphage LRVs were generally higher for 
Accusand columns compared to silica sand columns across doses; however, the control filters for 
both sand types achieved similar MS2 LRVs.  Control filters dosed with water receiving no 
chitosan (dose = 0 mg/L) did not exceed 0.5 LRV for MS2 coliphage for either sand type.  Filters 
dosed with water coagulated with 3 mg/L chitosan achieved on average 1.5-log10 and 1.0-log10 
reductions for MS2 coliphage in Accusand and silica sand columns, respectively.  Filters dosed 
with water coagulated with 10 mg/L chitosan achieved LRVs for MS2 coliphage of ~4.5-log10 
 52 
for Accusand columns and greater than 3.5-log10 for silica columns.  Filters dosed with water 
treated with 30 mg/L chitosan achieved average MS2 coliphage LRVs of ~4-log10 for Accusand 
columns and ~2.5-log10 for silica columns.  
 
Figure 4. Average Log10 Reduction Values with standard deviation error bars for MS2 coliphage 
in water treated by chitosan coagulation and Accusand and silica sand column filtration, based 
on 17 successive samples collected throughout the 57-day experiment period. 
The turbidity reductions observed for Accusand columns were typically slightly greater 
than those observed for silica sand columns across doses (Figure 5).  The turbidity reductions for 
both sand types ranged from less than 0.2-log10 to about 1-log10.  Control filters receiving no 
chitosan dose (chitosan dose = 0 mg/L) achieved 0.2 LRVs or less in turbidity for both sand 
types.  With a 3 mg/L chitosan dose followed by sand filtration LRVs were about 0.6-log10 for 
Accusand filters and about 0.5-log10 for silica sand filters. At a 10 mg/L chitosan dose followed 
by sand filtration LRVs were higher, reaching 1.0-log10 for Accusand  filters and about 0.9-log10 
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for silica sand filters. However, at the highest dose of chitosan tested, 30 mg/l, followed by sand 
filtration turbidity reductions were lower than at 10 mg/L chitosan dose and similar to the 3 mg/L 
chitosan dose, with LRVs of about 0.7-log10 for Accusand and around 0.6-log10 for silica sand. 
 
Figure 5. Average Log10 Reduction Values with standard deviation error bars for turbidity in 
water treated by chitosan coagulation and Accusand and silica sand column filtration, based on 
17 successive samples collected throughout the 57-day experiment period. 
Duplicate filters of same sand type and chitosan dose behaved somewhat differently in 
observed LRVs over the 57-day experimental period, but the average LRVs achieved between 
the duplicates were similar and the changes over time were typically correlated.  The average 
differences in LRV values between the duplicate filters are reported in Table 6 along with the 
range of differences observed over the 57-day study period.  For most conditions, duplicate 
filters had on average less than 0.5-log10 differences between duplicates for E. coli KO11 and 

































water coagulated with 30 mg/L chitosan had higher average differences between duplicate filters 
for E. coli KO11 and MS2 coliphage.  E. coli KO11 LRVs for water coagulated with 30 mg/L 
chitosan reported maximum differences between duplicate filters exceeding 3-log10 for both 
Accusand and silica sand columns.  MS2 coliphage LRVs for 30 mg/L chitosan followed by 
silica sand filtration reported an average of about 0.8-log10 difference between the duplicates, 
with a maximum difference of 1.6-log10.  These results suggest that duplicate columns of the 
same sand type and dose tend to achieve similar LRVs for bacteria, viruses and turbidity.  
Though substantial differences are observed, especially with filters dosed with 30 mg/L chitosan-
coagulated water, the similarities in performance are strong enough to combine the duplicate 
filter LRVs in subsequent analyses.  
Table 6. The average, minimum and maximum differences in LRVs between duplicate filters for 
each sand type and chitosan dose over the 57-day filter operating time 
  E. coli KO11 MS2 Coliphage Turbidity 
Sand type Dose 
(mg/L) 
Average Min.  Max.  Average Min.  Max. Average Min. Max. 
Accusand 0 0.105 0.000 0.356 0.136 0.002 0.363 0.194 0.003 1.024 
Accusand 3 0.087 0.012 0.247 0.194 0.024 0.632 0.135 0.029 0.472 
Accusand 10 0.340 0.000 1.041 0.328 0.041 0.829 0.152 0.035 0.550 
Accusand 30 0.608 0.000 3.395 0.370 0.008 1.322 0.162 0.002 0.449 
Silica 0 0.094 0.000 0.321 0.249 0.000 0.698 0.087 0.006 0.304 
Silica 3 0.120 0.010 0.293 0.204 0.007 0.509 0.135 0.029 0.472 
Silica 10 0.201 0.002 0.662 0.366 0.024 1.031 0.152 0.035 0.550 
Silica 30 1.146 0.127 3.046 0.804 0.000 1.600 0.162 0.002 0.449 
 
While Figure 3, Figure 4 and Figure 5 are useful to visualize and compare average 
LRVs achieved among the different chitosan doses and sand filter columns, box and whisker 
plots better present the LRV distributions and their extent of variability observed among these 
different treatment conditions.  In subsequent sections, line graphs are presented that give LRV 
results achieved over time for each duplicate condition of chitosan dose and filter sand type and 
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allow visualization of differences in performance between these duplicates.  Nonparametric 
analyses of LRVs are based on average results for duplicate conditions of chitosan dose and sand 
filter reductions, so only one distribution is presented for each set of conditions for chitosan dose 
and sand filter type.   
4.2 Reductions for Bacterial indicator E. coli KO11 by Sand Filter Columns Dosed with 
Chitosan Coagulated Water 
 
The E. coli KO11 LRVs for each individual column over the 57-day study period are 
displayed in Figure 6 (Accusand-filled columns) and Figure 7 (silica sand-filled columns).  
Variability was observed in LRVs achieved over the 57-day study period at each time point 
across doses and between duplicate columns of the same sand type and chitosan dose.  With the 
exception of the filters dosed with water coagulated with 30 mg/L chitosan, duplicate filters of 
same sand type and dose achieved similar LRVs over the 57-day experiment period.   
LRVs for control Accusand filter columns (chitosan dose = 0 mg/L) remained below 1-
log10 over the course of the experiment.  LRVs were initially low for Accusand-filled columns 
receiving water dosed with 3 and 30 mg/L, hovering around 1-log10.  By the latter part of the 57-
day experiment period, the LRVs were higher at about 5 to 6-log10 for the columns receiving 
water dosed with 30 mg/L chitosan and also lower at about 2.5-log10 for the columns receiving 
water dosed with 3 mg/L chitosan.  Substantial variability was observed between days 15 and 27 
for the duplicate Accusand columns receiving water dosed with 30 mg/L.  Columns receiving 
waters dosed with 10 mg/L chitosan achieved high LRVs, around 5-log10, at the beginning and 
end of the study period.  There was a substantial decrease in LRVs of about 2 log10 observed 
between day 27 and nearly day 40 for water dosed with 10 mg/L chitosan.  This decline 
correlates with the fall turnover event in University Lake that occurred over the end of 
November, early December.   
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The duplicate silica sand-filled columns dosed with 30 mg/L chitosan-treated water did 
not give a consistent and monotonic pattern of LRVs and displayed considerable variability in 
LRVs the middle weeks of the experiment period.  This variability occurred around the fall 
turnover event for University Lake, though the pattern of LRVs over this period is so 
inconsistent it is unclear how the changing lake water quality parameters factored into filter 
performance at this dose. However, towards the end of the 57-day dosing period these columns 
began to achieve similar LRVs of about 2.5 to 3 LRV or more. It is noteworthy LRVs were 
initially highest at about 4-log10 for the samples dosed with 10 mg/L chitosan and remained 
generally high throughout the experiment period.  LRVs were initially low for silica sand 
columns dosed with water coagulated with both 3 and 30 mg/L chitosan and LRVs increased 
over the 57-day course of the experiment. LRV increases by sand columns receiving water with 
these two chitosan doses occurred more rapidly for the 30 mg/L dose than the 3 mg/L dose and 




Figure 6. E. coli KO11 reductions for Accusand-filled columns for samples collected throughout 
the 57-day study period, plotted over time (N=17).  
 
Figure 7. E. coli KO11 reductions for silica sand-filled columns for samples collected 
throughout the 57-day study period, plotted over time (N=17). 
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Duplicate filters for each dose and sand type generally behaved similarly in LRVs over 
the experiment period, therefore LRVs computed from the duplicate values were compiled for 
nonparametric analyses.  The E. coli KO11 reductions for each chitosan dose and between each 
sand type over the 57-day study period are summarized in the box and whisker plot shown in 
Figure 8.  The LRVs ranged widely among the chitosan doses from less than 0.5-log10 to greater 
than 6-log10.  As with the line graphs in Figure 6 and Figure 7, significant variability was 
observed within each experimental condition of chitosan dose and sand type.  Filters receiving 
30 mg/L chitosan-treated water displayed a particularly large range of LRVs for both silica- and 
Accusand filters, as shown by the large boxes and whiskers.  
Examination of Figure 8 shows differences in LRVs between the four different chitosan 
dose conditions within the same sand type.  For the Accusand columns, substantial differences in 
LRVs were observed between filters receiving 0 mg/L and 10 mg/L chitosan-treated water, 0 and 
30 mg/L chitosan-treated water, 3 and 10 mg/L chitosan-treated water, and 3 and 30 mg/L 
chitosan-treated water.  For the silica sand-filled columns, substantial differences in LRVs were 
observed among chitosan doses, with the biggest LRV differences and the highest LRV value for 
filters receiving water with the 10 mg/L chitosan dose compared to all other doses. The medians 
and ranges of LRVs for each chitosan dose between the silica and Accusand filter columns gave 
similar patterns of performance, but the Accusand columns consistently achieved higher LRVs 
than the silica sand columns across all chitosan doses.  Nonparametric statistical tests were 
performed to assess if these differences are statistically significant.  
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Figure 8. E. coli KO11 LRVs among chitosan doses of 0, 3, 10 and 30 mg/L presented 
cumulatively over the 57-day experiment period for Accusand filter columns and silica sand 
columns.  
 
The Kruskal-Wallis test was used to assess differences in overall median LRVs of E. coli 
KO11 for each sand type based on chitosan dose and resulting p-values of this statistical analysis 
are presented in Table 7.  There were statistically significant differences in bacteria LRVs based 
on chitosan dose for both Accusand and silica sand columns.    
Table 7. Kruskal-Wallis analysis results comparing cumulative median LRVs of E. coli KO11 
by chitosan dose, stratified by sand type. Reported p-values were adjusted using the Bonferroni 
correction, m = 2 
Sand Type Comparison p-valuea 
Accusand Dose (0, 3, 10, 30 mg/L 
chitosan) 
< 4.40E-16  
silica Dose (0, 3, 10, 30 mg/L 
chitosan) 
< 4.40E-16 
aBolded p-values are statistically significant at p < 0.05  
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 To evaluate how specific chitosan doses performed relative to one another within the 
same sand type, overall median LRVs of E. coli KO11 by chitosan dose were compared with the 
Wilcoxon Rank-Sum test.  The resulting p-values are presented in Table 8.  LRVs achieved by 
all doses of chitosan for both sand types were statistically significantly different than those 
achieved by the controls (0 mg/L chitosan-treated water).  LRVs achieved by columns dosed 
with 3 mg/L chitosan-treated water were statistically significantly lower than those achieved by 
10 mg/L and 30 mg/L chitosan-treated for both sand types.  There was not a significant 
difference in achieved LRVs between 10 mg/L and 30 mg/L chitosan-treated water for the 
Accusand columns, but the LRVs were significantly different for the silica sand columns. 
Table 8. Results of the Wilcoxon Rank-Sum analysis comparing overall median LRVs of E. coli 
KO11 by chitosan dose, stratified by sand type.  Reported p-values were adjusted using the 
Bonferroni correction, m = 6 
Sand Type Dose 1 (mg/L) Dose 2 (mg/L) p-valuea 
Accusand 0 3 3.04E-03* 
0 10 8.44E-12* 
0 30 1.45E-08* 
3 10 9.22E-12* 
3 30 1.36E-05* 
10 30 1.00* 
 
silica 0 3 1.23E-06* 
0 10 8.44E-12* 
0 30 8.03E-11* 
3 10 2.37E-12 
3 30 3.37E-03 
10 30 6.36E-08 
aBolded p-values are statistically significant at p < 0.05  
*p-values estimated with ties 
 
 The Wilcoxon Rank-Sum test was also used to compare overall median LRVs of E. coli 
KO11 between columns receiving water with the same chitosan dose but different sand types.  
The results are presented in Table 9.  Statistically significant differences in achieved LRVs were 
observed between sand types for columns dosed with 0, 10 and 30 mg/L chitosan-treated water.  
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LRVs achieved by Accusand columns dosed with 3 mg/L chitosan-treated water were not 
significantly different than those achieved by silica sand columns at the same dose.   
Table 9. Results of the Wilcoxon Rank-Sum analysis comparing cumulative median LRVs of E. 
coli KO11 by sand type, stratified by chitosan dose.  Reported p-values were adjusted using the 
Bonferroni correction, m = 4 
Dose (mg/L) Sand Type 1 Sand Type 2 p-valuea  
0 Accusand silica 5.06E-04* 
3 Accusand silica 1.00 
10 Accusand silica 7.88E-04* 
30 Accusand silica 2.91E-03* 
aBolded p-values are statistically significant at p < 0.05  
*p-values estimated with ties 
 
 The influence of the length of filter operation time, which possibly accounts for such 
phenomena as filter maturation and increased biological activity in the filters, on E. coli KO11 
LRVs is shown in Figure 9 and Figure 10.  In these box and whisker plots, the experiments 
were binned into 4 time groups of filter operation to observe if there are differences between 
LRVs achieved at the beginning, early middle, late middle and end of the 57-day experiment 
period. Both Figure 4.7 and 4.8 present the same data, but Figure 4.7 shows the LRVs for each 
bin side-by-side for each chitosan dose and separated by sand type.  This data presentation helps 
observe differences between LRVs over time for columns of the same sand type and chitosan 
dose.  Figure 4.8 presents the binned E. coli KO11 LRV data paired by sand type and chitosan 
dose, separated by time bins. This data representation is useful for comparing LRVs of the same 
chitosan dose and in the same time bin between the two sand types.   
LRVs for E. coli KO11 increased substantially from time interval 1 to time interval 4 for 
0, 3 and 30 mg/L columns.  The control columns for both sand types, dosed with untreated 
challenge water, displayed an approximately linear pattern of increasing LRVs over time.  Both 
silica- and Accusand-filled columns dosed with 3 mg/L chitosan-treated water had consistent 
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LRV values of approximately 0.5-log10 but displayed a substantial improvement to over 2-log10 
in the 4th time quadrant of the study period.  Accusand-filled columns dosed with 30 mg/L 
chitosan-treated water experienced significant stepwise improvement between intervals 1, 2 and 
3, then declined slightly in the fourth time interval.  For the silica-filled columns of the same 
dose, substantial LRV improvement was observed from interval 1 to 2, specifically 0.5-log10 to 
2-log10, but only gradual LRV increases were observed in subsequent intervals.  Both silica and 
Accusand-filled columns dosed with 10 mg/L chitosan-treated water did not experience 
substantial increases/declines in achieved LRVs across intervals, reporting LRVs of around 4- to 
5-log10 for all intervals.  One exception to this pattern was the 4th interval for silica sand-filled 
columns, which experienced a slight LRV decline to approximately 3.5-log10.  
Accusand-filled columns consistently achieved similar or higher LRVs across doses and 
time intervals compared to silica sand-filled columns.  Only one exception to this trend is 





Figure 9. Time binned E. coli KO11 LRVs across chitosan doses of 0, 3, 10 and 30 mg/L 
presented in time intervals over the 57-day experiment period for Accusand filter columns and 
silica sand columns. 
 
 
Figure 10. Alternative representation of the time binned E. coli KO11 LRVs across chitosan 
doses of 0, 3, 10 and 30 mg/L presented in time intervals over the 57-day experiment period for 
Accusand filter columns and silica sand columns. 
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 The Kruskal-Wallis test was used to assess if the differences between binned median 
LRVs of E. Coli KO11 were statistically significant when stratified by time, across all doses 
within the same sand type.  The resulting p-values are presented in Table 10.  Significant 
differences in LRVs were observed across intervals for Accusand columns but not for silica 
columns.  
Table 10. Results of the Kruskal-Wallis analysis comparing median LRVs of E. coli KO11 by 
time interval, stratified by chitosan dose and sand type. Reported p-values were adjusted using 
the Bonferroni correction, m = 2 
Sand Type Dose (mg/L) Comparison p-valuea  
Accusand All doses (0, 3, 
10, 30) 
Time Interval (1-4) 6.57E-04 
Silica All doses (0, 3, 
10, 30) 
Time Interval (1-4) 0.1474 
aBolded p-values are statistically significant at p < 0.05  
 
In order to evaluate how Accusand columns, across all doses, performed over time, 
binned median LRVs of E. coli KO11 were compared based on time interval with the Wilcoxon 
Rank-Sum test for multiple comparisons.  This analysis was not run for the silica sand-filled 
columns because the differences between intervals were not statistically significant (Kruskal-
Wallis p > 0.05).  The resulting p-values are reported in Table 11.  The results suggest there are 
significant differences in achieved LRVs for Accusand columns across all doses only between 







Table 11. Results of the Wilcoxon Rank-Sum analysis comparing median LRVs of E. coli KO11 
by time interval, stratified by sand type. Reported p-values were adjusted using the Bonferroni 
correction, m = 6 
Sand Type Dose (mg/L) Interval 1 Interval 2 p-valuea  
Accusand All doses (0, 3, 
10, 30) 
1 2 1.00* 
Accusand All doses (0, 3, 
10, 30) 
1 3 0.0616* 
Accusand All doses (0, 3, 
10, 30) 
1 4 8.75E-05* 
Accusand All doses (0, 3, 
10, 30) 
2 3 1.00* 
Accusand All doses (0, 3, 
10, 30) 
2 4 0.0736* 
Accusand All doses (0, 3, 
10, 30) 
3 4 1.00* 
aBolded p-values are statistically significant at p < 0.05  
*p-values estimated with ties 
 
 The same Kruskal-Wallis analysis conducted in Table 10 was run again, but for each 
dose.  This serves to evaluate differences in time binned median LRVs based on interval but 
accounting for different doses and sand types.  The adjusted p-values are presented in Table 12.  
These results illustrate that the differences observed when comparing LRVs by interval for all 
chitosan doses (Table 10) are attributable to specific doses.  For Accusand-filled columns, 0, 3 
and 30 mg/L doses were all significantly different across intervals.  For silica sand-filled 
columns, significant differences between intervals are only observed for chitosan doses of 0 and 






Table 12. Results of the Kruskal-Wallis analysis comparing median LRVs of E. coli KO11 by 
time interval, stratified by chitosan dose and sand type. Reported p-values were adjusted using 
the Bonferroni correction, m = 4 
Sand Type Dose (mg/L) Comparison p-value  
Accusand 0 Time Interval (1-4) 3.61E-04 
Accusand 3 Time Interval (1-4) 1.84E-03 
Accusand 10 Time Interval (1-4) 1.00 
Accusand 30 Time Interval (1-4) 2.40E-05 
silica 0 Time Interval (1-4) 0.0414 
silica 3 Time Interval (1-4) 1.44E-03 
silica 10 Time Interval (1-4) 0.326 
silica 30 Time Interval (1-4) 1.10E-03 
aBolded p-values are statistically significant at p < 0.05  
 
In order to evaluate how columns of the same sand type and chitosan dose performed 
over time, time binned median LRVs of E. coli KO11 were compared based on time interval 
with the Wilcoxon Rank-Sum test.  The resulting p-values are presented in Table 13.  These tests 
were only run for doses that were statistically significantly different between time intervals 
(Kruskal Wallis, p < 0.05). 
Accusand columns dosed with untreated water experienced statistically significant 
improvements in LRVs from time interval 1 to 4, but the stepwise improvements between 
intervals were not always statistically significant.  At 3 mg/L, Accusand columns experienced a 
statistically significant improvement in LRV performance between time interval 3 and 4, but 
prior to that point had consistent low LRVs of around 0.5-log10.  Statistically significant 
differences were observed between intervals 1 to 2 and 2 to 3 for Accusand columns dosed with 
30 mg/L chitosan-treated water, but the declines in LRVs between intervals 3 and 4 were not 
statistically significant.   
For silica sand columns dosed with untreated water, no statistically significant differences 
in LRV trends over time was observed except between intervals 2 and 3.  Silica sand filters 
receiving water dosed with 3 mg/L chitosan had statistically significantly improved LRVs at 
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time interval 4 but achieved similar LRVs in the first three intervals. Silica columns dosed with 
30 mg/L had statistically significant increases in LRVs from interval 1 to 2 but did not 
significantly improve over the last three intervals.  
Table 13. Results of the Wilcoxon Rank-Sum analysis comparing time binned median LRVs of 
E. coli KO11 for the same chitosan dose and sand type, between time intervals.  Reported p-
values were adjusted using the Bonferroni correction, m = 6 
Dose (mg/L) Sand Type  Interval 1  Interval 2  p-valuea 
0 Accusand 1 2 0.499 
0 Accusand 1 3 0.0373 
0 Accusand 1 4 7.05E-03* 
0 Accusand 2 3 0.0420 
0 Accusand 2 4 5.59E-03* 
0 Accusand 3 4 0.108* 
     
3 Accusand 1 2 1.00 
3 Accusand 1 3 1.00 
3 Accusand 1 4 2.74E-04 
3 Accusand 2 3 1.00 
3 Accusand 2 4 9.32E-04 
3 Accusand 3 4 9.32E-04 
     
30 Accusand 1 2 5.48E-04 
30 Accusand 1 3 2.66E-03* 
30 Accusand 1 4 2.74E-04 
30 Accusand 2 3 8.02E-03* 
30 Accusand 2 4 0.124 
30 Accusand 3 4 0.394* 
     
0 silica 1 2 1.00* 
0 silica 1 3 0.0130* 
0 silica 1 4 0.410* 
0 silica 2 3 0.0886 
0 silica 2 4 1.41 
0 silica 3 4 5.75 
     
3 silica 1 2 1.00 
3 silica 1 3 1.00 
3 silica 1 4 2.74E-04 
3 silica 2 3 1.00 
3 silica 2 4 9.32E-04 
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3 silica 3 4 9.32E-04 
     
30 silica 1 2 0.0123 
30 silica 1 3 5.21E-03 
30 silica 1 4 2.74E-04 
30 silica 2 3 1.00 
30 silica 2 4 1.00 
30 silica 3 4 0.390 
aBolded p-values are statistically significant at p < 0.05  
*p-values estimated with ties 
 
The Kruskal-Wallis test was used to assess differences in time binned median LRVs of E. 
coli KO11 for each sand type based on dose of chitosan within a single time interval. The 
resulting p-values are presented in Table 14.  There are statistically significant differences in 
LRVs achieved by columns of both sand types and across all intervals based on dose.  
Table 14. Results of the Kruskal-Wallis analysis comparing time binned median LRVs of E. coli 
KO11 by chitosan dose, stratified by sand type. Reported p-values were adjusted using the 
Bonferroni correction, m = 2 
Bin Sand Type Comparison p-valuea  
1 Accusand Dose (0, 3, 10, 30 mg/L chitosan) 4.37E-06 
1 silica Dose (0, 3, 10, 30 mg/L chitosan) 6.28E-07 
2 Accusand Dose (0, 3, 10, 30 mg/L chitosan) 3.80E-05 
2 silica Dose (0, 3, 10, 30 mg/L chitosan) 2.30E-05 
3 Accusand Dose (0, 3, 10, 30 mg/L chitosan) 1.87E-05 
3 silica Dose (0, 3, 10, 30 mg/L chitosan) 2.80E-05 
4 Accusand Dose (0, 3, 10, 30 mg/L chitosan) 1.52E-05 
4 silica Dose (0, 3, 10, 30 mg/L chitosan) 8.04E-04 
aBolded p-values are statistically significant at p < 0.05  
 
 To compare how different doses performed within the same time interval, time binned 
median LRVs of E. coli KO11 for each sand type were compared based on dose with the 
Wilcoxon Rank-Sum test.  The resulting p-values are presented in Table 15.  In interval 1, LRVs 
achieved by all chitosan doses for both sand types were statistically significantly different than 
those achieved by the controls (0 mg/L chitosan-treated water).  LRVs achieved by Accusand 
and silica sand columns dosed with 10 mg/L chitosan-treated water were statistically 
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significantly higher than those dosed with 3 mg/L and 30 mg/L in interval 1.  Differences in 
median LRVs achieved by columns dosed with 3 mg/L and 30 mg/L chitosan-treated water were 
not statistically significant in interval 1.  
 In interval 2, LRVs achieved by columns dosed with 10 mg/L and 30 mg/L chitosan-
treated water were significantly different than those dosed with untreated and 3 mg/L.  This was 
observed for both sand types.  For both Accusand and silica sand columns, the LRVs reported for 
columns dosed with untreated water were not significantly different than those dosed with 3 
mg/L chitosan-treated water.  Differences in LRVs between 10 mg/L and 30 mg/L were also not 
statistically significant.  These patterns of differences were the same in interval 3, with one 
exception.  LRVs achieved by Accusand columns dosed with 10 mg/L and 30 mg/L were 
statistically significant in the 3rd interval.  
 In interval 4, statistically significant differences in achieved LRVs were observed 
between Accusand columns dosed with 3, 10 and 30 mg/L chitosan-treated water compared to 
the columns dosed with uncoagulated water.  LRVs for Accusand columns receiving 3 mg/L 
chitosan-treated water were statistically significantly lower than for 10 mg/L and 30 mg/L 
chitosan-treated water.  There was not a significant difference in performance in interval 4 
between columns dosed with 10 mg/L or 30 mg/L chitosan-treated water.  silica sand columns 
dosed with 3, 10 and 30 mg/L all had statistically significantly higher LRVs compared to control 
filters without chitosan coagulation, but no statistically significant differences in LRVs were 
observed between these chitosan doses.  
Table 15. Results of the Wilcoxon Rank-Sum analysis comparing time binned median LRVs of 
E. coli KO11 by chitosan dose, stratified by sand type.  Reported p-values were adjusted using 
the Bonferroni correction, m = 6 
Bin Sand Type Dose 1 (mg/L) Dose 2 (mg/L) p-value  
1 Accusand 0 3 9.03E-03 
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1 Accusand 0 10 1.09E-03* 
1 Accusand 0 30 9.03E-03 
1 Accusand 3 10 1.09E-03* 
1 Accusand 3 30 1.00 
1 Accusand 10 30 1.09E-03* 
     
1 silica 0 3 1.09E-03* 
1 silica 0 10 1.09E-03* 
1 silica 0 30 1.09E-03* 
1 silica 3 10 6.50E-05 
1 silica 3 30 1.00 
1 silica 10 30 6.50E-05 
     
2 Accusand 0 3 0.169 
2 Accusand 0 10 9.32E-04 
2 Accusand 0 30 9.32E-04 
2 Accusand 3 10 9.32E-04 
2 Accusand 3 30 9.32E-04 
2 Accusand 10 30 1.00 
     
2 silica 0 3 0.0625 
2 silica 0 10 9.32E-04 
2 silica 0 30 9.32E-04 
2 silica 3 10 9.32E-04 
2 silica 3 30 6.53E-03 
2 silica 10 30 0.124 
     
3 Accusand 0 3 1.00 
3 Accusand 0 10 9.32E-04 
3 Accusand 0 30 5.54E-03* 
3 Accusand 3 10 9.32E-04 
3 Accusand 3 30 5.54E-03* 
3 Accusand 10 30 8.02E-03* 
     
3 silica 0 3 0.963 
3 silica 0 10 9.32E-04 
3 silica 0 30 9.32E-04 
3 silica 3 10 9.32E-04 
3 silica 3 30 9.32E-04 
3 silica 10 30 0.124 
     
4 Accusand 0 3 5.59E-03* 
4 Accusand 0 10 5.59E-03* 
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4 Accusand 0 30 5.59E-03* 
4 Accusand 3 10 9.32E-04 
4 Accusand 3 30 9.32E-04 
4 Accusand 10 30 1.00 
     
4 silica 0 3 9.32E-04 
4 silica 0 10 9.32E-04 
4 silica 0 30 9.32E-04 
4 silica 3 10 1.00 
4 silica 3 30 1.00 
4 silica 10 30 1.00 
aBolded p-values are statistically significant at p < 0.05  
*p-values estimated with ties 
 
 Time binned median LRVs of E. coli KO11 for each dose were compared based on sand 
type with the Wilcoxon Rank-Sum test in order to evaluate differences in performance between 
Accusand and silica sand columns within the same time interval.  The resulting p-values are 
presented in Table 16.  The LRVs between the two sand types when dosed with untreated water 
were statistically significantly different in time intervals 2, 3 and 4, but not in interval 1.  
Accusand and silica sand columns dosed with 3 mg/L chitosan-treated water did not have 
significant differences in median LRVs across all time intervals.  Performance between the two 
sand types at 10 mg/L chitosan-treated water was significantly different in time intervals 1 and 4.  
At 30 mg/L, no statistically significant difference performance was observed in interval 1 
between the two sand types, but Accusand columns performed significantly better than silica 






Table 16. Results of the Wilcoxon Rank-Sum Analysis, comparing time binned median LRVs of 
E. coli KO11 by sand type, stratified by chitosan dose.  Reported p-values were adjusted using 
the Bonferroni correction, m = 4 
Bin  Dose (mg/L) Sand Type 1 Sand Type 2  p-valuea 
1 0 Accusand silica 0.302* 
1 3 Accusand silica 0.870 
1 10 Accusand silica 0.0113* 
1 30 Accusand silica 1.00 
     
2 0 Accusand silica 0.0186 
2 3 Accusand silica 1.00 
2 10 Accusand silica 1.00 
2 30 Accusand silica 0.0416 
     
3 0 Accusand silica 0.0827 
3 3 Accusand silica 1.00 
3 10 Accusand silica 1.00* 
3 30 Accusand silica 3.69E-03* 
     
4 0 Accusand silica 7.73E-03* 
4 3 Accusand silica 0.0590 
4 10 Accusand silica 6.22E-04 
4 30 Accusand silica 6.22E-04 
aBolded p-values are statistically significant at p < 0.05  
*p-values estimated with ties 
 
4.3 Reductions for Viral Indicator MS2 Coliphage by Sand Filter Columns Dosed with 
Chitosan Coagulated Water 
 
The MS2 Coliphage LRVs for each individual sand filter column over the 57-day 
experiment period are displayed in Figure 11 for Accusand columns and Figure 12 for silica 
columns.  Variability was observed in LRVs achieved over the 57-day experiment period at each 
time point among chitosan doses and between duplicate filter columns of the same sand type and 
chitosan dose.  Duplicate filters of same sand type and dose behaved similarly over the study 
period; however, the duplicate silica sand columns dosed with 30 mg/L chitosan-treated water 
had greater observable variability in LRVs throughout the study than observed for other chitosan 
doses.  As was observed with the E. coli KO11 reductions, columns receiving water dosed with 
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10 mg/L chitosan experienced a decline in LRVs during the middle of the study period, which 
corresponds to when the fall turnover event in University lake occurred.  This decline is also 
observed for the 3 mg/L chitosan dose with both sand types and for 30 mg/L chitosan in silica 
sand columns.     
 
Figure 11. MS2 coliphage reductions for Accusand-filled columns dosed with water coagulated 
with different chitosan doses for 17 successive samples collected over time throughout the 57-
day experiment period. 
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Figure 12. MS2 coliphage reductions for silica sand columns dosed with water coagulated with 
different chitosan doses for 17 successive samples collected over time throughout the 57-day 
experiment period. 
Because the duplicate sand filters for each chitosan dose and sand type performed 
similarly in LRV over the study period, the LRVs for the duplicates were compiled for 
nonparametric analyses.  The MS2 coliphage reductions for each chitosan dose and between each 
sand type over the 57-day experiment period are summarized in the box and whisker plot shown 
in Figure 13.  The LRVs range widely among chitosan doses from less than 0.5-log10 to greater 
than 4-log10.  As with the line graphs of LRVs in Figures 4.9 and 4.10, significant variability in 
LRVs is observed for each condition of chitosan dose and sand type, among these doses and 
between sand types.   
From examination of Figure 13, LRV differences are observed among the 4 different 
chitosan dose conditions within the same sand type.  For the Accusand columns, considerable 
LRV differences were observed between filters receiving 0 mg/L and 10 mg/L chitosan-treated 
water, 0 and 30 mg/L chitosan-treated water, 3 and 10 mg/L chitosan-treated water, and 3 and 30 
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mg/L chitosan-treated water.  Similar differences in LRVs were observed for the silica sand 
columns between those same chitosan dose pairs as well as between 10 mg/L and 30 mg/L 
chitosan doses. As with E. coli KO11, MS2 coliphage LRVs for Accusand columns consistently 
performed similarly or better than the silica sand columns across all chitosan doses.  
Nonparametric statistical tests were performed to assess if these observed LRV differences were 
statistically significant.  
 
Figure 13. MS2 coliphage LRVs among chitosan doses of 0, 3, 10 and 30 mg/L presented 
cumulatively over the 57-day experiment period for Accusand filter columns and silica sand 
columns. 
The Kruskal-Wallis test was used to assess differences in cumulative median LRVs of 
MS2 coliphage for each sand type based on chitosan dose.  The resulting p-values are presented 
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in Table 17.  There are statistically significant differences in virus LRVs based on dose of 
chitosan for both Accusand and silica sand filter columns.  
Table 17. Kruskal-Wallis analysis results comparing cumulative median LRVs of MS2 
coliphage by chitosan dose, stratified by sand type. Reported p-values were adjusted using the 
Bonferroni correction, m = 2 
Sand Type Comparison p-valuea  
Accusand Dose (0, 3, 10, 30 mg/L 
chitosan) 
< 4.40E-16  
silica Dose (0, 3, 10, 30 mg/L 
chitosan) 
< 4.40E-16 
aBolded p-values are statistically significant at p < 0.05  
 
The Wilcoxon Rank-Sum test was used to compare overall median LRVs of MS2 
coliphage based on chitosan dose in order to evaluate how specific doses of chitosan performed 
relative to one another within the same sand type.  The resulting p-values are presented in Table 
18.  LRVs reported for filter columns of both sand types dosed with 3, 10 and 30 mg/L of 
chitosan were statistically significantly different than those reported for columns dosed with 
untreated water.  Both 10 mg/L and 30 mg/L chitosan doses statistically significantly 
outperformed the 3 mg/L dose for both sand types.  Statistically significant differences in LRVs 
were observed between silica sand columns receiving 10 mg/L and 30 mg/L chitosan-treated 








Table 18. Wilcoxon Rank-Sum analysis results comparing cumulative median LRVs of MS2 
coliphage by chitosan dose pairs, stratified by sand type.  Reported p-values were adjusted using 
the Bonferroni correction, m = 6 
Sand Type Dose 1 (mg/L) Dose 2 (mg/L) p-valuea 
Accusand 0 3 3.25E-07 
0 10 1.32E-15 
0 30 1.32E-15 
3 10 2.79E-14 
3 30 3.35E-10 
10 30 1.00 
 
silica 0 3 1.68E-04* 
0 10 8.44E-12* 
0 30 8.44E-12* 
3 10 1.32E-15 
3 30 1.97E-07* 
10 30 7.37E-06* 
aBolded p-values are statistically significant at p < 0.05  
*p-values estimated with ties 
 
 To evaluate differences in LRVs between the two different sand filter column types 
receiving the same chitosan dose, a Wilcoxon Rank-Sum Test was used to compare median 
LRVs between sand filter column types for each of the chitosan doses.  The results are presented 
in Table 19.  There were no significant differences between the LRVs achieved by two different 
sand column types dosed with untreated water and 3 mg/L chitosan-treated water.  LRVs 
attained with Accusand filter columns were statistically significantly higher for 10 mg/L and 30 







Table 19. Results of the Wilcoxon Rank-Sum analysis comparing cumulative median LRVs of 
MS2 coliphage by sand type, stratified by chitosan dose.  Reported p-values were adjusted using 
the Bonferroni correction, m = 4 
Dose (mg/L) Sand Type 1 Sand Type 2 p-valuea  
0 Accusand silica 1.00* 
3 Accusand silica 0.934 
10 Accusand silica 0.0138 
30 Accusand silica 3.12E-05* 
aBolded p-values are statistically significant at p < 0.05  
*p-values estimated with ties 
 
The influence of duration of time of the experiment, which may account for maturation, 
increased biological activity and floc accumulation in the filters, on MS2 coliphage LRVs is 
shown in Figure 14 and Figure 15.  These box and whisker plots were created in the same way 
as were those for the E. coli KO11 time binned analysis.  Figure 14 and Figure 15 present the 
same data, but Figure 14 shows the MS2 coliphage LRVs for each time bin side-by-side for each 
dose, separated by sand type and Figure 15 presents the time binned LRV data paired by sand 
filter type and chitosan dose, separated by time bins.  
LRVs for MS2 coliphage increased substantially from time interval 1 to time interval 4 
for 0, 3 and 30 mg/L columns.  The control columns for both sand types, dosed with challenge 
water not treated with chitosan, achieved their maximum LRVs for MS2 coliphage in the 4th 
interval.  LRVs in intervals 1-3 did not conform to a specific pattern.  Both silica- and Accusand 
columns dosed with 3 mg/L chitosan-treated water had consistent LRV values of approximately 
0.5- to 1-log10 initially but displayed a substantial improvement to over 2-log10 and 3-log10 
reduction in the 4th time quadrant of the study period, respectively.  Accusand-filled columns 
dosed with 30 mg/L chitosan-treated water gave significant stepwise improvement in LRV 
between interval 1, 2 and 3, and then declined slightly in the fourth time interval.  For the silica-
filled columns of the same dose, significant improvement was observed from time interval 1 to 2, 
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specifically 2-log10 to 3-log10, but was around 3-log10 for subsequent time intervals.  Both silica 
and Accusand-filled columns dosed with 10 mg/L chitosan-treated water gave LRVs of 4 or 
more in time intervals 1 and 2, then experienced declines to about 3 LRV in time interval 3, but 
again improved to about 4-LRV in time interval 4.   
Accusand filter columns generally achieved similar or higher LRVs across chitosan doses 
and time intervals compared to silica sand filter columns.   
 
Figure 14. Time binned MS2 coliphage LRVs across chitosan doses of 0, 3, 10 and 30 mg/L 
presented in time intervals over the 57-day experiment period for Accusand filter columns and 




Figure 15. Alternative presentation of time binned MS2 coliphage LRVs across chitosan doses 
of 0, 3, 10 and 30 mg/L presented in time intervals over the 57-day experiment period for 
Accusand filter columns and silica sand columns. 
 
The Kruskal-Wallis test was used to assess if the differences between time binned median 
MS2 coliphage LRVs were statistically significant when stratified by time, across all doses 
within the same sand type.  The resulting p-values are presented in Table 20.  Significant 
differences in LRVs were not observed based on interval, across all doses and stratified by sand 
type.  No comparisons were run for specific intervals based on this data.  
Table 20. Results of the Kruskal-Wallis analysis comparing median LRVs of MS2 coliphage by 
time interval, stratified by chitosan dose and sand type. Reported p-values were adjusted using 
the Bonferroni correction, m = 2 
Sand Type Dose (mg/L) Comparison p-valuea  
Accusand All doses (0, 3, 
10, 30) 
Time Interval (1-4) 0.114 
Silica All doses (0, 3, 
10, 30) 
Time Interval (1-4) 0.197 
aBolded p-values are statistically significant at p < 0.05  
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 The same Kruskal-Wallis analysis conducted in Table 20 was run again, but for each 
chitosan dose rather than the cumulative doses considered together.  The adjusted p-values are 
presented in Table 21.  These results suggest that the despite the previous K-W results (Table 
4.14), there are significant differences between intervals for specific doses.  For Accusand-filled 
columns, 0, 3 and 30 mg/L doses were all significantly different across intervals.  For silica sand-
filled columns, significant differences between intervals are only observed for chitosan doses of 
3 and 10 mg/L.   
Table 21. Results of the Kruskal-Wallis analysis comparing median LRVs of MS2 coliphage by 
time interval, stratified by chitosan dose and sand type. Reported p-values were adjusted using 
the Bonferroni correction, m = 4 
Sand Type Dose (mg/L) Comparison p-valuea  
Accusand 0 Time Interval (1-4) 1.35E-03 
Accusand 3 Time Interval (1-4) 1.77E-03 
Accusand 10 Time Interval (1-4) 0.120 
Accusand 30 Time Interval (1-4) 7.17E-05 
silica 0 Time Interval (1-4) 0.203 
silica 3 Time Interval (1-4) 1.84E-03 
silica 10 Time Interval (1-4) 0.0276 
silica 30 Time Interval (1-4) 0.0773 
aBolded p-values are statistically significant at p < 0.05  
 
In order to evaluate how each column of the same sand type for each separate chitosan 
dose performed, median LRVs of MS2 coliphage were compared for each pair of time intervals 
with the Wilcoxon Rank-Sum test.  These pairwise comparisons were only run for those doses 
that were statistically significant in Table 21.  The resulting p-values are presented in Table 22.  
Accusand columns dosed with untreated water gave statistically significant improvements in 
LRVs between intervals 3 and 4, but differences in LRV in intervals 1 and 2 were not 
statistically significant.  The same pattern of LRV significance results, significance for time 
intervals 3 and 4 but not significant for time intervals 1 and 2 also occurred for Accusand column 
filters dosed with 3 mg/L chitosan-treated water.  Statistically significant improvements LRV in 
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performance were observed for Accusand columns dosed with 30 mg/L chitosan between 
intervals 1 and 2 and between intervals 2 and 3.  The apparent decline in performance from 
intervals 3 to 4 was not significant.   
As was observed with Accusand columns, the silica columns dosed with 3 mg/L 
chitosan-treated water gave significant increases in LRVs for time intervals 3 to 4 but were not 
significantly different for time intervals 1 and 2. Columns dosed with 10 mg/L chitosan-treated 
water had a statistically significant decline in performance between paired intervals 1 and 3 but 
not between paired intervals 2 and 4.   
Table 22. Wilcoxon Rank-Sum analysis results comparing pairs of time binned median LRVs of 
MS2 coliphage for the same chitosan dose and sand filter column type.  Reported p-values were 
adjusted using the Bonferroni correction, m = 6 
Dose (mg/L) Sand Type  Interval 1  Interval 2  p-valuea   
0 Accusand 1 2 1.00 
0 Accusand 1 3 1.00 
0 Accusand 1 4 1.10E-03 
0 Accusand 2 3 0.299 
0 Accusand 2 4 9.32E-04 
0 Accusand 3 4 9.32E-04 
     
3 Accusand 1 2 1.00 
3 Accusand 1 3 1.00 
3 Accusand 1 4 2.74E-04 
3 Accusand 2 3 1.00 
3 Accusand 2 4 9.32E-04 
3 Accusand 3 4 9.32E-04 
     
30 Accusand 1 2 1.92E-03 
30 Accusand 1 3 2.74E-04 
30 Accusand 1 4 2.74E-04 
30 Accusand 2 3 0.0112 
30 Accusand 2 4 0.498 
30 Accusand 3 4 0.963 
     
3 silica 1 2 1.00 
3 silica 1 3 1.00 
3 silica 1 4 2.74E-04 
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3 silica 2 3 1.00 
3 silica 2 4 9.32E-04 
3 silica 3 4 9.32E-04 
     
10 silica 1 2 1.00 
10 silica 1 3 3.29E-03 
10 silica 1 4 1.00 
10 silica 2 3 0.169 
10 silica 2 4 1.00 
10 silica 3 4 0.0625 
aBolded p-values are statistically significant at p < 0.05  
*p-values estimated with ties 
 
 To evaluate differences in time binned median LRVs of MS2 coliphage for each sand 
type based on chitosan dose, Kruskal-Wallis tests were conducted.  The resulting p-values are 
presented in Table 23.  There are statistically significant differences in LRVs attained by 
columns of both sand types and across all time intervals based on chitosan dose.   
Table 23. Kruskal-Wallis analysis results comparing time binned median LRVs of MS2 
coliphage by chitosan dose, stratified by sand filter column type. Reported p-values were 
adjusted using the Bonferroni correction, m = 2 
Bin Sand Type Comparison p-valuea 
1 Accusand Dose (0, 3, 10, 30 mg/L 
chitosan) 
3.63E-07 
1 silica Dose (0, 3, 10, 30 mg/L 
chitosan) 
7.68E-07 
2 Accusand Dose (0, 3, 10, 30 mg/L 
chitosan) 
1.52E-05 
2 silica Dose (0, 3, 10, 30 mg/L 
chitosan) 
2.77E-05 
3 Accusand Dose (0, 3, 10, 30 mg/L 
chitosan) 
4.29E-06 
3 silica Dose (0, 3, 10, 30 mg/L 
chitosan) 
3.30E-05 
4 Accusand Dose (0, 3, 10, 30 mg/L 
chitosan) 
1.75E-05 
4 silica Dose (0, 3, 10, 30 mg/L 
chitosan) 
4.63E-05 
aBolded p-values are statistically significant at p < 0.05  
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The Wilcoxon Rank-Sum test was used to compare time-binned LRVs of MS2 coliphage 
based on chitosan dose in order to evaluate how different chitosan doses performed within the 
same time interval.  The resulting p-values are in Table 24.  In interval 1, LRVs reported for 
each set of conditions were statistically significantly different from one another with one 
exception.  LRVs achieved by silica sand filter columns dosed with 0 and 3 mg/L chitosan-
treated water were not significantly different.  This lack of difference in LRVs for silica sand 
filter columns at these chitosan doses also remains true for time intervals 2 and 3. In interval 2, 
LRVs for Accusand filter columns treated with any dose of chitosan were statistically 
significantly higher than those for Accusand columns dosed with untreated water.  Chitosan 
doses of 10 mg/L and 30 mg/L performed statistically significantly better than the 3 mg/L dose, 
but no significant differences in LRVs are observed when these two chitosan doses are compared 
directly.  The 10 mg/L and 30 mg/L chitosan doses also had statistically significantly higher 
LRVs for silica sand filter columns compared to untreated and 3 mg/L chitosan-treated water.  
LRVs between both types of sand filter columns dosed with 10 and 30 mg/L chitosan-treated 
water were not statistically significant.   
 In interval 3, all dose combinations gave statistically significantly different LRVs for 
Accusand columns.  Silica columns dosed with 10 and 30 mg/L chitosan-treated water had 
statistically significantly higher LRVs than those dosed with untreated water and 3 mg/L 
chitosan-treated water.  No significant differences were observed between LRVs reported for 
silica columns dosed with water not chitosan-treated compared to 3 mg/L chitosan-treated water, 
and those dosed with 10 mg/L compared to 30 mg/L.  In interval 4, statistically significant 
differences in achieved LRVs were observed between Accusand columns dosed with 3, 10 and 
30 mg/L chitosan-treated water compared to the columns dosed with water not chitosan treated.    
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LRVs for Accusand columns receiving 3 mg/L chitosan-treated water were statistically 
significantly lower than for columns 10 mg/L and 30 mg/L.  There was not a significant 
difference in performance in interval 4 between columns dosed with 10 mg/L or 30 mg/L 
chitosan-treated water.  Silica sand columns dosed with 3, 10 and 30 mg/L all had statistically 
significantly higher LRVs compared to control filters, but no statistically significant differences 
in LRVs were observed between columns receiving water dosed with 3 and 30 mg/L chitosan 
and between columns receiving water dosed with 10 and 30 mg/L chitosan.  LRVs for silica sand 
columns receiving 3 mg/L chitosan-treated water were statistically significantly lower than those 
for 10 mg/L chitosan-treated water.   
Table 24. Wilcoxon Rank-Sum analysis results comparing time binned median LRVs of MS2 
coliphage by chitosan dose, stratified by sand filter columns type.  Reported p-values were 
adjusted using the Bonferroni correction, m = 6 
Bin  Sand Type Dose 1 (mg/L) Dose 2 (mg/L) p-valuea 
1 Accusand 0 3 4.35E-03 
1 Accusand 0 10 6.50E-05 
1 Accusand 0 30 6.50E-05 
1 Accusand 3 10 6.48E-05 
1 Accusand 3 30 4.35E-03 
1 Accusand 10 30 1.30E-04 
     
1 silica 0 3 0.535 
1 silica 0 10 6.48E-05 
1 silica 0 30 6.48E-05 
1 silica 3 10 6.48E-05 
1 silica 3 30 1.95E-03 
1 silica 10 30 6.50E-05 
     
2 Accusand 0 3 9.32E-04 
2 Accusand 0 10 9.32E-04 
2 Accusand 0 30 9.32E-04 
2 Accusand 3 10 9.32E-04 
2 Accusand 3 30 9.32E-04 
2 Accusand 10 30 1.00 
     
2 silica 0 3 0.395* 
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2 silica 0 10 5.59E-03* 
2 silica 0 30 5.59E-03* 
2 silica 3 10 9.32E-04 
2 silica 3 30 9.32E-04 
2 silica 10 30 0.299 
     
3 Accusand 0 3 9.32E-04 
3 Accusand 0 10 9.32E-04 
3 Accusand 0 30 9.32E-04 
3 Accusand 3 10 9.32E-04 
3 Accusand 3 30 9.32E-04 
3 Accusand 10 30 9.32E-04 
     
3 silica 0 3 0.299 
3 silica 0 10 9.32E-04 
3 silica 0 30 5.59E-03* 
3 silica 3 10 9.32E-04 
3 silica 3 30 5.59E-03* 
3 silica 10 30 0.935* 
     
4 Accusand 0 3 9.32E-04 
4 Accusand 0 10 9.32E-04 
4 Accusand 0 30 9.32E-04 
4 Accusand 3 10 0.0177 
4 Accusand 3 30 9.32E-04 
4 Accusand 10 30 0.299 
     
4 silica 0 3 9.32E-04 
4 silica 0 10 9.32E-04 
4 silica 0 30 9.32E-04 
4 silica 3 10 9.32E-04 
4 silica 3 30 0.782 
4 silica 10 30 0.390 
aBolded p-values are statistically significant at p < 0.05  
 
 Comparisons of MS2 coliphage LRVs between each sand column type, silica and 
Accusand, were statistically compared pairwise for all chitosan doses by the Wilcoxon Rank-
Sum test in order to evaluate performance differences within each of the four intervals.  The 
resulting p-values are in Table 25.  The differences in LRVs attained in time interval 1 by the 
two sand column types were not statistically significantly different for all 4 chitosan doses. In 
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time interval 2 the differences in LRVs between Accusand and silica sand filter columns were 
not significant for chitosan doses of 3, 10 and 30 mg/L but were significant for water not dosed 
with chitosan. In time interval 3 the differences in LRVs between the two sand filter columns 
were not statistically significant for water coagulated with chitosan doses of 0 and 3 mg/L but 
were statistically significant for water treated with chitosan doses of 10 and 30 mg/L. For time 
interval 4, the differences in LRV between the two sand filter column types were not statistically 
significant for water dosed with 10 mg/L chitosan but were significant for water dosed with 0, 3 
and 30 mg/L chitosan.  
When these same data comparing LRV between the two sand filter column types are 
examined across all 4 time bins by each separate chitosan dose, LRVs for waters not dosed with 
chitosan were not statistically significant in time intervals 1 and 3 but were statistically 
significant in time intervals 2 and 4.  For sand columns receiving waters dosed with 3 mg/L 
chitosan, LRVs for the two sand filter columns were not significantly different in time intervals 
1, 2 and 3 but were statistically significant in time interval 4.   For sand columns receiving waters 
dosed with 10 mg/L chitosan, LRVs for the two sand filter columns were not significantly 
different in time intervals 1, 2 and 4 but were statistically significantly different in time interval 
3.  For sand columns receiving waters dosed with 30 mg/L chitosan, LRVs for the two sand filter 
columns were not significantly different in time intervals 1 and 2 but were statistically 





Table 25. Wilcoxon Rank-Sum analysis results comparing time binned median LRVs of MS2 
coliphage between the two sand column types, stratified by chitosan dose.  Reported p-values 
were adjusted using the Bonferroni correction, m = 4 
Bin  Dose (mg/L) Sand Type 1 Sand Type 2  p-valuea 
1 0 Accusand silica 1.00 
1 3 Accusand silica 1.00 
1 10 Accusand silica 0.420 
1 30 Accusand silica 0.870 
     
2 0 Accusand silica 0.0401* 
2 3 Accusand silica 1.00 
2 10 Accusand silica 1.00 
2 30 Accusand silica 0.0590 
     
3 0 Accusand silica 0.780 
3 3 Accusand silica 1.00 
3 10 Accusand silica 0.0186 
3 30 Accusand silica 3.72E-03* 
     
4 0 Accusand silica 0.0280 
4 3 Accusand silica 1.24E-03 
4 10 Accusand silica 0.642 
4 30 Accusand silica 1.24E-03 
aBolded p-values are statistically significant at p < 0.05  
*p-values estimated with ties 
 
4.4 Reductions in Turbidity by Combined Chitosan Coagulation and Sand Column 
Filtration 
 
 The average turbidity values (+/- standard deviation) for both influent and effluent water 
samples are presented in Table 26. Substantial variability in turbidity is observed in the large 
standard deviation values.  This is attributable to changes in turbidity of the lake water over the 
course of the study.  The average influent turbidity level over the course of the study was low at 
6 NTU.  On average, control Accusand columns (0 mg/L chitosan) reduced turbidity by 1 NTU. 
Effluent water from control silica columns (0 mg/L chitosan) had average NTU values equal to 
that of the influent lake water.  Both Accusand and silica sand columns produced effluent waters 
of approximately 2 NTU.  Chitosan at 10 mg/L was the only dose to reduce turbidity levels to 
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less than 1 NTU for both sand types.  On average, Accusand and silica sand columns receiving 
waters dosed with 30 mg/L chitosan had effluent turbidity levels between 1 and 2 NTU.  
Table 26. Average turbidity values (+/- standard deviation) for influent and effluent samples 
Sample Turbidity (NTU) 
Lake Water 6.34 (+/- 2.86) 
Accusand + 0 mg/L 5.35 (+/- 4.96) 
Accusand + 3 mg/L 2.11 (+/- 2.18) 
Accusand + 10 mg/L 0.628 (+/- 0.431) 
Accusand + 30 mg/L 1.11 (+/- 0.507) 
Silica + 0 mg/L 6.08 (+/- 2.91) 
Silica + 3 mg/L 2.54 (+/- 2.03) 
Silica + 10 mg/L 0.807 (+/- 0.536) 
Silica + 30 mg/L 1.72 (+/- 1.59) 
 
The turbidity LRVs for each individual sand column over the 57-day experiment period 
are displayed in Figure 16 for Accusand columns and Figure 17 for silica sand columns.  Some 
variability is observed in turbidity LRVs achieved at each time point among the chitosan doses 
but LRVs between duplicate columns of the same sand filter column type and chitosan dose are 
similar.  As was observed with E. coli KO11 and MS2 coliphage, duplicate filters of the same 




Figure 16. Turbidity reductions for Accusand-filled columns dosed with water coagulated with 
different chitosan doses for 17 successive samples collected over time throughout the 57-day 
experiment period.   
 
Figure 17. Turbidity reductions for silica sand-filled columns dosed with water coagulated with 
different chitosan doses for 17 successive samples collected over time throughout the 57-day 
experiment period.   
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 Because the duplicate filters performed similarly over the study period, the turbidity 
LRVs for the duplicates were combined for nonparametric analyses.  The turbidity reductions for 
each chitosan dose and between each sand filter column type over the course of the experiment 
are summarized in the box and whisker plot shown in Figure 18.  The LRVs vary among 
chitosan doses from less than 0.25-log10 to around 1-log10.  Negative LRV values were 
sometimes observed and the reasons for them were not explored in this study.   
Differences in turbidity LRV between the 4 chitosan dose conditions and between the 
same doses but for different sand types can be examined in Figure 18.  Across chitosan doses, 
both Accusand columns and silica sand columns follow similar LRV patterns.  Filters dosed with 
10 mg/L chitosan-treated water reported the highest turbidity reductions, followed by chitosan 
doses 30 and 3 mg/L, respectively.  The sand columns dosed with untreated water gave the 
lowest turbidity LRVs.  Accusand filter columns consistently performed better than the silica 
sand filter columns across chitosan doses. Nonparametric statistical tests were performed to 
assess if these LRV differences are statistically significant.  
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Figure 18. Turbidity LRVs among chitosan doses of 0, 3, 10 and 30 mg/L presented 
cumulatively over the 57-day experiment period for Accusand filter columns and silica sand 
columns. 
 A Kruskal-Wallis analysis was conducted to compare differences in cumulative mean 
turbidity LRVs based on chitosan dose and sand filter column type and the resulting p-values are 
depicted in Table 27.  The results demonstrate that there are significant differences between the 
turbidity LRVs based on dose of chitosan for filter columns of both sand types.  
Table 27. Results of the Kruskal-Wallis analysis comparing cumulative median LRVs of 
turbidity by chitosan dose, stratified by sand type. Reported p-values were adjusted using the 
Bonferroni correction, m = 2 
Sand Type Comparison p-valuea  
Accusand Dose (0, 3, 10, 30 mg/L chitosan) 5.90E-14 
silica Dose (0, 3, 10, 30 mg/L chitosan) 6.80E-14 
aBolded p-values are statistically significant at p < 0.05  
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 Cumulative median turbidity LRVs were compared by the Wilcoxon Rank-Sum Test for 
pairs of specific chitosan doses relative to one another within the same sand type. The resulting 
p-values are presented in Table 28.  Turbidity LRVs for Accusand and silica columns dosed with 
untreated water were statistically significantly lower than those dosed with 3, 10 and 30 mg/L 
chitosan-treated water.  For Accusand filters, 10 mg/L chitosan dose gave statistically 
significantly higher turbidity LRVs compared to 3 mg/L and 30 mg/L chitosan dose.  The 
differences in turbidity LRVs between 3 mg/L and 30 mg/L chitosan doses were not significant.   
For silica sand columns, 10 mg/L chitosan dose gave statistically significantly greater turbidity 
LRVs compared to 3 mg/L chitosan dose.  Turbidity LRVs were not significantly between 3 
mg/L chitosan dose compared to 30 mg/L and for 10 mg/L chitosan dose compared to 30 mg/L 
chitosan dose. 
Table 28. Wilcoxon Rank-Sum analysis results comparing cumulative median LRVs of turbidity 
by chitosan dose, stratified by sand filter column type.  Reported p-values were adjusted using 
the Bonferroni correction, m = 6 
Sand Type Dose 1 (mg/L) Dose 2 (mg/L) p-valuea 
Accusand 0 3 3.94E-08 
0 10 < 1.32E-15 
0 30 4.78E-08 
3 10 1.13E-04 
3 30 1.00 
10 30 4.97E-03 
 
silica 0 3 4.34E-08 
0 10 < 1.32E-15 
0 30 2.98E-07 
3 10 6.35E-05 
3 30 1.00 
10 30 0.0198 
aBolded p-values are statistically significant at p < 0.05  
 Cumulative median turbidity LRVs were compared between sand filter column types 
using the Wilcoxon Rank-Sum Test.  The resulting p-values are given in Table 29.  No 
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significant differences were observed between the turbidity LRVs achieved by Accusand 
columns compared to silica columns across all doses of chitosan. 
Table 29. Wilcoxon Rank-Sum analysis results comparing cumulative median LRVs of turbidity 
by sand filter column type, stratified by chitosan dose.  Reported p-values were adjusted using 
the Bonferroni correction, m = 4 
Dose (mg/L) Sand Type 1 Sand Type 2 p-value  
0 Accusand silica 0.0726 
3 Accusand silica 0.560 
10 Accusand silica 0.690 
30 Accusand silica 1.00 
aBolded p-values are statistically significant at p < 0.05  
 
 Time interval binned turbidity LRVs are presented for each type of sand filter in Figure 
19 according to time intervals and in Figure 20 for each type of sand filter column. No 
consistent pattern of turbidity LRVs between time intervals is observed across chitosan doses 
and sand filter column types.  Turbidity removal generally improved from time interval 1 to time 
interval 4, but the extent to which this occurred in each time interval varied among chitosan 
doses.  As with E. coli KO11 and MS2 coliphage, the columns that received 10 mg/L chitosan-
treated water consistently performed better for turbidity LRV than the other chitosan doses. The 
next best chitosan dose for turbidity LRVs was 30 mg/L, followed by 3 mg/L and finally water 
untreated with chitosan. Accusand filter column consistently achieved similar or greater turbidity 
LRVs across chitosan doses and time intervals compared to Accusand sand filter columns.  
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Figure 19. Binned turbidity LRVs across chitosan doses of 0, 3, 10 and 30 mg/L presented in 
time intervals over the 57-day experiment period for Accusand filter columns and silica sand 
columns. 
 
Figure 20. Alternative presentation of binned turbidity LRVs across chitosan doses of 0, 3, 10 
and 30 mg/L presented in time intervals over the 57-day experiment period for Accusand filter 
columns and silica sand columns. 
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The Kruskal-Wallis test was used to assess if the differences between time binned median 
turbidity LRVs were statistically significant when stratified by time, across all doses within the 
same sand type.  The resulting p-values are presented in Table 30.  Significant differences in 
LRVs were observed based on time interval, across all doses, for both sand types.  
Table 30. Results of the Kruskal-Wallis analysis comparing median LRVs of turbidity by time 
interval, stratified by chitosan dose and sand type. Reported p-values were adjusted using the 
Bonferroni correction, m = 2 
Sand Type Dose (mg/L) Comparison p-valuea  
Accusand All doses (0, 3, 10, 30) Time Interval (1-4) 3.39E-05 
Silica All doses (0, 3, 10, 30) Time Interval (1-4) 9.02E-06 
aBolded p-values are statistically significant at p < 0.05  
 
In order to evaluate how both types of sand performed over time, across all doses, binned 
median LRVs of turbidity were compared based on time interval with the Wilcoxon Rank-Sum 
test for multiple comparisons.  This analysis was not run for both types of sand columns because 
the differences between intervals were statistically significant (Kruskal-Wallis p < 0.05).  The 
results are presented in Table 31.  The results suggest there are significant differences in 
achieved LRVs for columns of both sand types across all doses only between time intervals 1 








Table 31. Results of the Wilcoxon Rank-Sum analysis comparing median LRVs of turbidity by 
time interval, stratified by sand type. Reported p-values were adjusted using the Bonferroni 
correction, m = 6 
Sand Type Dose (mg/L) Interval 1 Interval 2 p-valuea  
Accusand All doses (0, 3, 10, 30) 1 2 0.858 
Accusand All doses (0, 3, 10, 30) 1 3 0.0306 
Accusand All doses (0, 3, 10, 30) 1 4 9.98E-07 
Accusand All doses (0, 3, 10, 30) 2 3 1.00 
Accusand All doses (0, 3, 10, 30) 2 4 0.0139 
Accusand All doses (0, 3, 10, 30) 3 4 0.478 
     
Silica All doses (0, 3, 10, 30) 1 2 0.127 
Silica All doses (0, 3, 10, 30) 1 3 7.40E-03 
Silica All doses (0, 3, 10, 30) 1 4 5.86E-07 
Silica All doses (0, 3, 10, 30) 2 3 1.00 
Silica All doses (0, 3, 10, 30) 2 4 0.0443 
Silica All doses (0, 3, 10, 30) 3 4 0.165 
aBolded p-values are statistically significant at p < 0.05  
 
 The same Kruskal-Wallis analysis conducted in Table 30 was run again, but for each 
chitosan dose rather than the cumulative doses considered together.  The adjusted p-values are 
presented in Table 32.  These results suggest that there are significant differences in LRVs 
between time intervals for specific doses.  With the exception of the control Accusand columns 
dosed with untreated water, all other dose and sand combinations achieved statistically 








Table 32. Results of the Kruskal-Wallis analysis comparing median LRVs of turbidity by time 
interval, stratified by chitosan dose and sand type. Reported p-values were adjusted using the 
Bonferroni correction, m = 4 
Sand Type Dose (mg/L) Comparison p-valuea  
Accusand 0 Time Interval (1-4) 0.0695 
Accusand 3 Time Interval (1-4) 1.01E-03 
Accusand 10 Time Interval (1-4) 2.80E-03 
Accusand 30 Time Interval (1-4) 8.22E-04 
silica 0 Time Interval (1-4) 0.0359 
silica 3 Time Interval (1-4) 7.57E-04 
silica 10 Time Interval (1-4) 3.03E-03 
silica 30 Time Interval (1-4) 3.48E-03 
aBolded p-values are statistically significant at p < 0.05  
 
 In order to evaluate how the columns of the same sand type and chitosan dose performed 
over time, the Wilcoxon Rank-Sum test was used to compare time binned median LRVs of 
turbidity based on time interval.  The resulting p-values are reported in Table 33.  These tests 
were run for all conditions except the untreated Accusand columns (Kruskal-Wallis, p > 0.05).  
Silica sand columns receiving untreated water (0 mg/L chitosan) had significantly different 
LRVs between time intervals 1 and 4 and between time intervals 3 and 4.  For Accusand 
columns receiving water dosed with 3 mg/L chitosan, interval 4 was statistically significantly 
different than all other intervals, but differences between the first three intervals were not 
significant.  Silica sand columns with 3 mg/L chitosan had significant improved turbidity 
removal performance in the 4th time interval compared to the earlier time intervals.  Turbidity 
LRVs for Accusand columns receiving water treated with 10 mg/L chitosan experienced a 
significant decline after interval 1 and did not significantly improve until time interval 4.  For 
silica sand columns at the same chitosan dose, significant improvements in turbidity removal 
performance were observed between time intervals 1 and 2, but LRVs in subsequent intervals 
were not statistically different.  Accusand columns receiving water dosed with 30 mg/L chitosan 
achieved low turbidity reductions in the first interval then significantly increased LRVs in 
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interval 2.  Differences in LRVs after that point were not significant.  Silica sand columns 
receiving water dosed  with 30 mg/L chitosan followed the same LRV performance pattern as 
the 10 mg/L chitosan-dosed silica columns.  
Table 33. Results of the Wilcoxon Rank-Sum analysis comparing time binned median LRVs of 
turbidity for the same chitosan dose and sand type, between time intervals.  Reported p-values 
were adjusted using the Bonferroni correction, m = 6 
Dose (mg/L) Sand Type  Interval 1  Interval 2  p-valuea 
3 Accusand 1 2 0.874 
3 Accusand 1 3 1.00 
3 Accusand 1 4 2.74E-04 
3 Accusand 2 3 1.00 
3 Accusand 2 4 9.32E-04 
3 Accusand 3 4 9.32E-04 
     
10 Accusand 1 2 0.732 
10 Accusand 1 3 2.74E-04 
10 Accusand 1 4 2.74E-04 
10 Accusand 2 3 1.00 
10 Accusand 2 4 0.782 
10 Accusand 3 4 1.00 
     
30 Accusand 1 2 0.0184 
30 Accusand 1 3 2.74E-04 
30 Accusand 1 4 5.48E-04 
30 Accusand 2 3 0.782 
30 Accusand 2 4 1.00 
30 Accusand 3 4 1.00 
     
0 silica 1 2 1.00 
0 silica 1 3 1.00 
0 silica 1 4 0.0184 
0 silica 2 3 0.963 
0 silica 2 4 0.629 
0 silica 3 4 9.32E-04 
     
3 Accusand 1 2 1.00 
3 Accusand 1 3 1.00 
3 Accusand 1 4 2.74E-04 
3 Accusand 2 3 0.299 
3 Accusand 2 4 9.32E-04 
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3 Accusand 3 4 9.32E-04 
     
10 Accusand 1 2 0.0263 
10 Accusand 1 3 0.0373 
10 Accusand 1 4 2.74E-04 
10 Accusand 2 3 1.00 
10 Accusand 2 4 1.00 
10 Accusand 3 4 0.629 
     
30 silica 1 2 8.23E-03 
30 silica 1 3 1.92E-03 
30 silica 1 4 3.29E-03 
30 silica 2 3 1.00 
30 silica 2 4 1.00 
30 silica 3 4 1.00 
aBolded p-values are statistically significant at p < 0.05  
 
Kruskal-Wallis analyses were conducted to evaluate differences in time interval binned 
median turbidity LRVs for each sand filter column type based on chitosan dose.  The resulting p-
values are presented in Table 34.  The results demonstrate that there are statistically significant 
differences between the turbidity LRVs achieved across chitosan doses within the same sand 
filter column type.   
Table 34. Kruskal-Wallis analysis results comparing time binned median LRVs of turbidity by 
chitosan dose, stratified by sand filter column type. Reported p-values were adjusted using the 
Bonferroni correction, m = 2 
Bin Sand Type Comparison p-valuea 
1 Accusand Dose (0, 3, 10, 30 mg/L chitosan) 6.63E-05 
1 silica Dose (0, 3, 10, 30 mg/L chitosan) 5.40E-04 
2 Accusand Dose (0, 3, 10, 30 mg/L chitosan) 3.19E-04 
2 silica Dose (0, 3, 10, 30 mg/L chitosan) 4.96E-05 
3 Accusand Dose (0, 3, 10, 30 mg/L chitosan) 4.43E-05 
3 silica Dose (0, 3, 10, 30 mg/L chitosan) 4.65E-05 
4 Accusand Dose (0, 3, 10, 30 mg/L chitosan) 1.56E-04 
4 silica Dose (0, 3, 10, 30 mg/L chitosan) 4.22E-05 
aBolded p-values are statistically significant at p < 0.05  
 
The Wilcoxon Rank-Sum test was used to compare time-binned LRVs of turbidity based 
on chitosan dose in order to evaluate how different chitosan doses performed within the same 
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time interval.  The resulting p-values are in Table 35.  In time interval 1, turbidity LRVs 
reported for both sand types were significantly different between chitosan doses of 0 and 3, 0 and 
10, and 10 and 30 mg/L.  LRVs for Accusand columns in time interval 2 were significantly 
higher for 10 mg/L and 30 mg/L chitosan doses compared to the control but were not 
significantly different when directly compared.  Filters receiving water treated with 10 mg/L 
chitosan also performed better than those treated with the 3 mg/L dose, but this was not true 
when comparing 3 to 30 mg/L.  For silica sand columns in interval 2, LRVs at 0 mg/L and 3 
mg/L chitosan doses were not significantly different when directly compared, but both were 
significantly lower than doses of 10 mg/L and 30 mg/L chitosan.  Differences in LRVs between 
10 mg/L and 30 mg/L were not statistically significant within this interval and sand type.  
In interval 3, Accusand filters receiving untreated water (0 mg/L) achieved significantly 
lower turbidity LRVs compared to all chitosan doses.  The 10 mg/L chitosan dose had 
significantly higher LRVs compared to 3 mg/L and 10 mg/L chitosan doses.  All chitosan dose 
combinations gave statistically significantly different LRVs for silica sand columns in time 
interval 3 except between doses 10 and 30 mg/L.    In interval 4, the control filters (0 mg/L) for 
both sand types achieved significantly lower LRVs compared to all chitosan doses.   When 
comparing all other doses for both sand types, the turbidity LRVs are not significantly different 
except between 10 mg/L and 30 mg/L followed by silica sand filtration.     
Table 35. Wilcoxon Rank-Sum analysis results comparing time binned median LRVs of 
turbidity by chitosan dose, stratified by sand filter columns type.  Reported p-values were 
adjusted using the Bonferroni correction, m = 6 
Bin  Sand Type Dose 1 (mg/L) Dose 2 (mg/L) p-valuea 
1 Accusand 0 3 1.23E-03 
1 Accusand 0 10 4.55E-04 
1 Accusand 0 30 0.631 
1 Accusand 3 10 0.213 
1 Accusand 3 30 0.0690 
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1 Accusand 10 30 4.35E-03 
     
1 silica 0 3 0.0125 
1 silica 0 10 6.50E-05 
1 silica 0 30 1.00 
1 silica 3 10 0.173 
1 silica 3 30 0.993 
1 silica 10 30 0.0312 
     
2 Accusand 0 3 0.498 
2 Accusand 0 10 9.32E-04 
2 Accusand 0 30 0.0177 
2 Accusand 3 10 1.86E-03 
2 Accusand 3 30 0.169 
2 Accusand 10 30 0.782 
     
2 silica 0 3 0.228 
2 silica 0 10 9.32E-04 
2 silica 0 30 1.86E-03 
2 silica 3 10 9.32E-04 
2 silica 3 30 6.53E-03 
2 silica 10 30 0.629 
     
3 Accusand 0 3 0.0280 
3 Accusand 0 10 9.32E-04 
3 Accusand 0 30 9.32E-04 
3 Accusand 3 10 9.32E-04 
3 Accusand 3 30 0.228 
3 Accusand 10 30 0.124 
     
3 silica 0 3 9.32E-04 
3 silica 0 10 9.32E-04 
3 silica 0 30 9.32E-04 
3 silica 3 10 0.0112 
3 silica 3 30 0.0280 
3 silica 10 30 1.00 
     
4 Accusand 0 3 9.32E-04 
4 Accusand 0 10 9.32E-04 
4 Accusand 0 30 9.32E-04 
4 Accusand 3 10 1.00 
4 Accusand 3 30 0.390 
4 Accusand 10 30 0.0886 
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4 silica 0 3 9.32E-04 
4 silica 0 10 9.32E-04 
4 silica 0 30 9.32E-04 
4 silica 3 10 0.390 
4 silica 3 30 0.0625 
4 silica 10 30 0.0112 
aBolded p-values are statistically significant at p < 0.05  
 
Comparisons of turbidity LRVs between each sand column type, Accusand and silica, 
were statistically compared pairwise for all chitosan doses by the Wilcoxon Rank-Sum test.  This 
was used to evaluate performance differences within each of the time intervals between sand 
types.  The resulting p-values are in Table 36.  Of all comparisons, only the LRVs for the control 
filters (0 mg/L chitosan) in time interval 4 were statistically significantly different between sand 
types.  This suggests that both sand types, despite differences in sand particle size and filtration 














Table 36. Wilcoxon Rank-Sum analysis results comparing binned median LRVs of turbidity 
between the two sand column types, stratified by chitosan dose.  Reported p-values were 
adjusted using the Bonferroni correction, m = 4 
Bin  Dose (mg/L) Sand Type 1 Sand Type 2  p-valuea 
1 0 Accusand silica 0.492 
1 3 Accusand silica 0.492 
1 10 Accusand silica 0.173 
1 30 Accusand silica 1.00 
     
2 0 Accusand silica 1.00 
2 3 Accusand silica 1.00 
2 10 Accusand silica 1.00 
2 30 Accusand silica 1.00 
     
3 0 Accusand silica 0.522 
3 3 Accusand silica 1.00 
3 10 Accusand silica 0.113 
3 30 Accusand silica 1.00 
     
4 0 Accusand silica 6.22E-04 
4 3 Accusand silica 0.113 
4 10 Accusand silica 1.00 
4 30 Accusand silica 0.420 
aBolded p-values are statistically significant at p < 0.05  
 
4.5 Impact of Chitosan on pH 
 
Previous research has shown that chitosan has limited impact on water pH regardless of 
chitosan dose (Christensen et al., 2016; Soros, 2015; Soros et al., 2019).  These findings were 
supported by the pH results of this research.  The % change in pH is represented in Figure 21.  
The raw % decrease in pH values for all filters on each sampling day are presented in Appendix 
8.  In most cases only limited changes in pH, +/- 5%, were observed.  Outliers are also observed 
that extended to greater than 30% change.  Outliers may be explained by instrument error. 
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Figure 21. Percent reduction in pH across chitosan doses of 0, 3, 10 and 30 mg/L presented 
cumulatively over the 57-day experiment period for Accusand columns and silica sand columns. 
 
4.6 Flow Rate Changes in Sand Filter Columns Over the Experiment Period 
 
 The sand filters in this study were not run like typical biosand filter systems that promote 
growth of the schmutzdecke and require idle time within the filter to enhance microbial 
reductions.  The filters in this study were operated intermittently, were subjected to weekly 
scouring, and the daily volume dosed into the filters greatly exceeded the pore-volume within the 
sand bed.  These conditions, as well as the fact that there no measurable parameter was used as a 
proxy to estimating filter maturation over time, meant that the impact of flow rate or filtration 
rate on the removal capacity of the sand filter columns was not directly studied.   
 106 
Flow rate measurements were conducted on each sampling day except on sampling day 2.  
These measurements were taken by measuring the duration of time for the first 50 mL of water 
to pass through the filter after the filter was filled to the maximum head of 7 cm.  When 
maximally full, the flow rate was at the maximum rate.  As the head declined, the flow rate 
declined because the pressure forcing the water through the filter declined.  This decline in flow 
rate varied for each filter and was not directly measured in this study.  Flow rates were converted 
to filtration rates because filtration rates do not depend on the sand bed surface area.  The 
filtration rate is a measure of flow rate per square meter of the surface area of the sand filter 
column.  The average filtration rates over the course of the experiment, with standard deviation 
error bars, are presented in Figure 22.  The raw filtration rate values for all filters on each 
sampling day are presented in Appendix 9. CAWST (2012) recommends biosand filters operate 
at a maximum filtration rate of 0.4 m/hr.  The silica sand filter columns in this experiment had an 
average filtration rate of 1.2 m/hr (+/- 0.18), while the Accusand filter columns had an average 
filtration rate of 0.6 m/hr (+/- 0.07).   
The filtration rates for each column with the same sand type were adjusted to remain 
approximately equal over the duration of the study. Because this adjustment was achieved by 
moving the outlet tube up and down the length of the column, there was still substantial 
variability in flow rate observed over time.  Additionally, despite weekly sand filter column 
scouring procedures for the top 3 cm of the filter column, filters receiving water treated with any 
dose of chitosan did experience flow rate decline over time.  Occasionally over the course of the 
study, the flow rate of the filters declined to such an extent that moving the outlet tube to well 
below the column bed still did not sufficiently increase the flow rate of the column back to the 
target flow rate range.  When this occurred, more rigorous scouring procedures were used to 
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disturb the sand bed to about 10 cm down the length of the column.  After this more rigorous 
scouring procedure, the flow rates could be successfully adjusted back to the target range for 
each sand type.   
 
Figure 22. Average filtration rate, with standard deviation error bars, for Accusand filter 
columns and silica sand filter columns receiving water with different chitosan doses for 16 
successive samples collected throughout the 57-day experiment period  
Previous studies have reported improved removal of target indicator organisms and 
turbidity with filtration technologies at lower filtration rates (Napotnik & Jellison, 2014; Singer 
et al., 2017).  It is possible that variability in filtration rate in this study may account for 
variability in LRVs for bacteria, viruses and turbidity.  A Spearman’s rank-order correlation test 
was used in order to evaluate if there was an association between flow rate of the sand filter 
columns and LRVs for E. coli KO11, MS2 coliphage and turbidity.  The correlation matrix is 


































and is color coded with blue and red-white to indicate strong and weak associations, respectively.  
A very strong monotonic relationship is observed between E. coli KO11 and MS2 coliphage 
LRVs, as well as between both of these variables and turbidity LRVs.  This was expected based 
on the matching patterns in LRVs achieved by columns of the same sand type and dose across 
these variables.  Very weak associations between filtration rate and LRVs for these variables are 
observed, suggesting no monotonic relationship between filtration rate and LRVs of bacteria, 
viruses and turbidity.  
Table 37. Correlation matrix produced by the Spearman’s rank-order correlation test to compare 
LRVs and Filtration Rates 




Turbidity LRVs Filtration Rates 
E. coli KO11 
LRVs 
1.000 0.906 0.767 -0.099 
MS2 Coliphage 
LRVs 
0.906 1.000 0.727 -0.071 
Turbidity LRVs 0.767 0.727 1.000 -0.068 





Figure 23. Matrix graphical display of strengths of Spearman rank-order correlations for LRVs 
of E. coli KO11, MS2 coliphage, turbidity and flow rate.  
 A chart of this correlation matrix including numeric correlation values is presented in 
Figure 24.  The distribution of values for each variable is shown on the diagonal.  Below the 
diagonal are bivariate scatter plots with fitted lines, and above the diagonal is the correlation 
value, rho, with significance levels indicated by stars.  Based on these results, there is not 
sufficient evidence to suggest there is a correlation between filtration rate and LRVs for bacteria, 
viruses and turbidity.  There is strong evidence supporting associations between LRVs for 
bacteria compared to viruses, bacteria compared to turbidity, and viruses compared to turbidity.   
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Figure 24. Chart display of the Spearman Rank correlation matrix and correlation values for 
LRVs of E. coli KO11, MS2 coliphage, turbidity and flow rate with p-values.  Significance 
levels are shown as symbols: 0 = “***”, 0.001 = “**”, 0.01 = “*” , 0.05  = “.” 
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CHAPTER 5: DISCUSSION 
5.1 Performance Efficacy of Chitosan Coagulation and Sand Filtration 
 
The results of this study demonstrate that the LRVs for indicator bacteria and viruses 
achieved using small scale, shallow bed sand column models of intermittently-operated slow 
sand filtration systems can be significantly improved for bacteria, virus and turbidity removal by 
pre-treating challenge waters with chitosan salts.  The small-scale filters dosed with water treated 
with 3, 10 and 30 mg/L chitosan demonstrated significantly improved LRVs for both bacteria 
and viruses compared to those dosed with uncoagulated water (Kruskal-Wallis, p < 0.05).  
Chitosan at 10 mg/L and 30 mg/L doses with Accusand columns consistently produced 
significantly higher LRVs for bacteria and viruses, both reaching about 4.0 to 4.5-log10, than the 
3 mg/L dose of about 1.0 to 1.5-log10.  Silica columns receiving water dosed with 10 mg/L 
chitosan achieved greater than 3.5-log10 reductions for both bacteria and viruses compared to 
about 2 to 2.5-log10 and about 1-log10 reductions for 30 mg/L and 3 mg/L chitosan doses, 
respectively.  Silica and Accusand filter columns dosed with 10 mg/L chitosan typically reported 
greater LRVs for bacteria and viruses compared to 30 mg/L, although this trend was not 
consistent over the entire study period (Wilcoxon rank-sum, p < 0.05).  The maximum average 
LRVs of E. coli KO11 and MS2 coliphage were achieved with a dose of 10 mg/L of chitosan 
acetate and Accusand miniature column filtration, reaching 4.75 (+/- 0.99) and 4.43 (+/- 0.74) 
log10, respectively.  By comparison, Accusand filtration without chitosans achieved maximum 
average LRVs of 0.42 (+/- 0.29) for bacteria and 0.36 (+/- 0.53) for viruses.  The average 
reported reductions at 10 mg/L and 30 mg/L chitosan doses with Accusand filter columns met 
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the 2-star protective LRV targets set by the WHO for HWT technologies, exceeding the 3-log10 
reduction level for viruses and the 2-log10 reduction level for bacteria.  These performance 
targets were also met for 10 mg/L silica sand filter columns in the first half of the study; 
however, cumulative median LRVs for MS2 coliphage eventually were below the 4-log10 target 
by the end of the 57-day study period.  
 Pretreatment with chitosan salts followed by miniature column sand filtration as a model 
ISSF also improved turbidity reductions.  All three doses of chitosan tested significantly 
improved turbidity reductions compared to filtration alone; however, the 10 mg/L chitosan dose 
was the only dose to achieve <1 NTU for average effluent turbidity with both sand filter column 
types.  Filtration alone without chitosan coagulation pre-treatment produced average filtrate 
water turbidity levels between 4-6 NTU.  The 10 mg/L chitosan pretreatment followed by sand 
filtration achieved on average maximum and minimum filtrate water turbidites of 0.90 NTU (+/- 
0.67) and 0.56 NTU (+/- 0.27), respectively.  This chitosan dose coupled with filtration met the 1 
NTU level recommended by the WHO GDWQ for turbidity.  In terms of turbidity LRVs, all 
three chitosan doses followed by small scale sand column filtration exceeded an average of 0.4-
log10 for turbidity reduction, with 10 mg/L exceeding 0.8-log10 for both sand types.  By 
comparison, filtration alone achieved on average < 0.25-log10 turbidity removal.  The addition of 
chitosan to challenge waters did not significantly change pH, even at the highest chitosan dose. 
Generally, Accusand filter columns performed better than silica sand filter columns for 
all performance indicators used in the study.  This was expected based on the smaller pore sizes 
and slower filtration rates of this sand.  Although both were silica-based sands, the comparisons 
between the two sand types are made with caution because they were operated with different 
experimental conditions.  Differences in median LRVs achieved by the two sand types studied, 
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when considered cumulatively, typically increased with increasing chitosan dose.  Filters 
receiving untreated water or water treated with 3 mg/L chitosan reported median LRVs within 
<0.5-log10 between Accusand and silica sand media for both bacteria and viruses.  These 
differences in average median LRVs for bacteria and viruses between sand types increased to 
0.5-1 and 2-3 for 10 mg/L and 30 mg/L chitosan doses, respectively.  The analyses of 
performance results for the successive time intervals over the 57-day experiment frequently gave 
higher LRVs for Accusand than silica sand across time periods and chitosan doses, but 
exceptions to this trend are observed for some chitosan doses and time intervals.  The differences 
in median LRVs for turbidity do not increase with increasing chitosan dose, but median LRVs 
for turbidity were always greater with Accusand sand columns than with silica sand columns.  
However, these LRV differences between sand types were not significantly different (Wilcoxon 
rank-sum, p < 0.05).  Filtration rate decline was not investigated specifically in this study. 
Differences in the rate of media aging for each sand type as a function of operating time and 
reduction of contaminants also was not evaluated.   
Removal efficiency did not correlate with sand particle size, as is observed with the 
achieved LRVs for bacteria compared to viruses.  This may be because coagulation increases the 
effective size of these microorganisms as they floc together.  Differences between E. coli KO11 
and MS2 coliphage isoelectric points may also account for similarities in removal efficiency 
between the surrogate microbes.  The isoelectric point for MS2 coliphage is between 3.5-3.9 
compared to 5.6 for unmodified E. coli cells (Collins et al., 2004; Sherbet & Lakshmi, 1973).  
The pH of the challenge water used in this experiment was 6.87 (+/- 0.228).  Because E. coli 
KO11 has a higher isoelectric point, it should have a less negative net charge than MS2 
coliphage at neutral pH.  With a more negative net charge, MS2 coliphage and cationic chitosan 
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polymers may have had a greater electrostatic attraction compared to E. coli KO11 and cationic 
chitosan polymers.  Previous studies have documented MS2 adsorbing to positively charged 
membranes at a higher concentration than other commonly used virus surrogates with higher 
relative isoelectric points (Dika et al., 2015).  The enhanced electrostatic attractive forces 
between the polymers and microbes would likely have to exceed the negative electrostatic forces 
between the microbes and the sand grains because existing evidence suggests higher isoelectric 
points for viruses are associated with improved removal via granular filtration compared to those 
with lower isoelectric points (Dowd, Pillai, Wang, & Corapcioglu, 1998).  These explanations 
for why bacteria and virus removal are comparable are only speculative, as many other 
experimental conditions can also impact electrokinetic properties, electrostatic forces, surface 
charges and adsorption.   
Results from the time-binned analysis demonstrate that the influence of time on filter 
performance was not consistent across chitosan doses or sand types. However, improvements in 
contaminant reduction performance over time were observed for the majority of conditions.  
Reported LRVs for bacteria and viruses in the last time interval were statistically significantly 
better than those in the 1st time interval for untreated, 3 mg/L and 30 mg/L chitosan-treated 
water.  This pattern was observed for columns of both sand types.  The 10 mg/L chitosan dose 
followed by sand filtration achieved high bacteria and virus LRVs in all time intervals, although 
their magnitudes varied substantially in each bin.  In some cases, the 1st time interval had greater 
reported LRVs for bacteria and viruses than the last time interval, suggesting a decline in filter 
performance over time.    
The fall turnover event occurred for University Lake towards the end of November, early 
December 2018.  This correlates with time intervals 2 and 3 as defined in this investigation.  
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Declines in filter performance for filters of both sand types receiving water dosed with 10 mg/L 
chitosan were correlated with the approximate dates of the turnover event.  Differences in LRVs 
were more apparent for E. coli KO11 than MS2 coliphage. LRVs for 3 mg/L chitosan dose also 
decreased in these time intervals, but the differences were not significant (Wilcoxon rank-sum, p 
> 0.5).  At 30 mg/L chitosan dose, there was consistently improved LRV performance over these 
time intervals for both sand types.    
Previous studies have associated filter maturation or media aging to improved microbial 
reductions (Elliott et al., 2011, 2015).  Typically, filtration rate is used as a proxy to indicate 
media aging.  Filtration rates in this study were kept within a target range for each sand type, 
therefore media aging effects in filtration rate and performance were not directly investigated.  
Separating LRVs into time intervals may provide indirect insight into how media aging may 
impact filter performance. However, because media aging was not directly evaluated as an 
experimental variable, potential impacts are only speculative.  The results suggest that when 
water is treated with an optimal chitosan dose for the influent water quality, in this case 10 mg/L 
chitosan, substantially improved reductions for bacteria and viruses are achieved independent of 
filter operating time and filter maturation.  At non-optimal chitosan doses and for untreated 
water, media aging is correlated with increased LRVs.  However, variability in performance 
across time intervals suggests improvements in reductions occur at different rates for different 
chitosan doses and sand filter column types.  Additionally, the extent to which filter maturation 
enhances microbial reductions are likely chitosan dose-dependent and influenced by sand type.  
Declines in LRVs over time may indicate a plateau-effect in terms of the extent to which media 
aging may improve filter performance, or it may indicate that media aging is less important an 
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indicator of LRVs compared to other experimental parameters such as surface water quality, 
chitosan dose or type of sand.  
The filtration rate for each column was variable over the study period, but filtration rates 
were not correlated with LRVs for bacteria, viruses or turbidity (Spearman Rank Correlation 
coefficient -0.1 < rho < 0.1).  The Accusand filters and silica sand filters gave average filtration 
rates of 0.6 m/hr (+/- 0.07) and 1.2 m/hr (+/- 0.18), respectively.   These filtration rates are 
somewhat faster than the recommended filtration rate of 0.4 m/hr for BSFs (CAWST, 2012), 
although much slower than the filtration rates of rapid sand filters.  These results suggest that 
filtration rates may be increased over those of the BSF while maintaining high LRVs for bacteria 
and viruses when using chitosan coagulation-flocculation prior to sand filtration. Such increased 
filtration rates would increase the volume of water treated per day per household.  Furthermore, 
performance in terms of LRVs for bacteria and viruses may be further enhanced if columns were 
operated at the recommended filtration rate for BSFs.   
Small diameter (3.9 cm), shallow sand bed bench-scale filters were advantageous for 
study design because all 16 filters could be operated simultaneously and duplicate filters could 
be used to helped improve data representativeness and statistical power.  Replicate columns of 
the same sand type and chitosan dose allowed conclusions about the extent to which chitosan 
coagulation-flocculation improves sand filtration performance to be made with higher 
confidence.  Limitations in costs and labor were preventative factors for using full-scale 
household sand filters in this study.  
Though duplicate filters helped improve statistical power, the variability observed 
between duplicate filters of the same set of conditions resulted in measurable standard errors and 
standard deviation.  Variability in the performance of duplicate filters, coupled with non-
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Normality of the LRV data lowers statistical power, making it more difficult to accurately and 
precisely estimate how each set of conditions impacted chitosan dose and filter performance.  
Prior research evaluating BSFs with replicate columns of the same conditions have also 
experienced some lack of reproducibility for experimental conditions and LRV results (Elliott et 
al., 2011, 2015).  Different rates of maturation or ripening of the filter, including chitosan 
accumulation, increased biological activity in the sand column of the filter, and weekly scouring 
procedures are potentially responsible for variability in LRVs within each column and between 
duplicate columns.  Additionally, regrowth in stored samples and analytical instrument 
imprecision may account for the variability observed in turbidity measurements.  Without further 
investigation of these parameters, it is impossible to determine to what extent experimental 
design limitations and unavoidable errors in sand filtration system design and operation 
contribute to observed performance variability.  
A primary target for this research was to evaluate if improved microbial reductions could 
be achieved using chitosan coagulation-flocculation as a pretreatment process before slow sand 
filtration.  Performance was evaluated according to the WHO HWTS performance levels for 
bacteria and viruses.  These targets are based on the acceptable risk, or tolerable disease burden, 
as health-based targets presented in DALYs.  Based on these targets, the use of chitosan 
coagulation-flocculation followed by intermittently-operated sand filtration significantly 
increases the low average 0.42-log10 bacteria and 0.30- to 0.36-log10 virus reductions by 
Accusand filtration alone by an additional 0.57- to 4.33-log10 and 1.14- to 4.08-log10 for bacteria 
and viruses, respectively.  Low average 0.15- to 0.17-log10 E. coli bacteria reductions and 0.23- 
to 0.35-log10 MS2 coliphage reductions by silica sand alone are improved by an additional 0.87- 
to 3.80-log10 and 0.76- to 3.72-log10, respectively.  Although the 30 mg/L chitosan dose did not 
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consistently meet the WHO 2-star, protective performance level, this dose did reduce bacteria 
and virus reductions by greater than 1.5-log10, which still provides considerable morbidity risk 
reduction. The 10 mg/L doses of chitosan consistently met the WHO 2-star, protective level for 
bacteria, >2-log10, and viruses, >3-log10, for both sand types.  This provides a substantial 
reduction in morbidity risks compared to the performance of the ISSFs dosed with water not pre-
treated by chitosan coagulation.  These results support the use of chitosan coagulation-
flocculation as a pretreatment step to improve ISSF performance in terms of microbial reductions 
and reduced health risks.  
Another main target of this research was to evaluate chitosans compared to other existing 
and widely used inorganic coagulants.  Chitosan was identified as a potential alternative to them, 
especially in household settings where coagulant dose and pH are not easily optimized.  
Attractive properties of chitosan for water treatment are its non-toxicity, biodegradability, 
availability and sustainability (Renault, Sancey, Badot, & Crini, 2009).  The results from this 
study, as well as those documenting chitosan with water treatment in the literature, demonstrate 
that chitosan pretreatment works over a range of doses and natural surface waters and does not 
significantly alter pH after treatment.  Unlike inorganic coagulants, there are not substantial 
health risks associated with over- or under-dosing water to be treated.  At optimal doses, chitosan 
coagulation followed by ISSF improves natural surface water qualities by reducing turbidity to 
below the WHO GDWQ target of 1 NTU, making it safer for household consumption.  
Pretreating water with chitosan also enhances bacteria and virus reductions for ISSFs to meet the 
WHO 2-star protective targets, thereby reducing morbidity risks from drinking water.  This dual 
barrier system produces safer drinking water compared to conventional household sand filters.  
Chitosan is a more appropriate POU coagulant for household use than inorganic coagulants 
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because of its versatility, non-toxicity and effective microbial reduction performance over a 
range of doses.  
5.2 Performance Compared to Prior Studies of ISSFs and Polymer Coagulation of Water   
 
 Information on turbidity and microbial reductions achieved when water is treated with 
other natural coagulant polymers is limited.  At optimal dose and grain size conditions, chitosan 
coagulation coupled with ISSF achieved greater turbidity and microbial reductions than those 
reported for M. oleifera and RSF, although there were clear design and operation differences 
between the two studies that likely contribute to these differences (Babu & Chaudhuri, 2005).  In 
a study evaluating coagulation with Opuntia cochenillifera followed by ISSF, reported average 
turbidity and E. coli removal was 77% and 2.86-log10, respectively (Freitas & Sabogal-Paz, 
2019).  Based on the results of this study, chitosan appears to enhance turbidity and microbial 
removal to a greater extent than observed with O. cochenillifera; however, differences in 
experimental design and filter operation between the two studies make this comparison weak.  
Nevertheless, the proposed dual-treatment barrier of chitosan coagulation and ISSF evaluated in 
this study clearly demonstrates improved reduction performance for bacteria, viruses and 
turbidity.   
 In terms of chitosan efficacy specifically, the turbidity and microbial reductions observed 
in this study resemble those reported in the literature.  According to results reported in Abebe et 
al. (2016), chitosan coagulation was less effective at enhancing reduction performance for ISSFs 
than ceramic filters.  This may be due to smaller pore sizes and different flow rates between 
these filter technologies.  Chitosan pretreatment at optimal doses with ISSFs compared to 
continuously-operated RSFs achieved slightly lower LRVs for E. coli but greatly exceeded those 
reported for viruses.  Again, these results are not directly comparable due to different study 
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parameters and conditions; however, these results suggest that chitosan may also be effective 
with continuously-operated SSFs at the household level.  
 The bench-scale columns dosed with untreated water achieved microbial reductions 
somewhat lower than those reported in studies evaluating BSFs in optimal conditions.  This is 
likely explained by the differences in filter design and operating parameters between this study 
and what is recommended by CAWST.  Physical straining through the schmutzdecke and 
biological activity during idle times are primary mechanisms for microbial reduction in BSFs, 
but the operating conditions in this study did not promote these mechanisms.  Chitosan as a 
pretreatment significantly improved ISSF performance in terms of turbidity and microbial 
removal.  This dual treatment barrier produced better performance improvements compared to 
modifications of zero valent iron coatings; however, the use of iron-oxide amended sand 
columns reported higher LRVs for viruses over long-term use.  These comparisons are tentative 
due to substantial differences in both filter properties and experimental design.  
5.3 Possible Mechanisms of Microbial Reduction by Chitosans & ISSFs 
 
 The specific mechanisms by which microorganisms and turbidity were removed via 
chitosan coagulation-flocculation and slow sand filtration were not directly investigated in this 
research.  General principles and information from the literature may provide some insight into 
plausible mechanistic considerations, but these explanations and interpretations are speculative 
and require further testing.  The mechanisms by which chitosan acts as a coagulant are 
documented in the literature, but the interactions between the formed chitosan-colloid floc and 
the sand media in ISSFs are not well-characterized.  The two primary coagulation processes 
associated with chitosan are charge neutralization and interparticle bridging (Kumar et al., 2004; 
Rinaudo, 2006; Soros, 2015; Soros et al., 2019).  Negatively charged particles in water, including 
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microorganisms, clay and other inorganic and organic material, adsorb to the cationic sites on the 
chitosan polymer chain.  These attraction forces between the polymer and particles promote 
coagulation-flocculation.  The resulting floc, if neutralized and dense, settles out of solution via 
sedimentation.  The supernatant water, with remaining suspended floc, is dosed into ISSFs.  
The processes by which bacteria and viruses are removed with ISSFs and BSFs are likely 
different after water has been pretreated with chitosan. Prior research has suggested the 
schmutzdecke plays an important role in bacterial reductions either by physical straining or 
reduced flow rate resulting in enhanced depth filtration (Elliott et al., 2015; Hijnen et al., 2004; 
Unger & Collins, 2008).  Bacteria are more amenable to physical straining than viruses because 
they are larger.  Physical straining through the schmutzdecke has little effect on virus removal, 
therefore other removal or inactivation mechanisms are likely responsible for virus reductions 
from slow sand and biosand filtration (DeLoyde, 2007; Elliott et al., 2011; Hijnen et al., 2004).  
Proposed mechanisms include sorption to the granular media, attachment to biofilms, predation 
and biological activity (Elliott et al., 2011).  With the addition of a chitosan coagulation-
flocculation pretreatment step, it is unclear to what extent the importance of each mechanism 
changes.  These mechanisms were not directly studied, but speculative mechanistic 
considerations are proposed based on how the processes function under regular operating 
conditions. 
Despite weekly cleaning and disruption of the schmutzdecke, high LRVs were still 
observed for bacteria and viruses in this study.  This suggests that the development of the 
schmutzdecke is not necessarily important for slow sand filtration if water is pretreated with 
chitosan.  The impact on microbial reduction performance as a result of incorporating a diffuser 
plate into the bench-scale column design and altering the cleaning procedure to promote 
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schmutzdecke growth requires further investigation.  Physical straining and deep-bed filtration 
may be more important mechanisms for removal when operated without the biological layer and 
with a coagulant, which makes the particles to be removed from water larger and easier to 
remove.  
Previous work has highlighted the importance of net electrostatic forces between viruses 
and granular media.  Dowd et al. (1998) found that improved removal via granular filtration is 
achieved for viruses with higher isoelectric points.  With the introduction of a cationic polymer 
to influent water, it is unclear if electrostatic repulsion is enhanced or negated.  The extent of 
such effects is also influenced by the surface charge properties of the viruses themselves, which 
differs among them.  Aforementioned differences in isoelectric points may explain why viruses 
are removed to a similar extent as bacterial removal.    
 Many of the proposed mechanisms for virus removal are also dependent on idle time 
within the filter.  Prior studies have shown that increased idle time within the ISSF improves 
microbial attenuation within the filter (Elliott et al., 2011, 2008; M. W. Jenkins et al., 2011; 
Stauber et al., 2006).  In this study, water was pretreated with chitosan and allowed to mix and 
flocculate for a 30-minute period before it was dosed in the filters.  The daily charge volume 
greatly exceeded the pore volume of the filters, and effluent samples were taken after 300 mL 
had already passed through the media bed.  This means the collected effluent spent little time 
within the filter column where it would be exposed to the biological processes that enhance 
removal.  This short contact time suggests that biological mechanisms are probably not primary 
mechanisms for removal.  Short contact times also make this dual-treatment barrier a potentially 
more convenient, reliable and sustainable process than traditional BSFs.   
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5.4 Limitations  
 
 This research demonstrates that combining chitosan coagulation-flocculation with ISSFs 
improves filter performance in terms of microbial and turbidity reductions; however, there were 
limitations to this study which could be addressed in future research.  
 The design of the bench-scale column filters was very basic.  This was in part due to 
limited resources.  Filters were designed with graduated cylinders and were not equipped with an 
upper receptacle to maintain constant head.  Manual dosing introduced variability in flow rates 
which was dependent on how quickly the columns were refilled to maximum head.  They were 
not designed to meet the specifications of any existing ISSF or BSF.  Maximum head and sand 
bed depth were determined based on available supplies for filter construction.  Filter operation 
was also not optimized based on ISSF or BSF guidelines.  Optimal conditions for schmutzdecke 
growth were not prioritized.  Absence of the diffuser plate and weekly cleaning procedures likely 
disrupted any biological growth on the top of the sand media bed.  Idle time within the filter was 
also not maximized, as is suggested in BSF operation.  Idle time within the filter, which allows 
for biological processes to occur, accounts for much of the virus attenuation typically observed 
in BSF use (Elliott et al., 2011).  The sand types used in this study were purposely chosen based 
on typical grain size ranges for BSFs and RSFs; however, the target filtration rate ranges were a 
compromise based on column design limitations.  Filtration rates were maintained within a 
certain range over the course of the 57-day evaluation, but that range exceeded recommended 
rates for BSFs and was far below those recommended for RSFs (CAWST, 2012; Crittenden et 
al., 2012).  Maintaining filtration rate also eliminated a common variable, decline in filtration 
rate over time, used as a proxy for filter maturation and media aging.  Because these variables 
were effectively removed from the experimental design in this study, the mechanisms behind 
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enhanced microbial and turbidity reductions with chitosan and sand filtration are likely different 
than those documented for SSFs and BSFs.  Due to cost, time and personnel constraints, these 
mechanisms were not directly evaluated.  
 This study did not evaluate chitosan coagulation coupled with ISSF performance in terms 
of removal of protozoa.  For the purposes of this study, it was assumed that since protozoa are 
larger than bacteria and the removal technology studied was filtration, bacteria can serve as a 
proxy for protozoa and protozoan LRVs would likely be similar to or greater than achieved 
bacteria LRVs.   
 Variability in LRVs for bacteria, viruses and turbidity may be attributable to variable 
water qualities, weekly scouring procedures, column design and filter maturation rates.  
Differences in observed LRVs between sand media types may be due to a variety of factors 
including flow rates, grain sizes and inorganic composition.  Without further investigation, it is 
not possible to determine the extent to which each of these factors had an impact on LRVs. This 
study did coincide with the fall turnover event at University Lake, and some variability in LRVs 
may be associated with changes in water quality parameters over that time.  The changing lake 
water conditions on chitosan coagulation efficacy were not directly evaluated in this research.  
Unintended consequences of using chitosan with granular media filtration systems, 
including accelerated filter clogging, impacts on other water quality variables such as taste and 
odor as aesthetic concerns and impacts on microbial communities within the filter, were not 
systematically evaluated in this study.   
There are a few notable limitations to extending these results to field use conditions.  The 
challenge water used was of relatively good quality because it is from a protected source water of 
a drinking water supply.  Therefore, it is unclear how chitosan pretreatment followed by sand 
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filtration will perform with surface waters of poor quality.  Other indicator bacteria and viruses 
that resemble other common pathogenic microorganisms and pathogens themselves should be 
used to evaluate microbial reductions.  The size of the columns and daily charge volume were far 
smaller than sand filters used in field settings, so further studies evaluating treatment 
effectiveness at full-size should be conducted.  Finally, it is unclear how seasonal effects, 
including temperature and changes in source water quality, may impact chitosan-coagulation and 
filter performance.   
5.5 Future Work 
 
This study marks the first effort to demonstrate improved microbial reduction 
performance of intermittently-operated slow sand filtration systems by using chitosan 
coagulation-flocculation as a water pretreatment step.  Due to limited resources, only basic sand 
filtration systems using two different sand types were evaluated.  Many different aspects of 
conventional slow sand filtration and biosand filtration were not directly investigated in this 
research.  Despite the limitations of this study, the results presented here suggest that many 
different and promising directions can be pursued with regards to combining chitosan and slow 
sand filter technologies.   
Future work evaluating this treatment combination should be conducted with simple sand 
filtration systems both at bench- and full-scale with different filter design and operation 
parameters.  The operation and maintenance of the filters could closely resemble those used in 
this study, i.e. intermittently-operated, short residence times for water in the filter, and absence 
or limited biological removal mechanisms.  Studies could evaluate different operational filtration 
rates for sand filters receiving waters dosed with chitosans.  Reduced filtration rates may further 
enhance microbial removal for sand filters with chitosan pretreatment, potentially reaching 3-star 
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performance targets outlined by the WHO.  Additionally, faster filtration rates through the media 
bed may still provide substantial microbial and turbidity reductions at optimal chitosan doses, 
which could increase the quantity of water households could treat per day.  Different sand media 
compositions within the filter columns should also be evaluated, potentially with locally sourced 
materials, wider ranges of grain sizes and different inorganic compositions.  Adsorption of the 
chitosan-colloid floc particles to naturally-sourced sand media compositions may differ 
compared to the high-purity silica sand used in this study due to higher concentrations of iron 
and aluminum in natural granite or fine sand sources (Elliott et al., 2015).  It would be important 
to validate consistent improved performance for sand filters with chitosan in low resource 
settings where specific, specialized sand grain sources are not readily available.  Furthermore, 
only one sand bed depth (16 cm) was used in this investigation.  Different sand media bed depths 
should be studied to see if microbial removal performance of chitosan-coagulation followed by 
sand filtration is improved to 3-star performance targets in sand columns of greater depth.  
Finally, the maintenance procedure for the sand beds in this study did not result in substantial 
declines in contaminant removal performance.  Future studies could evaluate how different filter 
maintenance procedures improve or reduce filter performance.   These should be developed in 
the context of real-use-conditions with the end-user in mind to ensure the additional treatment 
barrier is not a burden to individuals and families.  
The design and operating parameters in this investigation were not an optimal 
environment for the facilitation of the biological mechanisms typically employed in SSFs and 
BSFs.  Coagulation with chitosan may improve filter performance for traditional designs of BSFs 
and SSFs if use conditions are optimized.  Future work should specifically study influences 
chitosan may have on filter maturation, schmutzdecke development, decline in filtration rates 
 127 
over time and development of microbial communities within BSFs.  This study did not 
investigate how the quality of water stored within the filter during idle times between doses 
changes with chitosan pretreatment.  Future work should evaluate how chitosan impacts microbe 
attenuation during idle times.  Furthermore, this study did not evaluate how chitosan may impact 
dissolved oxygen within the filter media bed.  Future research should evaluate if chitosan 
accelerates or decelerates the development of anoxic conditions when used with traditional BSF 
setups.  The results of this investigation do identify a chitosan dose that consistently achieves 
high microbial and turbidity reductions over time with sand filtration.  Any future work with 
BSFs should further narrow the range of effective chitosan doses with this filtration technology.  
The established chitosan dose should be effective over a range of influent water qualities so the 
suggested use conditions are not drastically different based on geographic location or water 
service level.  An alternative to a single optimized dose for all conditions would be a stepwise, 
incremental dose increase based on generic source water quality indicators such as appearance 
and water source characteristics.  This would translate to an easily adjustable coagulant dosing 
system based on the needs of the individual household.   
Ultimately, the optimization of chitosan coagulation with POU sand filters should be 
household-oriented.  Any proposed use conditions, dosing mechanisms or maintenance 
procedures should keep the end-user in mind.  Chitosan as a pretreatment mechanism prior to 
granular media filtration is only effective if it is used consistently.  The market infrastructure for 
BSFs and ISSFs is already globally established.  The development of a chitosan coagulation 
POU treatment product should be studied and optimized in a user-focused manner, based on 
ease-of-use, low-costs and sustainable adoption.  Keeping operating parameters for BSFs and 
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SSFs simple, despite the additional chitosan pretreatment step, should be an important 




CHAPTER 6: SUMMARY AND CONCLUSIONS 
 This study reports the first results evaluating the effectiveness of using chitosans as a 
coagulation-flocculation pretreatment in natural waters to improve the removal capacity of 
bacteria, viruses and turbidity by intermittently-operated slow sand filtration.  Extensive 
reductions of bacteria, viruses and turbidity were achieved by sand columns dosed with 10 mg/L 
and 30 mg/L chitosan-pretreated water.  Sand columns dosed with water treated with 10 mg/L 
met the protective performance targets specified by the WHO for HWT technologies.  Filter 
performance varied over time, possibly due to scouring procedures, variable source water quality 
and inconsistent flow rates.  
These results were observed in simply-designed, intermittently-operated, falling-head 
sand filter setups.  Variables such as filter media characteristics, filtration rate, microbial 
communities, source water quality and mechanisms for microbial reduction were not directly 
investigated in this study.  Despite these limitations and further research questions, this study 
demonstrates that intermittently-operated slow sand filtration can be significantly improved 
using chitosan as a coagulant-flocculant pretreatment step.  The chitosan coagulation-
flocculation pretreatment step should be further optimized with granular filtration technologies to 
improve these POU systems.   
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APPENDIX 1: ACCUSAND U.S. SIEVE ANALYSIS PROVIDED BY UNIMIN 
CORPORATION 
 
Sieve Size (mm) 
mm 
Sieve Size, U.S. 
Sieves (mesh) 
mesh 
Accusand 30/40 Accusand 40/60 Accusand 50/70 
0.84 20 0 0 0 
0.59 30 0.6 0 0 
0.5 35 56.1 0 0 
0.42 40 42.5 0 0 
0.345 45 0.8 2.7 0.1 
0.3 50 0.1 80.4 1 
0.25 60 0 15.8 57.4 
0.21 70 0 1.1 37.7 
0.149 100 0 0 3.8 
 




APPENDIX 2: FULL CHARACTERIZATION OF SILICA SAND MEDIA CONDUCTED 






APPENDIX 3: PARTICLE SIZE ANALYSIS OF SILICA SAND MEDIA CONDUCTED 











APPENDIX 4: CERTIFICATE OF ANALYSIS FOR FOOD GRADE CHITOSAN 





APPENDIX 5: E. COLI KO11 LRVS FOR ALL FILTERS OVER 57-DAY OPERATING TIME 
 
E. coli KO11 LRVs 
Duplicate Filter # Sand Type Dose (mg/L) 
Filter Operating Time (indicates specific days of sampling over the 57-day experiment) 
1 6 9 13 15 20 23 27 29 34 36 41 43 50 52 55 57 
1 Accusand 0 0.09 0.68 0.00 0.16 0.07 0.22 0.33 0.27 0.21 0.31 0.46 0.72 0.61 0.62 0.46 1.11 0.82 
2 Accusand 0 0.22 0.41 0.06 0.06 0.19 0.24 0.30 0.13 0.30 0.22 0.40 0.53 0.60 0.98 0.46 1.07 0.91 
1 Accusand 3 0.30 0.36 0.57 0.68 0.85 0.96 0.64 0.16 0.50 0.28 0.28 1.24 0.99 1.78 2.54 2.39 2.70 
2 Accusand 3 0.29 0.60 0.49 0.77 0.87 0.98 0.67 0.27 0.37 0.26 0.15 1.13 0.98 1.68 2.34 2.41 2.55 
1 Accusand 10 5.06 5.49 4.72 4.99 5.37 5.31 5.60 3.06 3.31 3.05 3.05 5.14 5.58 4.81 4.98 5.83 4.86 
2 Accusand 10 4.95 4.82 4.19 4.75 5.37 5.46 5.46 3.26 3.48 2.60 2.99 5.58 5.88 5.22 6.03 5.39 5.27 
1 Accusand 30 1.20 0.31 0.33 1.10 0.53 1.27 2.64 4.91 5.21 5.70 6.03 6.43 6.52 5.80 6.39 5.89 4.84 
2 Accusand 30 1.19 0.30 0.38 1.66 0.50 4.66 4.98 4.51 5.87 6.18 6.03 6.43 6.22 5.15 5.69 6.49 4.98 
 
1 silica 0 0.06 0.13 -0.03 -0.02 0.09 0.12 0.18 0.23 0.06 0.40 0.12 0.23 0.35 -0.15 0.30 0.41 0.15 
2 silica 0 0.13 0.13 -0.02 -0.14 0.16 -0.02 0.17 0.15 0.02 0.19 0.13 0.34 0.41 0.13 0.62 0.43 0.11 
1 silica 3 0.37 0.53 0.19 0.51 0.80 0.73 0.41 0.13 0.23 0.40 0.21 0.99 0.56 3.88 3.32 2.31 2.62 
2 silica 3 0.28 0.32 0.27 0.55 0.82 0.99 0.29 0.18 0.16 0.27 0.10 0.69 0.55 3.96 3.20 2.59 2.56 
1 silica 10 4.14 4.49 3.95 3.93 5.22 4.65 4.68 2.89 3.81 2.92 3.07 5.14 5.18 2.89 3.71 3.94 3.02 
2 silica 10 3.90 4.06 4.03 3.72 4.74 4.36 4.71 2.60 3.15 2.92 3.07 5.18 5.07 3.12 3.70 3.65 3.04 
1 silica 30 0.54 0.46 0.31 0.43 0.68 1.24 0.72 0.93 1.06 1.00 1.85 3.09 3.75 2.28 3.28 3.28 2.68 





APPENDIX 6: MS2 COLIPHAGE LRVS FOR ALL FILTERS OVER 57-DAY OPERATING TIME 
 
MS2 Coliphage LRVs 
Duplicate Filter # Sand Type Dose (mg/L) 
Filter Operating Time (indicates specific days of sampling over the 57-day experiment) 
1 6 9 13 15 20 23 27 29 34 36 41 43 50 52 55 57 
1 Accusand 0 0.27 0.09 -0.25 -0.23 0.52 0.09 0.15 0.20 0.32 -0.11 0.09 0.17 0.07 1.95 0.70 1.11 1.01 
2 Accusand 0 0.64 -0.16 -0.26 -0.02 0.32 0.09 0.07 0.00 0.28 -0.20 0.11 -0.01 0.00 1.89 0.51 0.80 1.06 
1 Accusand 3 0.41 0.92 0.26 1.13 1.96 1.65 0.82 0.51 0.60 0.25 0.27 1.38 1.61 2.73 3.96 3.59 3.51 
2 Accusand 3 0.47 0.94 0.90 0.99 1.88 1.75 0.77 0.63 0.70 0.42 0.22 1.71 1.96 2.79 4.00 2.98 3.89 
1 Accusand 10 4.07 5.98 5.33 4.54 5.17 5.18 5.56 3.43 4.21 4.10 3.78 3.26 3.64 4.33 4.03 4.92 3.94 
2 Accusand 10 3.77 5.28 4.50 4.39 4.95 5.23 5.24 3.37 4.31 4.56 4.03 3.54 3.97 4.60 4.34 4.28 3.65 
1 Accusand 30 2.48 1.46 1.38 3.17 2.91 3.10 4.04 4.12 4.60 4.71 4.85 5.22 5.05 4.64 4.86 5.33 4.03 
2 Accusand 30 3.80 1.53 1.87 3.58 2.91 3.91 4.45 4.67 5.07 4.72 5.08 5.55 5.12 4.77 5.08 4.85 4.29 
 
1 silica 0 -0.19 0.07 -0.55 0.07 0.94 0.62 0.27 0.35 0.67 -0.13 0.35 0.40 0.33 0.80 0.65 0.99 0.35 
2 silica 0 0.35 0.56 -0.80 0.13 0.65 0.50 0.27 0.26 0.28 -0.35 0.27 0.25 0.05 0.39 0.54 0.30 0.28 
1 silica 3 0.73 0.12 -0.55 1.10 1.37 1.23 0.85 0.40 0.28 0.81 0.08 1.15 0.96 2.52 2.75 2.63 2.44 
2 silica 3 0.52 0.36 -0.16 1.13 1.75 1.33 1.01 0.47 0.49 0.30 0.10 1.16 1.25 2.54 2.61 2.22 2.72 
1 silica 10 3.26 3.88 4.73 4.28 5.11 4.92 4.60 3.80 3.49 3.57 3.29 3.46 3.58 4.36 3.92 3.59 3.36 
2 silica 10 3.60 4.08 4.55 4.07 5.04 4.60 4.35 3.42 2.93 3.18 2.99 2.43 2.61 4.93 4.24 3.57 3.25 
1 silica 30 1.43 1.42 1.23 2.55 2.50 2.72 2.78 2.20 2.01 1.66 2.21 2.96 3.50 2.55 2.54 3.12 2.19 




APPENDIX 7: TURBIDITY LRVS FOR ALL FILTERS OVER 57-DAY OPERATING TIME 
 
Turbidity LRVs 
Duplicate Filter # Sand Type Dose (mg/L) 
Filter Operating Time (indicates specific days of sampling over the 57-day experiment) 
1 6 9 13 15 20 23 27 29 34 36 41 43 50 52 55 57 
1 Accusand 0 0.18 -0.68 -0.03 -0.13 0.18 0.18 0.34 -0.24 -0.83 0.19 0.13 -0.04 -0.01 0.30 0.33 0.38 0.32 
2 Accusand 0 0.28 0.34 -0.03 0.09 0.36 0.28 0.62 -0.01 -0.09 0.24 0.15 0.12 0.04 0.26 0.31 0.35 0.36 
1 Accusand 3 0.62 0.16 0.49 1.02 0.65 0.62 0.52 0.34 0.13 0.32 0.23 0.89 0.81 1.25 1.33 1.07 1.15 
2 Accusand 3 0.41 0.36 0.46 0.55 0.52 0.41 0.48 0.18 0.17 0.37 0.04 0.80 0.84 1.06 1.25 1.02 1.05 
1 Accusand 10 0.70 0.22 0.56 0.88 0.88 0.70 0.84 1.37 1.15 1.14 1.17 1.27 1.02 1.54 1.16 1.10 1.13 
2 Accusand 10 0.62 0.77 0.72 0.73 0.81 0.62 0.68 1.34 1.26 1.35 1.30 1.37 1.22 1.58 1.41 1.00 1.27 
1 Accusand 30 0.62 0.25 0.06 0.47 -0.03 0.62 0.59 1.11 1.05 1.15 1.23 0.75 0.73 0.85 1.21 0.60 0.74 
2 Accusand 30 0.38 0.28 0.19 0.31 0.11 0.38 0.27 1.04 1.05 1.07 1.18 1.02 0.71 1.12 1.12 1.05 0.96 
 
1 silica 0 -0.25 -0.02 -0.10 0.06 0.16 -0.25 0.26 -0.05 -0.12 0.08 0.05 0.03 0.02 0.22 0.24 0.24 0.17 
2 silica 0 -0.14 -0.19 -0.03 -0.24 0.28 -0.14 0.39 -0.18 0.00 0.10 0.01 0.02 -0.05 0.19 0.22 0.21 0.19 
1 silica 3 0.46 -0.11 0.25 0.58 0.33 0.46 0.10 0.15 0.20 0.22 0.18 0.44 0.70 1.10 1.06 1.02 1.00 
2 silica 3 0.60 0.03 0.24 0.53 0.41 0.60 0.19 0.17 0.20 0.24 0.21 0.75 0.72 0.90 1.06 0.83 0.93 
1 silica 10 0.68 0.58 0.43 0.51 0.63 0.68 0.65 1.40 1.39 1.10 1.07 0.33 0.84 1.32 1.40 0.89 1.03 
2 silica 10 0.75 0.43 0.52 0.35 0.71 0.75 0.66 1.26 1.20 1.28 1.09 1.18 0.85 1.49 1.32 1.02 1.24 
1 silica 30 0.62 -0.23 -0.12 0.17 0.12 0.62 0.32 0.98 0.86 0.76 1.19 0.46 0.63 0.88 0.81 0.75 0.54 




APPENDIX 8: PERCENT DECREASE IN pH FOR ALL FILTERS OVER 57-DAY OPERATING TIME 
 
Percent Decrease in pH, influent to effluent (%) 
Duplicate Filter # Sand Type Dose (mg/L) 
Filter Operating Time (indicates specific days of sampling over the 57-day experiment) 
1 6 9 13 15 20 23 27 29 34 36 41 43 50 52 55 57 
1 Accusand 0 -5.85 0.14 -4.30 7.11 2.38 1.52 12.18 -5.79 6.01 1.10 -1.27 -22.06 3.15 -1.21 0.83 -0.27 2.51 
2 Accusand 0 -6.26 -1.68 -5.06 1.98 1.83 -2.00 8.79 0.79 6.63 0.83 -0.28 -10.83 -1.94 -0.54 1.11 0.80 1.86 
1 Accusand 3 -1.48 -6.05 -9.41 -7.41 5.33 -3.18 8.33 0.95 8.30 -1.25 -2.90 -10.22 7.03 -2.72 -3.85 -0.27 3.62 
2 Accusand 3 -1.73 2.90 -8.46 -6.64 -1.17 0.14 8.46 -2.37 7.32 -1.39 0.53 -10.85 8.27 4.90 0.55 -0.41 3.62 
1 Accusand 10 0.75 0.54 -4.94 1.14 -6.07 2.86 5.38 -1.68 5.94 -1.79 -1.39 -15.85 11.62 4.17 -0.69 0.00 1.72 
2 Accusand 10 2.34 6.53 -4.65 2.39 -6.37 -2.00 6.03 0.82 6.32 -3.21 -1.39 -5.70 13.91 3.54 -0.41 0.41 0.67 
1 Accusand 30 -0.37 -0.82 -5.71 2.56 5.04 -0.28 -1.80 -4.89 5.77 0.55 -0.98 -1.21 4.17 1.97 -0.41 1.62 1.73 
2 Accusand 30 -1.51 1.21 -5.71 3.93 -5.60 2.86 5.63 -4.31 5.90 1.09 -1.84 -14.79 3.42 1.06 0.41 1.35 2.51 
 
1 silica 0 -2.09 0.41 -5.67 -0.87 -2.65 -5.32 4.99 -3.03 5.88 2.83 5.91 -1.91 8.56 -2.32 1.92 -2.06 4.52 
2 silica 0 -3.87 -9.02 -6.13 5.98 4.78 -0.14 8.30 -4.46 6.63 0.14 5.03 -10.01 7.06 -6.68 1.38 -0.13 5.74 
1 silica 3 -5.94 6.00 -2.02 -0.14 8.94 3.26 12.00 -0.55 3.33 -0.83 -6.59 -7.28 7.90 4.14 -1.96 -1.80 -0.13 
2 silica 3 -1.23 -0.27 -2.86 -7.26 3.35 -0.14 11.76 1.21 3.73 -2.10 -2.76 -0.79 6.39 3.75 -1.39 -0.27 0.80 
1 silica 10 1.12 6.41 -1.09 0.00 -6.37 1.25 3.52 0.14 3.86 -2.35 -1.53 -30.36 8.94 -0.14 1.88 -1.80 4.25 
2 silica 10 1.73 4.95 -2.20 6.21 -2.60 3.52 5.90 0.41 4.26 -2.21 -2.39 -17.47 10.42 0.67 2.01 -1.38 2.23 
1 silica 30 0.98 4.54 -7.39 1.01 2.19 3.39 -2.50 -3.87 3.44 2.43 0.55 -1.76 0.27 -2.47 -0.83 -0.69 3.28 





APPENDIX 9: FILTRATION RATE FOR ALL FILTERS OVER 57-DAY OPERATING TIME 
 
Filtration Rate (m/hr) 
Duplicate Filter # Sand Type Dose (mg/L) 
Filter Operating Time (indicates specific days of sampling over the 57-day experiment) 
1 9 13 15 20 23 27 29 34 36 41 43 50 52 55 57 
1 Accusand 0 0.75 0.45 0.58 0.46 0.48 0.41 0.35 0.53 0.58 0.36 0.66 0.62 0.53 0.64 0.74 0.68 
2 Accusand 0 0.58 0.48 0.73 0.50 0.57 0.46 0.35 0.43 0.61 0.35 0.61 0.63 0.46 0.82 0.74 0.65 
1 Accusand 3 0.66 0.29 0.54 0.35 0.42 0.47 0.47 0.50 0.42 0.62 0.46 0.57 0.68 0.89 0.59 0.82 
2 Accusand 3 0.72 0.27 0.45 0.47 0.41 0.37 0.42 0.50 0.46 0.52 0.49 0.53 0.60 0.71 0.56 0.60 
1 Accusand 10 0.59 0.53 0.51 0.58 0.86 0.51 0.61 0.48 0.46 0.67 0.85 0.74 0.55 1.04 0.88 0.97 
2 Accusand 10 0.72 0.75 0.60 0.66 0.81 0.59 0.55 0.54 0.46 0.64 0.71 0.68 0.77 0.83 0.83 0.68 
1 Accusand 30 0.37 0.39 0.44 0.39 0.60 0.60 0.32 0.40 0.45 0.41 0.52 0.64 0.57 0.65 0.63 0.84 
2 Accusand 30 0.45 0.47 0.38 0.51 0.36 0.56 0.32 0.39 0.39 0.55 0.36 0.59 0.64 0.73 0.53 0.75 
 
1 silica 0 1.77 1.88 1.35 1.73 1.77 1.48 1.15 1.57 1.71 0.82 1.77 1.03 1.49 1.30 1.57 1.55 
2 silica 0 2.25 1.45 1.08 0.66 1.21 1.59 0.78 1.77 1.38 1.30 1.66 1.12 1.41 1.35 1.67 1.27 
1 silica 3 2.25 0.95 0.97 0.62 0.25 0.95 0.64 0.61 0.99 0.72 0.63 0.94 1.22 1.27 1.35 1.42 
2 silica 3 2.09 1.48 1.01 0.81 0.24 0.93 0.91 0.81 1.16 0.70 1.44 1.19 1.03 1.59 1.12 1.64 
1 silica 10 2.01 1.67 1.36 1.11 1.05 1.55 1.44 0.70 0.89 0.80 0.93 0.93 1.10 1.24 1.42 1.25 
2 silica 10 2.15 1.66 1.29 1.57 1.64 1.49 1.24 0.90 1.21 0.75 1.17 1.31 1.06 1.12 1.36 1.44 
1 silica 30 1.46 1.32 1.51 1.22 1.20 1.04 0.64 0.76 1.16 0.87 0.81 0.73 1.28 1.08 0.89 1.06 
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